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ABSTRACT 
Lindsay M. Jaacks: The 3C Nutrition Ancillary Study: describing the integration of diet and 
disease self-management among adolescents and adults with type 1 diabetes in China 
(Under the direction of Elizabeth J. Mayer-Davis) 
 
The incidence of type 1 diabetes (T1D) is increasing in China and morbidity and 
mortality may be substantially higher there than in the U.S. While results of clinical trials support 
intensive disease self-management to reduce the risk of complications, our knowledge of self-
management practices in China is limited in scope and outdated. 
In order to address this gap, a cross-sectional study was conducted in Beijing from 
January-August 2013. Data collection entailed a fasting blood draw, a questionnaire, and three 
24-hour dietary recalls. Telephone administration of the 24-hour recalls was validated against 
in-person administration in a pilot study. Data on individuals without diabetes were from the 
China Health and Nutrition Survey. The aims were three-fold: among individuals with T1D in 
Beijing, 1) to describe the contribution of nutrition education to disease self-management and 
diet, 2) to compare their dietary intake to individuals without diabetes in Beijing, and 3) to use 
reduced rank regression to identify dietary pattern(s) that maximize the explained variation in 
key cardiometabolic risk factors.  
Participants (n=100) averaged 41.7 ±16.3 years old, diabetes duration, 11.8 ±9.7 years. 
Fewer than half of participants had “ever” met with a dietitian and only 18% had attended a 
diabetes education session that covered nutrition in the past 12 months. Nutrition therapy for 
T1D typically involved matching fixed insulin doses to a diet that was rigid with respect to 
amount and timing, rather than an individualized, flexible approach recommended by
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international Diabetes Associations. One effect of this was that participants with T1D had a 
significantly lower mean percentage of energy from carbohydrates and higher mean 
percentages of energy from fat and protein compared to a cohort of individuals without diabetes 
in Beijing. Finally, we identified a dietary pattern characterized by high intakes of wheat products 
and low-sugar cakes, and low intakes of beans and pickled vegetables that was significantly 
associated with lower HbA1c and LDL cholesterol.  
Together, these results highlight an important need for nutrition counseling for 
individuals with T1D in China that is consistent with current clinical practice guidelines to 
promote health and reduce risk for complications of diabetes.  
 v 
 
To my parents, for their unceasing support and encouragement. 
 vi 
 
ACKNOWLEDGEMENTS 
 
I am indebted to the individuals with type 1 diabetes in Beijing and the surrounding area 
whose participation made this study possible, and to my interviewers: Yang Xiao, Jing Lv, 
Wenjia Yang, Jia Liu, Han Feifei, and Lihua Zhang. I would also like to thank Wei Liu, who was 
integral to completing data collection in Beijing. Finally, I would like to acknowledge Linong Ji, 
who first invited me to China to learn about a disease, and ended up teaching me about a 
culture.  
This project was supported by funding from the Sanofi Global Scholars Program and the 
Fogarty International Center (5D43TW009077) and National Center for Advancing Translational 
Sciences (ULTR000083) of the U.S. National Institutes of Health. None of the aforementioned 
funding sources had a role in the design, analysis, or writing of this dissertation. 
 
 vii 
 
PREFACE 
 
Parts of this work were done in collaboration with other scientists.  The 3C Nutrition 
Ancillary Study (3CNAS) was designed in collaboration with Linong Ji at Peking University 
People’s Hospital and with the help of Elizabeth Mayer-Davis, Barry Popkin, Shufa Du, and 
Michelle Mendez at The University of North Carolina, Chapel Hill. Wei Liu at Peking University 
People’s Hospital was a co-project manager throughout the duration of data collection and was 
in charge of verifying the translation and submitting necessary documents to the Peking 
University Institutional Review Board. Without her ongoing assistance with data collection this 
project would not have been possible. 
Chapters 2 and 3 contain material published prior to writing this dissertation with the 
following citation: 
Jaacks LM, Liu W, Ji L, Mendez M, Du S, Crandell J, Rosamond W, Mayer-Davis EJ. 
Diabetes nutrition therapy and dietary intake among individuals with type 1 diabetes in 
China. Diabetic Medicine, 2014. 
 
Permission to include the article in its entirety in a Ph.D. dissertation was retained from John 
Wiley & Sons, Inc. (publisher of Diabetic Medicine). All co-authors have given me permission to 
include this work in my dissertation. 
Chapter 4 contains material accepted for publication in the Asia Pacific Journal of 
Clinical Nutrition published by HEC press. Chapter 5 represents unpublished research.  I 
prepared the 3CNAS dataset, completed all statistical analyses, and wrote the manuscript drafts 
corresponding to these chapters. For Chapter 4, Shufa Du assisted with preparing and cleaning 
the China Health and Nutrition Survey dataset. 
 viii 
 
My committee, as well as Shufa Du, Wei Liu, Linong Ji, and for Chapter 5, Archana 
Lamichhane, provided valuable feedback throughout the analysis and writing process. 
 ix 
 
TABLE OF CONTENTS 
 
LIST OF TABLES ..................................................................................................................... xiii 
LIST OF FIGURES ................................................................................................................... xv 
LIST OF ABBREVIATIONS ...................................................................................................... xvi 
CHAPTER 1:   BACKGROUND AND RATIONALE .................................................................... 1 
Section 1.1   Pathophysiology of type 1 diabetes .................................................................... 1 
Section 1.1.1   Classification ............................................................................................... 1 
Section 1.1.2   Etiology ....................................................................................................... 2 
Section 1.1.3   Diagnosis .................................................................................................... 2 
Section 1.2   Epidemiology of type 1 diabetes ........................................................................ 3 
Section 1.2.1   Prevalence and incidence ........................................................................... 3 
Section 1.2.2   Long-term complications and mortality ........................................................ 5 
Section 1.3   Treatment of type 1 diabetes.............................................................................. 7 
Section 1.3.1   Self-monitoring of blood glucose and insulin therapy ................................... 8 
Section 1.3.2   Diabetes nutrition therapy ............................................................................ 9 
Section 1.3.3   Comorbidities .............................................................................................10 
Section 1.4   Burden of type 1 diabetes in China ...................................................................11 
Section 1.5   Type 1 diabetes treatment barriers in China ......................................................12 
Section 1.5.1   Limitations of healthcare providers and the healthcare system ...................13 
Section 1.5.2   Diabetes self-management education is difficult to obtain ..........................14 
Section 1.5.3   Blood glucose monitoring and insulin regimens remain suboptimal ............15 
Section 1.6   Comorbidities, complications, and mortality in China ........................................16
 x 
 
Section 1.7   Need for Chinese standards of medical care for type 1 diabetes .......................17 
Section 1.7.1   Unique and dynamic Chinese food environment ........................................17 
Section 1.7.2   Evidence of positive effect of recommendations in China ...........................20 
Section 1.8   The 3C Nutrition Ancillary Study: improving our understanding                           
of current self-management practices among adolescents and adults with                           
type 1 diabetes in China ........................................................................................................20 
CHAPTER 2:   RELATIVE VALIDITY OF TELEPHONE VERSUS FACE-TO-FACE                  
24-HOUR DIETARY RECALLS IN ADULTS WITH TYPE 1 DIABETES IN CHINA ...................22 
2.1   Introduction ....................................................................................................................22 
2.2   Methods .........................................................................................................................23 
2.3   Results ..........................................................................................................................24 
2.4   Discussion .....................................................................................................................26 
CHAPTER 3:   DIABETES NUTRITION EDUCATION AND DIETARY INTAKE                
AMONG INDIVIDUALS WITH TYPE 1 DIABETES IN CHINA ...................................................29 
3.1   Introduction ....................................................................................................................29 
3.2   Methods .........................................................................................................................30 
3.2.1   Sample population ..................................................................................................30 
3.2.2   Diabetes nutrition therapy assessment ....................................................................30 
3.2.3   Dietary intake assessment ......................................................................................31 
3.2.4   Covariates ...............................................................................................................31 
3.2.5   Statistical analysis ...................................................................................................31 
3.3   Results ..........................................................................................................................32 
3.4   Discussion .....................................................................................................................41 
3.5   Supplemental figures and tables ....................................................................................45 
CHAPTER 4:   COMPARISON OF THE DIETARY INTAKES OF INDIVIDUALS                   
WITH AND WITHOUT TYPE 1 DIABETES IN CHINA ...............................................................50 
4.1   Introduction ....................................................................................................................50 
4.2   Methods .........................................................................................................................51 
4.2.1   Study samples ........................................................................................................51 
 xi 
 
4.2.2   Dietary intake assessment ......................................................................................51 
4.2.3   Covariate assessment .............................................................................................52 
4.2.4   Statistical analysis ...................................................................................................53 
4.3   Results ..........................................................................................................................54 
4.4   Discussion .....................................................................................................................62 
4.5   Supplemental figure .......................................................................................................67 
CHAPTER 5:   DIETARY PATTERNS ASSOCIATED WITH HBA1C AND                               
LDL CHOLESTEROL AMONG INDIVIDUALS WITH TYPE 1 DIABETES IN CHINA ................68 
5.1   Introduction ....................................................................................................................68 
5.2   Methods .........................................................................................................................69 
5.2.1   Sample population ..................................................................................................69 
5.2.2   Data collection ........................................................................................................69 
5.2.3   Statistical analysis ...................................................................................................71 
5.3   Results ..........................................................................................................................72 
5.4   Discussion .....................................................................................................................81 
5.5   Supplemental tables ......................................................................................................84 
CHAPTER 6:   CHALLENGES ..................................................................................................85 
6.1   Data collection ...............................................................................................................85 
6.1.1   Institutional Review Board approval ........................................................................85 
6.1.2   Recruitment.............................................................................................................87 
6.1.2.1   Following up with 3C Study participants ............................................................87 
6.1.2.2   Type 1 diabetes stigma .....................................................................................87 
6.1.3   Dietary assessment .................................................................................................88 
6.1.4   Conversion of food lists into nutrients ......................................................................91 
6.2   Data analysis .................................................................................................................92 
6.2.1   Small sample size ...................................................................................................92 
6.2.1.1   Implications for subgroup analyses within 3CNAS ............................................94 
 xii 
 
6.2.1.2   Implications for comparing 3CNAS to SEARCH for Diabetes in Youth ..............95 
6.2.2   Selection bias ..........................................................................................................96 
6.2.3   Dietary pattern analysis ......................................................................................... 100 
6.2.3.1   Specification of predictor variables ................................................................. 100 
6.2.3.2   Selection of predictor variables ....................................................................... 104 
6.2.3.3   Selection of response variables ...................................................................... 107 
CHAPTER 7:   IMPLICATIONS AND FUTURE DIRECTIONS ................................................ 108 
7.1   Improving type 1 diabetes surveillance in China .......................................................... 108 
7.2   Improving type 1 diabetes care in China ...................................................................... 109 
7.2.1   Summary of key 3CNAS results ............................................................................ 109 
7.2.2   Gaps that remain in addressing 3CNAS specific aims ........................................... 110 
7.2.3   Next research questions........................................................................................ 112 
7.2.3.1   Improving training for healthcare providers ..................................................... 112 
7.2.3.2   Stigma and psychosocial issues ..................................................................... 114 
7.2.3.3   Improving access to and use of glucose monitoring supplies .......................... 116 
7.3   Translating results to type 1 diabetes in other resource-limited settings ....................... 117 
7.4   Concluding remarks ..................................................................................................... 119 
WORKS CITED ....................................................................................................................... 121 
 xiii 
 
LIST OF TABLES 
 
Table 1.1   Age-specific glycemic control targets for individuals with type 1 diabetes ................ 7 
Table 1.2   Summary of the American Diabetes Association’s recommendations                       
for self-monitoring of blood glucose (SMBG), HbA1c testing, and insulin therapy                       
for patients with type 1 diabetes ................................................................................................. 9 
Table 1.3   Summary of reported dietary intakes of populations in China ..................................19 
Table 2.1   Agreement between face-to-face and telephone administered 24-hour             
dietary recalls among adults with type 1 diabetes in China (n=13) ............................................25 
Table 3.1   Demographic and clinical characteristics of individuals with type 1                 
diabetes in China participating in the 3C Nutrition Ancillary Study .............................................33 
Table 3.2   Diabetes nutrition therapy and dietary intake according to insulin                    
regimen among individuals with type 1 diabetes in China .........................................................36 
Table 3.3 Estimated mean (standard error) nutrient and food group intakes,                    
adjusted for age and occupation, across groups of diabetes nutrition education                       
and therapy among individuals with type 1 diabetes in China ....................................................39 
Supplemental Table S3.1   Diabetes nutrition therapy and dietary intake according                  
to self-monitoring of blood glucose among individuals with type 1 diabetes in China ................46 
Supplemental Table S3.2   Relationship between diabetes nutrition therapy                  
variables among individuals with type 1 diabetes in China ........................................................48 
Supplemental Table S3.3   Comparison of characteristics of individuals with                         
type 1 diabetes in China meeting HbA1c goals and not meeting HbA1c goals ..........................49 
Table 4.1   Comparison of demographic and clinical characteristics between              
participants without diabetes and those with type 1 diabetes (T1D) in China,                  
combined and stratified by insulin regimen ................................................................................56 
Table 4.2   Comparison of nutrient intake between participants without diabetes                     
and those with type 1 diabetes (T1D) in China, combined and stratified by                          
insulin regimen ..........................................................................................................................58 
Table 4.3   Comparison of food group intake between participants without                       
diabetes and those with type 1 diabetes (T1D) in China, combined and stratified                       
by insulin regimen .....................................................................................................................60 
Table 5.1   Food groups strongly associated (factor loadings ≥0.25) with the dietary        
patterns obtained by reduced rank regression among individuals with                                     
type 1 diabetes in China (n=99) ................................................................................................74 
 xiv 
 
Table 5.2   Demographic and diabetes self-management characteristics                        
according to tertiles of dietary patterns obtained by reduced rank regression                      
among individuals with type 1 diabetes in China .......................................................................76 
Table 5.3   Bivariate associations of food groups that loaded heavily                               
(loadings ≥0.25) on the reduced rank regression-derived dietary patterns with                    
HbA1c and LDL cholesterol in individuals with type 1 diabetes in China (n=99) ........................78 
Supplemental Table S5.1   Food groups consumed by individuals with                                  
type 1 diabetes in China included in the reduced rank analysis .................................................84 
Table 6.1   External validity of 3C Nutrition Ancillary Study .......................................................98 
Table 6.2   Factor loadings for food groups that loaded heavily (factor loading ≥0.25)               
on dietary patterns derived using reduced rank regression after backwards                   
elimination of food groups ....................................................................................................... 105 
 xv 
 
LIST OF FIGURES 
 
Figure 1.1   Summary of long-term complications of type 1 diabetes ......................................... 6 
Figure 1.2 Hypothetical blood insulin levels on a) basal-bolus insulin regimens                       
and b) pre-mixed twice-daily insulin regimens. Arrows indicate insulin injections ....................... 8 
Figure 2.1   Bland-Altman plot for percentage of total energy from fat showing                     
mean agreement (---) and 95% limits of agreement (__) between telephone and                    
face-to-face administration of 24-hour recalls ............................................................................26 
Supplemental Figure S3.1   Directed acyclic graph for relationship between                   
meeting with a dietitian and fruit intake as drawn using the tool, www.dagitty.net.                   
Two minimal sufficient adjustment sets were identified for estimating the total                       
effect of meeting with a dietitian on fruit intake: {age, occupation} and {marital status, 
occupation} ...............................................................................................................................45 
Supplemental Figure S4.1   Directed acyclic graph for relationship between                  
diabetes status (yes or no, T1D) and dietary intake as drawn using the tool,          
www.dagitty.net. Body mass index (BMI) was identified as a collider. No minimal            
sufficient adjustment sets were identified for estimating the total effect of diabetes               
status on dietary intake. One minimal sufficient adjustment set was identified to              
estimate the direct effect of diabetes status on dietary intake: {education, income,              
marital status, occupation, and residence status (urban versus rural)} ......................................67 
Figure 5.1   Mean adjusted HbA1c (%) and 95% confidence intervals from analysis                  
of covariance according to tertiles of A) reduced rank regression-derived dietary                
pattern 1 score and B) dietary pattern 2 score among individuals with type 1 diabetes                
in China (n=99). Adjusted for age and household income. *p<0.05 comparing 1st and             
3rd tertiles .................................................................................................................................79 
Figure 5.2   Mean adjusted LDL cholesterol (mmol/L) and 95% confidence intervals              
from analysis of covariance according to tertiles of A) reduced rank regression-                 
derived dietary pattern 1 score and B) dietary pattern 2 score among individuals with             
type 1 diabetes in China (n=99). Adjusted for age and household income. *p<0.05       
comparing 1st and 3rd tertiles .....................................................................................................80 
Figure 6.1   Examples of culturally appropriate portion size picture guides from                     
book given to 3C Nutrition Ancillary Study participants in their Introductory Packet ...................90 
Figure 6.2   Participant flow in the 3C Nutrition Ancillary Study ................................................93 
Figure 6.3   Examples of bimodal distribution of residuals calculated for two food             
groups: a) rice and b) eggs ..................................................................................................... 103 
Figure 7.1   Overview of basic needs for type 1 diabetes in resource-limited settings............. 118 
 xvi 
 
LIST OF ABBREVIATIONS 
 
3CNAS   3C Nutrition Ancillary Study 
ADA    American Diabetes Association  
ANOVA   Analysis of variance 
ANCOVA   Analysis of covariance  
ACE   Angiotensin-converting enzyme 
ARB    Angiotensin receptor blocker  
BMI    Body mass index  
CVD    Cardiovascular disease  
CHNS    China Health and Nutrition Survey  
CIDE    China Initiative for Diabetes Excellence  
DAISY   Diabetes Autoimmunity Study in the Young  
DCCT    Diabetes Control and Complications Trial  
DERI    Diabetes Epidemiology Research International 
DIPP    Diabetes Prediction and Prevention Project 
DSME    Diabetes self-management education  
DKA    Diabetic ketoacidosis  
DBP    Diastolic blood pressure  
EMR    Electronic medical records  
EDIC    Epidemiology of Diabetes Interventions and Complications  
GAD    Glutamic acid decarboxylase  
HbA1c   Hemoglobin A1c  
HDL    High-density lipoprotein  
HLA    Human leukocyte antigen  
 xvii 
 
IRB    Institutional review board  
IA    Insulinoma-associated  
IDF    International Diabetes Federation  
ISPAD   International Society for Pediatric and Adolescent Diabetes  
ICC    Intraclass correlation coefficients  
LDL    Low-density lipoprotein  
MDI    Multiple daily injections  
PEDC    Pittsburgh Epidemiology of Diabetes Complications  
RAPIA   Rapid assessment protocol for insulin access 
RRR    Reduced rank regression  
SEARCH   SEARCH for Diabetes in Youth Study  
SMBG   Self-monitoring of blood glucose  
SBP    Systolic blood pressure  
TEDDY   The Environmental Determinants of Diabetes in the Young 
T1D    Type 1 diabetes  
T2D    Type 2 diabetes  
WHO    World Health Organization 
 1 
 
CHAPTER 1:   BACKGROUND AND RATIONALE 
Section 1.1   Pathophysiology of type 1 diabetes 
Section 1.1.1   Classification  
Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from 
impairments in insulin production, insulin action, or both. The American Diabetes Association 
(ADA) classifies diabetes into four clinical categories: type 1 diabetes (T1D), type 2 diabetes 
(T2D), gestational diabetes, and other diabetes including diabetes due to genetic defects and 
drug- and chemical-induced diabetes.1 The vast majority of diabetes cases are either T1D (5-
10% of cases) or T2D (90-95% of cases), where T1D is an autoimmune disease resulting in 
insulin deficiency and T2D is insulin resistance often associated with obesity;1 however, in some 
cases this distinction may not be clear-cut. For example, among youth (<20 years old) with 
physician-diagnosed T1D in the United States, 15% did not test positive for autoantibodies and 
26% had insulin resistance.2 The situation is further complicated in individuals with so-called 
“latent autoimmune diabetes in adults,” a classification that is still under debate.3-5 Much of this 
uncertainty stems from the fact that we do not understand immune-mediated beta cell failure in 
adults >30 years old.3 The work presented herein concerns autoimmune T1D occurring at any 
age that results in an absolute deficiency of endogenous insulin production.  
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Section 1.1.2   Etiology 
The interaction of genetic predisposition and environmental factors triggers a T-cell 
mediated autoimmune response that results in pancreatic islet inflammation (insulitis), beta cell 
apoptosis, and ultimately overt T1D.6-8 Support for the autoimmune pathogenesis of T1D comes 
from the presence of one or more markers of the humoral immune response at diagnosis in 
about 85-90% of patients,2,9,10 most commonly autoantibodies to insulin (IAA),11 glutamic acid 
decarboxylase (GAD65),12 the tyrosine phosphatase-like insulinoma-associated protein 2 (IA-
2A),13 and the cation efflux transporter ZnT8 (ZnT8Ab).9 However, the observation that insulitis 
affects few islets and is only present in about one-third of T1D cases highlights the fact that we 
do not fully understand the etiology of T1D.14 Three important studies, Diabetes Autoimmunity 
Study in the Young (DAISY) in the United States,15 Type 1 Diabetes Prediction and Prevention 
Project (DIPP) in Finland,16,17 and BABYDIAB in Germany,18 will continue to provide insight into 
the etiological processes leading up to T1D onset.  
Genetic susceptibility to T1D is predominantly determined by human leukocyte antigen 
(HLA) genotypes, though 41 other genetic loci have been identified in genome-wide association 
studies.19 The environmental trigger for T1D is unknown, though there is evidence to support a 
role of viral infection, the gut microbiome, vitamin D deficiency, and cow’s milk during infancy.20 
The Environmental Determinants of Diabetes in the Young (TEDDY) Study in the United States, 
Finland, Sweden, and Germany will prospectively explore these potential triggers in newborns 
born between 2004 and 2009 and followed for 15 years.21  
 
Section 1.1.3   Diagnosis 
To date, most studies of T1D incidence (number of new cases each year) have only 
enrolled children and adolescents, and have reported a peak age of onset of 10-14 years.22 
However, the disease can occur at any age. Indeed, life-table methods have estimated that the 
cumulative recurrence risk of T1D in siblings of individuals with T1D up to 18 years of age is 
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2.5%, up to 30 years is 6.4%, and up to 60 years is 9.6%.23 Furthermore, studies from South 
Africa,24 Ethiopia,25 and China26 have reported much later peak onset ages (early- to mid-
twenties). In younger patients, onset tends to be more acute with rapid beta cell destruction, 
while in older patients, symptoms are more moderate and beta cell destruction is less rapid 
making it difficult to distinguish from T2D.27 
Clinical manifestation of T1D is very heterogeneous, likely due to the multifactorial 
etiology of the disease and different ages of onset, discussed previously. Symptoms of the 
hyperglycemia that accompanies the onset of T1D typically include polyuria (excessive passage 
of urine), polydipsia (excessive thirst), weight loss, and in some cases polyphagia (excessive 
hunger) and blurred vision.1 Without medical attention, severe hyperglycemia can lead to 
diabetic ketoacidosis (DKA), and in serious cases, coma and even death.28 The prevalence of 
DKA at diagnosis of T1D in youth (<20 years) in the United States was most recently reported to 
be 31.1% (2008-2010), and has remained stable over time (30.2%, 2002-2003, and 29.1%, 
2004-2005).29 In Europe, the prevalence tends to be lower: 17.9% in Denmark (1996-2009),30 
18.9% in northern Finland (1992-2001),31 and 26.3% in southwestern Germany (1987-1997).32 
 
Section 1.2   Epidemiology of type 1 diabetes  
Section 1.2.1   Prevalence and incidence 
Worldwide, longitudinal prevalence and incidence data on T1D largely come from three 
studies of children and adolescents: the SEARCH for Diabetes in Youth Study (SEARCH) in the 
United States,33 the EURODIAB Study in Europe,34 and the World Health Organization’s (WHO) 
Multinational Project for Childhood Diabetes (DIAMOND Project).35 The DIAMOND Project 
collected data on T1D incidence from 50 countries worldwide between 1990 and 1999, and 
reported a 350-fold difference in T1D incidence in 0-14 year-olds between the lowest (China, 
0.1 cases per 100,000 per year) and highest (Sardinia, 36.8 cases per 100,000 per year) 
countries.22  
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More recently, results from SEARCH indicated that the prevalence of T1D in children 
and adolescents <20 years old in the United States in 2001 was 1.48 per 1000 and in 2009 it 
was 1.93 per 1000, an increase of 21.1% over 8 years after adjustment for completeness of 
ascertainment.36 The incidence of T1D in non-Hispanic SEARCH participants is also increasing: 
the age- and sex-adjusted incidence of T1D was 24.4 per 100,000 in 2002 and 27.4 per 
100,000 in 2009, a relative annual increase of 2.72%.37 Similarly, in Canada, the incidence in 0-
14 year-olds increased by a factor of 1.03 per 100,000 per year between 1987 and 2010,38 and 
in Europe (EURODIAB Study), the incidence increased by an average of 3-4% per year 
between 1989 and 2008.39 Some countries in Europe have reported a plateau in the incidence 
of T1D in children 0-14 years old: in Finland, the incidence increased annually by 3.6% from 
1988 to 2005 and then leveled off from 2005 to 2011,40 and in Sweden, the incidence leveled off 
from 2000 to 2007.41 
A few studies have also explored incidence rates in older age groups. One study in 
northern Italy reported an average annual increase of 4.3% in children (0-14 years old) and 
2.8% in young adults (15-29 years old) between 1984 and 2004 (difference not statistically 
significant).42 Further age-stratification in that study revealed the largest annual increase was in 
the 0-4 year-olds: 4.3% compared to 2.8% in 5-9 year-olds and 2.7% in 10-14 year-olds, but 
again, the difference was not statistically significant.42 Studies in Finland reported an average 
annual increase of 4.2% in children (0-14 years old)22 and 3.9% in young adults (15-39 years 
old) between 1992 and 2001.43 A study in West Yorkshire, United Kingdom, found that the 
incidence rate was stable in 15-29 year-olds (0.2% average increase per year) from 1991 to 
1999 while it increased, on average, 5.9% per year in 0-14 year-olds.44 In Antwerp, Belgium, an 
average annual increase of 1.8% was observed in 0-14 year-olds and 5.0% in 0-5 year-olds, but 
an average annual decrease of 3.8% was observed in 15-39 year-olds.45 Similar results were 
reported in 0-34 year-olds in Sweden between 1983 and 1998.46 Together, this scientific 
evidence suggests that the global increase in T1D is not only the result of an overall increase in 
 5 
 
disease incidence, but also earlier disease onset. Additional research, particularly in young 
adults, is needed to understand these complex age-period-cohort effects. 
 
Section 1.2.2   Long-term complications and mortality  
As the natural history of T1D progresses, individuals are at risk of developing several 
complications (Figure 1.1). Two seminal studies of T1D in the United States, the Diabetes 
Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications 
[DCCT/EDIC]47,48 and the Pittsburgh Epidemiology of Diabetes Complications (PEDC) study,49 
have reported the cumulative incidence of complications after a T1D duration of 30 years 
(individuals diagnosed in the 1980s). In the observational study (PEDC), 47% of participants 
developed retinopathy, 17% developed nephropathy, and 14% developed cardiovascular 
disease (CVD).50 The trial (DCCT/EDIC) participants who were randomized to conventional 
treatment had similar cumulative incidence rates to the observational cohort: 50% retinopathy, 
25% nephropathy, and 14% CVD.50 However, the trial participants who were randomized to 
intensive treatment had lower cumulative incidence rates: 21% retinopathy, 9% nephropathy, 
and 9% CVD.50 While these numbers are much improved relative to outcomes of individuals 
diagnosed in the 1950s-1970s,51-53 CVD rates remain significantly higher in adults with T1D 
relative to the general population.52 
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Diabetic retinopathy is the leading cause of blindness among adults aged 20-74 years,54 
however, the absolute risk of this functional impairment in the United States is actually quite low. 
For example, in the DCCT/EDIC conventional and intensive treatment groups, only 0.1% and 
1% of participants, respectively, developed blindness after 12 years of follow-up.50 In the PEDC 
study, only 4% of participants developed blindness after 18 years of follow-up.50 The cumulative 
incidence rate of blindness after 25 years of follow-up in a Danish registry was higher at 7.5%, a 
difference the authors attributed to lower rates of loss-to-follow-up in registry studies compared 
to other observational cohorts (blind patients may be more likely to drop out).55   
 The number one cause of death among individuals with T1D is CVD.56-58 While mortality 
rates among individuals with T1D have improved over time, they remain significantly higher than 
that of the general population.52,59,60 A recent analysis of 10 European countries (EURODIAB 
study) found that there were twice as many deaths as expected from national mortality rates 
among individuals diagnosed with T1D in childhood (<15 years of age).61 Age of onset 
influences mortality, with excess mortality compared to the general population being lower in 
individuals with late onset T1D (aged 15-29 years) versus individuals with early onset T1D 
 
Figure 1.1   Summary of long-term complications of type 1 diabetes 
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(aged 0-14 years),51 an observation consistent with lower rates of complications such as end-
stage renal disease, proliferative retinopathy, and microalbuminuria in those with later onset 
T1D.62-65 However, one study in Finland reported that individuals with early onset T1D had 
improved survival over time (1970 to 2007) while those with late onset T1D had an increase in 
mortality since the 1980s (though the cumulative mortality in the late onset group was quite low, 
1-1.5% over the first 15 years of the study).51 Furthermore, there is substantial geographic 
variation in mortality rates even among developed countries,66,67 suggesting that improvements 
in T1D treatment have not been shared equally across the globe. 
 
Section 1.3   Treatment of type 1 diabetes 
 Treatment goals for T1D are two-fold: 1) maintain tight glycemic control (Table 1.1) and 
2) reduce CVD risk factors such as hypertension and dyslipidemia.68 The most commonly used 
measure of glycemic control is glycated hemoglobin A1c (HbA1c), which is formed in a non-
enzymatic process when circulating hemoglobin in red blood cells is exposed to glucose, and 
therefore correlates with average blood glucose levels.69 
 
Table 1.1   Age-specific glycemic control targets for individuals 
with type 1 diabetes 
Age HbA1c target 
68
 
Corresponding 3-month 
average blood glucose 
69
 
≥20 years <7% 154 mg/dL 
13-19 years <7.5% 169 mg/dL 
6-12 years <8% 183 mg/dL 
0-6 years <8.5% 198 mg/dL 
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Section 1.3.1   Self-monitoring of blood glucose and insulin therapy 
The DCCT provided unequivocal evidence that tight glycemic control significantly 
reduces the risk of developing chronic complications of T1D.70,71 This level of glycemic control is 
typically achieved through intensifying self-monitoring of blood glucose (SMBG) and insulin 
dose adjustments.68,69 The ADA68 and other national standards of medical care, including those 
in Canada72 and Europe,73 now emphasize the use of a flexible T1D treatment regimen (Figure 
1.2). This involves using data from SMBG (typically 6-8 tests per day) to adjust insulin (typically 
3-4 injections per day of basal and prandial insulin analogs or an insulin pump), dietary intake, 
and physical activity in order to achieve blood glucose goals. A summary of self-management 
recommendations, goals, and corresponding patient education is provided in Table 1.2. 
 
 
Figure 1.2 Hypothetical blood insulin levels on a) basal-bolus insulin regimens and b) pre-mixed twice-
daily insulin regimens. Arrows indicate insulin injections 
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Table 1.2   Summary of the American Diabetes Association’s recommendations for self-
monitoring of blood glucose (SMBG), HbA1c testing, and insulin therapy for patients with type 1 
diabetes 
 Recommendations 
68
 Goals Education 
SMBG 
Prior to meals and snacks, 
occasionally postprandially, 
at bedtime, prior to 
exercise, when 
hypoglycemia is suspected, 
after treating hypoglycemia, 
and prior to critical tasks 
(e.g. driving) 
 
6-8 times per day 
Pre-prandial blood glucose 
70-130 mg/dL 
 
Peak postprandial blood 
glucose <180 mg/dL 
 
Prevent hypoglycemia 
 
 
What target blood 
glucose is 
 
How to use data to 
adjust food intake and 
exercise to achieve 
glycemic goals 
 
HbA1c 
testing 
4 times per year 
 
Decrease to 2 times per 
year if in good control  
Achieve HbA1c targets 
 
Goal should be 
individualized based on 
diabetes duration, age, 
comorbidities, and 
hypoglycemic unawareness 
What target HbA1c is 
Insulin 
therapy 
Multiple-dose insulin 
injections (3-4 per day of 
basal and prandial insulin) 
or insulin pump 
 
Match prandial insulin to 
carbohydrate intake, pre-
prandial blood glucose, and 
anticipated physical activity  
 
Use of insulin analogs 
(especially if hypoglycemia 
is a problem) 
Achieve HbA1c targets 
 
Prevent hypoglycemia 
How to adjust insulin to 
achieve glycemic goals 
 
 
Section 1.3.2   Diabetes nutrition therapy 
The coordination of insulin with dietary intake is essential among patients with T1D in 
order to maintain near-normal blood glucose levels and prevent acute and chronic 
complications. Both national72,74,75 and international76 Diabetes Associations recognize 
individualized diabetes nutrition therapy as an integral part of diabetes self-management. 
Several approaches are available for patients with T1D, including use of nutrient-based 
approaches (e.g. counting carbohydrates), glycemic index, and food-based approaches (e.g. 
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dietary exchanges). Evidence among youth with T1D in the United States suggests that the vast 
majority of patients have been taught carbohydrate counting77 and that use of this diabetes 
nutrition therapy approach is associated with improved glycemic control and reduced CVD 
risk.78,79 The ability of other diabetes nutrition therapy approaches to improve clinical outcomes 
among patients with T1D is not well-established.80 
Adherence to dietary recommendations has also been associated with improved 
metabolic outcomes81 and lower hypertension risk82 among individuals with T1D. However, 
neither youth83 nor adults84-87 with T1D in the United States and Europe are consuming healthful 
diets, particularly with respect to total fat, saturated fat, and sucrose.  
 
Section 1.3.3   Comorbidities 
Individuals with T1D have higher rates of hypertension compared to the general 
population.88 For example, in the United States (2000-2002), the prevalence of hypertension in 
a cohort of T1D patients with no history of coronary artery disease (mean age 37 years) was 
43% compared to only 15% in control participants (mean age 39 years).88 While patients with 
T1D in that study were significantly more likely to receive treatment for their hypertension 
compared to controls (87% versus 47%, respectively), only 64% of patients with T1D who 
received treatment achieved blood pressure control.88 The prevalence of hypertension was 
lower in the EURODIAB study (1989-1990; mean age 33 years): on average, across 16 
countries, 24%.89 Furthermore, the proportion of patients with T1D and hypertension who were 
receiving treatment in the EURODIAB study was much lower: only 42.2%.89 These observations 
are especially disconcerting because hypertension is a major risk factor for both CVD and 
microvascular complications (e.g. nephropathy).90 
Because of this increased risk of hypertension among individuals with T1D, blood 
pressure control is a key target of T1D care. The ADA recommendation for blood pressure is 
<140/80 mmHg (systolic blood pressure [SBP]/diastolic blood pressure [DBP]).90 Treatment to 
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reduce blood pressure includes lifestyle modifications (weight loss if overweight, DASH dietary 
pattern reducing sodium intake and increasing potassium intake, increased physical activity, 
and moderation of alcohol intake) and pharmacological therapy (angiotensin-converting enzyme 
[ACE] inhibitor or angiotensin receptor blocker [ARB] or multiple-drug therapy).90 
 The prevalence of dyslipidemia is also very high among individuals with T1D. For 
example, in the EURODIAB study, 45% of participants had a low-density lipoprotein (LDL)  
cholesterol >3.35 mmol/L and 12% of men and 8% of women had triglyceride levels >1.7 
mmol/L.91 In a large cohort of German and Austrian youth (0-26 years old) with T1D, 28.6% had 
dyslipidemia, but only 0.4% received medical treatment.92 Similarly, in a cohort of youth (mean 
age 15 years) with T1D in the United States (SEARCH study), 18.1% had high triglycerides and 
10.1% had high-density lipoprotein (HDL) cholesterol levels <40 mg/dL.93 Another key target of 
T1D care is therefore lipid management. The target for blood lipids are as follows: LDL 
cholesterol <100 mg/dL (2.6 mmol/L), triglycerides <150 mg/dL (1.7 mmol/L), and HDL 
cholesterol >40 mg/dL (1.0 mmol/L) for men and >50 mg/dL (1.3 mmol/L) for women.90 Similar 
to hypertension, treatment recommendations for dyslipidemia include both lifestyle modifications 
(reducing saturated fat, trans fat, and cholesterol intake, increasing omega-3 fatty acid and fiber 
intake, weight loss if overweight, and increased physical activity) and pharmacological therapy 
(statins).90 
 
Section 1.4   Burden of type 1 diabetes in China  
We do not know how many people in China are currently living with T1D. However, we 
do have some information regarding how many people develop T1D annually. Between 1990 
and 1999, the WHO DIAMOND Project94-99 was conducted at 23 centers across China covering 
a population of 19.5 million children, or about 7% of this age group in China.22 Two papers have 
been published regarding this data and have reported drastically different incidence rates. The 
first used data spanning a nine-year period (1988-1996) and excluding three of the 23 centers 
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that were missing data from a secondary independent source (Guilin, Xuzhou, and Zunyi).100  A 
total of 883 cases were registered at the remaining 20 centers and an overall incidence rate of 
0.59 per 100,000 person-years was reported.100 The second used data spanning a seven-year 
period (1990-1996), excluded only one of the 23 centers (Xuzhou), and reported an overall 
incidence rate of 0.1 per 100,000 person-years (ranging from 0.1 per 100,000 person-years in 
Zunyi to 4.5 per 100,000 person-years in Wuhan).22 
Beginning in 2000, the International Diabetes Federation (IDF) has published the 
Diabetes Atlas, a compilation of prevalence and incidence estimates for T1D and T2D around 
the world. The most recent edition (6th), published in 2013, continues to use estimates from the 
WHO DIAMOND Project (1990-1996) for T1D incidence in China.101 
Since the completion of the WHO DIAMOND Project, many of the participating centers 
have continued to register T1D cases. In Shanghai, for example, the WHO DIAMOND Project 
documented an average incidence rate of 0.61 per 100,000 person-years between 1980 and 
1991,102 and two subsequent studies have reported mean annual incidence rates: 0.96 per 
100,000 between 1989 and 199399 and 3.1 per 100,000 person-years between 1997 and 
2011.103 Similarly, a study conducted in Harbin between 1990 and 2000 reported a mean annual 
incidence rate of 0.73 per 100,000 person-years and a mean annual increase of 7.4% per 
year.104  
A national, hospital-based T1D registry in China (10 centers) is under development and 
will provide updated estimates of the incidence and the first estimates of the prevalence of T1D 
in China.  
 
Section 1.5   Type 1 diabetes treatment barriers in China 
Implementation of standards of medical care for T1D requires affordable and accessible 
insulin and self-monitoring supplies (e.g. glucose meters, lancets, and strips); a multidisciplinary 
healthcare team trained in T1D care; continuing diabetes education for patients; and familial, 
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institutional, and community support. These aspects of care are beginning to be addressed in 
urban China, but in most parts of the country, the implementation of standards of medical care 
remains an insurmountable challenge. Barriers to achieving treatment goals are discussed in 
detail in the sections that follow. 
 
Section 1.5.1   Limitations of healthcare providers and the healthcare system  
It is common for Chinese specialists such as endocrinologists to meet with over 100 
patients per day in outpatient departments, spending about 3 minutes with each patient.105 
These severe time limitations have undoubtedly contributed to poor patient-provider 
relationships in China, which in turn have led to a crisis of violence against healthcare 
providers.106 Another substantial barrier to improving interactions with patients in China is the 
lack of adoption of electronic medical records (EMR) despite research supporting positive 
effects on efficiency and effectiveness of care as well as provider and patient satisfaction.107 
While the Communist Party of China Central Committee emphasized that hospital EMRs should 
be a priority of healthcare reform in 2007108 and the Central Government allocated 1.5 billion 
USD to promote the use of health information technology in 2011,109 the use of this technology 
to monitor chronic diseases such as T1D over time has been limited. Patients continue to carry 
hard copies of their health records to outpatient department visits. Indeed, most research on 
EMR implementation in China has been conducted in inpatient departments with outcomes 
relating to hospitalization and infectious diseases.110,111  
Given the low incidence rate of T1D in China,22 physicians, including endocrinologists, 
rarely encounter T1D. In contrast, T2D is increasingly common throughout China: the 
prevalence among adults (≥18 years of age) is 11.6% (113.9 million adults),112 compared to 
12.3% among adults (≥20 years of age) in the United States.113 This lack of familiarity with T1D 
relative to T2D could lead to misdiagnosis or mistreatment, especially in more remote hospitals, 
as has been reported in other low- and middle-income countries.114 National healthcare provider 
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education programs such as the China Initiative for Diabetes Excellence (CIDE) have been 
shown to significantly improve diabetes knowledge,115 but largely focus on T2D. T1D-specific 
modules integrated into ongoing healthcare provider training have the potential to improve care, 
but must be tested in the context of China. 
 
Section 1.5.2   Diabetes self-management education is difficult to obtain 
The ADA and the International Society for Pediatric and Adolescent Diabetes (ISPAD) 
recommend ongoing, tailored diabetes self-management education (DSME) provided by a 
multidisciplinary healthcare team.68,116 DSME is typically divided into primary diabetes education 
(survival skills) and secondary diabetes education (continuing diabetes education curriculum 
contributing to an in-depth understanding of self-management).116 Survival skills include blood 
glucose targets, basic nutrition advice, an explanation of what to do for hyper- and 
hypoglycemia, how to handle diabetes during illness, and psychological issues concerning 
diabetes.116  Continuing diabetes education curriculums include, for example, meeting with a 
dietitian annually and receiving information about diabetes camps and other support groups.116 
The difficulty in obtaining DSME, particularly continuing diabetes education, is a major 
treatment barrier for patients with T1D in China. The first evidence of structured diabetes 
education in Mainland China was in 1990117 yet in 2004 fewer than 500 nurses were trained 
diabetes educators and few of these nurses had participated in a standardized training 
program.118 Indeed, there is currently no Chinese equivalent of the professional certified 
diabetes educator found in the United States and Europe, and therefore not only the quantity, 
but also the quality of diabetes education in China may be deficient. There are some signs of 
improvements in this area, particularly in Beijing, Shanghai, Jiangsu, and Guangdong, where a 
diabetes specialist training program for nurses has been initiated.119 Most patient education is 
administered by nurses or physicians, though dietitians have become increasingly accessible in 
endocrinology departments at tertiary hospitals. Multidisciplinary care is rare. Interestingly, a 
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recent systematic review of diabetes education interventions in China reported that half of the 
interventions were conducted in inpatient settings.117 The lack of diabetes educators and the 
common requirement for inpatient admission to receive diabetes education are significant 
barriers for patients with T1D. 
 
Section 1.5.3   Blood glucose monitoring and insulin regimens remain suboptimal 
Between 2001 and 2002, the IDF found that children and adolescents with T1D in China 
had the lowest mean daily insulin dose and the lowest frequency of SMBG among Western 
Pacific countries.120 Only 76% of youth in this study practiced SMBG, checking their blood 
glucose, on average, 8 times per month. This is a stark contrast to youth in the United States, 
75% of whom test ≥4 times per day.121 Furthermore, most children (68%) with T1D in China in 
the IDF study were on 1-2 insulin injections per day,120,121 in comparison to the United States, 
where only 27% of children are on 1-2 insulin injections per day.121  
The acute outcome of these suboptimal treatment regimens is poor glycemic control. 
Only 53% of patients in the IDF study had the recommended ≥3 HbA1c tests in the past year 
and the HbA1c for the sample at the time of the study was (mean ±SD) 9.5 ±1.9%,120 one 
percentage point higher than the average HbA1c among children with T1D in the United States 
(8.5 ±1.5%).121 Even children on 1-2 insulin injections per day in the United States achieved 
HbA1c levels (8.6 ±1.7%) lower than that reported in China.121 
Recent clinical trials conducted in China suggest that more intensive insulin regimens 
are safe and improve glycemic control in this population.122-124 However, cost remains a 
substantial barrier preventing patients from receiving adequate self-management supplies. 
Insulin is covered by insurance, but insulin injection tools (e.g. pens, needles, syringes, and 
pumps), blood glucose testing strips, and blood glucose meters are not. On average, one-third 
of an urban family’s income in China is spent on care for a patient with T1D.125 In rural villages it 
is conceivable that a more substantial proportion of the family’s income will be spent on care 
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and that families must make sacrifices in diabetes self-management (e.g. testing infrequently 
and using less insulin than prescribed) in order to accommodate this expense.  
 
Section 1.6   Comorbidities, complications, and mortality in China 
No study has evaluated the effectiveness of prevention interventions such as the DCCT 
in China, where the coexistence of diabetes with other CVD risk factors is exceptionally 
high.120,126 Data from 1998-1999 (Diabcare-Asia Study) suggest that 30% of patients with T1D in 
Asia also have hypertension and 11% smoke.126 More recent data from Guangdong, China, 
suggest that a similar proportion of T1D patients smoke (11.3%).26  Estimates from 2001-2002 
of hypertension in youth <15 years old with T1D in two centers in China suggest a hypertension 
prevalence of 24%.120  
There is limited data on complications and mortality from China. However, data from 
other East Asian countries may be informative. The Diabetes Epidemiology Research 
International (DERI) mortality study was launched in 1986 in four countries (United States, 
Finland, Japan, and Israel) and reported that Japan had a markedly higher age-adjusted 
mortality rate compared to the other three countries: 681 deaths per 100,000 person-years of 
diabetes in Japan compared to, for example, 230 deaths per 100,000 person-years of diabetes 
in the United States.127 At follow-up in that study (1985), 20% of Japanese participants 
diagnosed at 15-17 years of age had died compared to <8% of participants from the other three 
countries.127 The leading causes of death in the Japanese cohort were acute complications 
(42% of deaths) and end-stage renal disease (33% of deaths).128 More recent follow-up (2005) 
of the DERI cohort in Japan has shown that among individuals with T1D for more than 20 years, 
the leading cause of death is CVD.129 Of note, a comparison of participants within the DERI 
cohort in Japan showed that those who visited an integrated management system under 
specialists and a multidisciplinary team were three times less likely to die and five times less 
likely to develop end-stage renal disease compared to those who did not.130 
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 The Thailand Diabetes Registry Project has also provided valuable insight into T1D 
complications in Asia. In 2003, the Registry reported a prevalence of diabetic retinopathy among 
patients with T1D (mean T1D duration 9.2 years) of 21.6% and of diabetes-related legal 
blindness of 1.0%.131 A study conducted in Japan in 2004 (mean T1D duration 26.9 years) 
reported that 25.0% of males and 31.1% of females had proliferative diabetic retinopathy and 
25.0% of males and 22.2% of females had diabetic nephropathy.132 The prevalence of 
comorbidities was also high in this cohort: 53.6% of males and 42.2% of females had 
hypertension and 39.3% of males and 26.7% of females had dyslipidemia.132 An earlier study 
(1995) also conducted in Japan found a high prevalence of blindness: 23.3% in those 
diagnosed with T1D between 1965 and 1969 and 2.1% in those diagnosed with T1D between 
1975 and 1989, representing a significant decrease in the proportion of patients diagnosed with 
blindness over time.133 
 
Section 1.7   Need for Chinese standards of medical care for type 1 diabetes  
Although general treatment goals for T1D care (e.g. glycemic control and reducing CVD 
risk) are not different across countries and cultures, the optimal approach to achieving these 
goals will likely differ.  
 
Section 1.7.1   Unique and dynamic Chinese food environment 
Dietary intake is uniquely complex in China due to shared dishes, highly variable 
recipes, and a rapidly changing food environment. The China Health and Nutrition Survey 
(CHNS) has monitored the dietary intake of the Chinese general population since 1989.134 
Together, results from CHNS and several cross-sectional studies have improved our 
understanding of changes in dietary intake in China over the past 25 years (Table 1.3). In 
China, as in many other low- and middle-income countries, consumption of vegetable oils from 
frying food, animal-source foods, and away-from-home foods are increasing, as are snacking 
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behaviors.135-137 Given this confluence of factors, studies and recommendations based on 
Western diets, while increasingly more relevant in China, may not be entirely culturally 
appropriate. 
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Table 1.3   Summary of reported dietary intakes of populations in China 
Ref 
Study 
Sample Size;  
Age (mean or range) 
Method 
Energy 
(kcal/day) 
Carbohydrates Fat 
Fiber 
(g/day) 
Rice 
(g/day) 
Fruits 
(g/day) 
Vegetables 
(g/day) 
137 China Health and 
Nutrition Survey 
5000; 18-45 years 
 
24-hr 
recall 
2150  Not  
reported 
Not  
reported 
Not 
reported 
348  Not 
reported 
Not  
reported 
138 Chinese National 
Nutrition and Health 
Survey 
140,010; >18 years 
 
FFQ Not 
reported 
48.5% total kcal 
(urban) 
35.0% total 
kcal (urban) 
Not 
reported 
Not 
reported 
Not 
reported 
Not  
reported 
139 Shanghai Women’s 
Health Study 
191; 55.4 years  
 
FFQ 1665  284.2 g/day 27.4 g/day 9.9 310 377 335 
140 Shanghai Men’s 
Health Study 
195; 54.8 years  
FFQ 1929.5 318.5 g/day 32.5 g/day 11.5 364.3 132.3 348.8 
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Section 1.7.2   Evidence of positive effect of recommendations in China 
Implementation of population-specific recommendations by healthcare providers in 
China has the potential to result in improved adherence and glycemic control, and subsequently 
the prevention of complications. Researchers in Guangzhou Province recently reported that 
receiving a recommendation from a provider to get regular eye examinations was associated 
with having an eye examination in the last year among patients (>18 years) with diabetes.141 A 
individualized nutrition therapy intervention among 20 children (5-12 years) with T1D conducted 
in Sichuan Province in China reported significant improvements in nutrition knowledge and 
quality of life.142 
 
Section 1.8   The 3C Nutrition Ancillary Study: improving our understanding of current 
self-management practices among adolescents and adults with type 1 diabetes in China 
     
The incidence of T1D is increasing in China and morbidity and mortality in this 
population may be higher than in developed countries. While results of randomized controlled 
trials in the United States and Europe support intensive disease self-management to achieve 
tight glycemic control and reduce diabetes-related complications, our knowledge of self-
management practices in China is limited in scope and outdated. In order to address this gap, a 
cross-sectional study, called the 3C Nutrition Ancillary Study (3CNAS), was conducted in 
Beijing, China, from January to August 2013. Individuals were recruited from the participant 
roster of the 3C Study, an epidemiological study of the coverage, cost, and care of diabetes in 
Beijing and Shantou conducted in 2011. Data collection for 3CNAS entailed a fasting blood 
draw for risk factor assessment, a questionnaire for nutrition education and self-management 
practices, and three 24-hour recalls for dietary intake. Telephone administration of the 24-hour 
recalls was validated against in-person administration in a pilot study. The aims of the main 
study were three-fold: 1) to describe the contribution of diabetes nutrition therapy to disease 
self-management and dietary intake among individuals with T1D in Beijing, 2) to compare the 
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dietary intake of individuals with T1D to those without diabetes in Beijing, and 3) to use reduced 
rank regression (RRR) to identify dietary patterns maximizing the explained variation in two key 
health indicators, HbA1c and LDL cholesterol, among individuals with T1D in Beijing. All 
procedures were approved by the University of North Carolina Office of Human Research Ethics 
and the Peking University Biomedical Institutional Review Board, and all participants provided 
written informed consent (≥18 years of age) or written parent permission and participant assent 
(<18 years of age). The pilot study and each of the three aims are described in detail in the 
chapters that follow.  
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CHAPTER 2:   RELATIVE VALIDITY OF TELEPHONE VERSUS FACE-TO-FACE 24-HOUR 
DIETARY RECALLS IN ADULTS WITH TYPE 1 DIABETES IN CHINA 
 
2.1   Introduction 
While studies in Europe143,144 and the United States145-147 have not found significant 
differences in self-reported dietary intake when 24-hour recalls are administered via telephone 
instead of face-to-face, no study has evaluated the relative validity of 24-hour recalls 
administered via telephone in China where the diet is uniquely complex. Compounding the 
challenge of dietary assessment, individuals who are diagnosed with T1D are considered 
‘monsters’ by society.148 Because of this stigma, individuals with T1D often hide their disease; 
thus it would not be culturally acceptable for research staff to visit participants at their homes to 
conduct face-to-face 24-hour recalls. Furthermore, the participant burden of traveling to a clinic 
site to complete the multiple 24-hour recalls needed to assess usual dietary intake would be 
prohibitive, resulting in low compliance. These barriers could be addressed by using telephone 
administered 24-hour recalls.  
The aim of the Relative Validity Study presented in this chapter was to compare the 
results of two approaches to measuring dietary intake in individuals with T1D in China: the 
proposed method, telephone 24-hour recalls, and the widely accepted and implemented method 
in China, face-to-face 24-hour recalls.  
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2.2   Methods 
Informed by a priori power calculations, a random subset of 19 adults was selected to 
participate in the Relative Validity Study from a pool of 159 eligible 3C Study participants. 
Eligibility criteria included: ≥18 years of age, no severe diabetes complications (e.g. advanced 
micro- and macrovascular complications, including nephropathy and stroke), Beijing resident, 
and in-service telephone number available. Individuals expressing an interest in participating 
during a recruitment call were mailed an introductory packet containing instructions for a 
previous-day dietary recall, blank food and recipe record forms, and a portion size picture guide 
developed by the Chinese Center for Disease Control. Within one week of mailing the 
introductory packet participants were randomized to receive either the face-to-face interview 
followed by the telephone interview or vice-versa (46% telephone first). Participants were 
instructed to record their intakes using the forms provided on the day prior to the scheduled 
interviews, to be used as a memory prompt as in other studies.149,150 Interviews were conducted 
by trained study staff in Chinese on the same day with a minimum of six hours in between.  
The 24-hour recall was administered using a two-pass approach: 1) collect a detailed 
food list and 2) review and confirm the detailed food list. During the first pass, an outline of the 
previous day’s intake was collected. Interviewers probed for meal type, preparation setting, 
preparation method, and detailed information on any additions to the food, food type, brand 
names and portion size. During the second pass, the detailed food list was re-read and missing 
foods, beverages, and eating occasions were probed.  
Food lists were converted into nutrients and food groups using the most recent versions 
of the Chinese Food Composition Tables.151,152 Due to the non-normal distribution of the 
nutrients and food groups, aggregate agreement was evaluated using nonparametric Wilcoxon’s 
matched-pairs signed rank tests. Individual agreement between the two methods was visualized 
using Bland-Altman plots, and quantified using intraclass correlation coefficients (ICC) and 
Spearman’s rank correlation coefficients (rho). A sensitivity analysis was conducted comparing 
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the first and second interview, regardless of interview type; no differences were found between 
median intakes for any of the nutrients or food groups reported (all p >0.05). All statistical 
analyses were conducted using SAS 9.2 (SAS Institute, Cary, North Carolina).  
 
2.3   Results 
Of the 19 eligible participants recruited, two declined to participate due to time 
limitations, three did not attend their scheduled visit, and one refused to provide written consent 
(enrollment rate: 68%). Participants (n=13; 62% male) were (mean ±SD) 37 ±11 years old and 
had a T1D duration of 11 ±8.6 years.  
There were no statistically significant differences between median intakes for any of the 
nutrients or food groups reported by telephone versus face-to-face interview (all p<0.05; Table 
2.1). Power calculations for paired t-tests (α=0.05, n=13, SD=160 kcal, within-subject 
correlation=0.8) indicated that we had a 74% power to detect a mean difference in total energy 
intake of 80 kcal.  
The mean ICC was 0.79, ranging from 0.46 for fiber to 0.97 for energy (Table 2.1). 
Similarly, all rho values were significantly different from zero and all but two rho values (fiber, 
rho=0.60 and eggs, rho=0.61) were ≥0.75. The percent of participants with perfect agreement 
between telephone and face-to-face interviews for reported grams of the food groups ranged 
from 15% (n=2) for vegetables to 85% (n=11) for fruits. The percent of participants with 
agreement within 100 g was >90% for all food groups except vegetables (69%; n=9). Bland-
Altman plots did not support the existence of systematic biases between telephone and face-to-
face interviews (for example, percentage of total calories from fat, Figure 2.1).  
In sensitivity analyses, there were no differences between median intakes for any of the 
nutrients or food groups reported comparing the first versus second interview (all p >0.05; data 
not shown).  
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Table 2.1   Agreement between face-to-face and telephone administered 24-hour dietary recalls among adults with type 1 diabetes in 
China (n=13) 
 
Administration Method 
Difference in 
Means 
1
 
P- 
value 
2
 
ICC rho 
Face-to-face 
Median (25
th
-75
th
 percentile) 
Telephone
 
Median (25
th
-75
th
 percentile) 
Energy (kcal/day) 1467 (1334 – 1946) 1459 (1323 – 2134) 54 ± 101 0.07 0.97 0.96 
Fat (% kcal) 39.5 (28.1 – 43.7) 37.4 (30.5 – 39.7) 1.2 ± 7.6 0.24 0.77 0.75 
Carbohydrate (% kcal)  44.8 (41.0 – 53.2) 50.7 (41.3 – 52.4) -0.5 ± 6.0 0.79 0.86 0.92 
Protein (% kcal) 15.3 (13.1 – 17.2) 15.5 (14.2 – 17.7) -0.6 ± 2.1 0.17 0.71 0.77 
Fiber (g/1000 kcal) 7.3 (5.7 – 9.8) 8.4 (6.6 – 9.5) -0.2 ± 3.3 0.38 0.46 0.60 
Rice (g/day)  100 (75 – 200) 106 (80 – 190) 28 ± 94 0.63 0.68 0.91 
Wheat (g/day) 100 (70 – 110) 90 (20 – 200) -16 ± 65 0.63 0.86 0.94 
Vegetables (g/day) 260 (163 – 520) 265 (199 – 560) -3 ± 126 0.65 0.86 0.89 
Fruit (g/day)  0 (0 – 200) 0 (0 – 175) 18 ± 53 0.50 0.93 0.98 
Red meat (g/day) 50 (0 – 75) 50 (0 – 80) -6 ± 16 0.25 0.93 0.93 
Eggs (g/day) 60 (60 – 70) 60 (50 – 60) 2 ± 23 0.90 0.64 0.61 
 
1 
Mean ± SD difference between nutrient and food group means reported in face-to-face and telephone interviews. Negative values indicate 
telephone > face-to-face 
2 
Wilcoxon signed rank test 
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Figure 2.1   Bland-Altman plot for percentage of total energy from fat showing 
mean agreement (---) and 95% limits of agreement (
__
) between telephone and 
face-to-face administration of 24-hour recalls 
 
 
 
 
2.4   Discussion  
To our knowledge, this is the first study to evaluate the relative validity of telephone 
versus face-to-face 24-hour recalls in China. For all nutrients and food groups analyzed, results 
supported that telephone interviews are a reliable method compared to face-to-face interviews 
among individuals with T1D in China. A limited number of relative validity assessments have 
been conducted previously in China, all in non-diabetic adults, including a study validating a 
combined 24-hour recall and weighed household food record against  doubly-labeled water,153 
and a study validating face-to-face 24-hour recalls against household weighed food records.154  
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Although food frequency questionnaires have been validated for urban Chinese 
populations in the past 5 years,155,156 their use would not have been appropriate for our target 
population given that the diets of individuals with T1D may differ significantly from non-diabetics, 
especially in settings with limited access to blood glucose testing supplies and insulin. Because 
of the acute effects of dietary intake on blood glucose levels in individuals using exogenous 
insulin, we hypothesized that our target population would be more “food aware,” meaning that 
they could more easily recall foods and portion sizes than the general population. Furthermore, 
given that previous studies in China have reported the use of fixed insulin regimens among 
individuals with T1D,120 we anticipated that their dietary intake would have low day-to-day 
variability. Indeed, previous studies in China have reported very low day-to-day variability in the 
general population compared to the United States and Europe.157 Together, these factors could 
partially explain the high level of agreement between interviews and further support the use of 
telephone administered 24-hour recalls in our target population.   
Energy intake in this sample was low: median intake from the telephone interview was 
only 1459 kcal/day. Two clinical factors may explain this: anthropometrics and insulin dose. The 
average height of participants was 169 cm (approximately 5.5 feet) and the average BMI was 
21.5 kg/m2. Because greater food intakes, particularly carbohydrate staples such as rice and 
wheat noodles, require greater insulin doses to achieve near-normal blood glucose levels, 
individuals with T1D in China may be reducing dietary intake in order to accommodate smaller 
insulin doses. Indeed, one study reporting caloric intake in Taiwanese youth with T1D found that 
21% consumed >30% fewer calories than recommended and 27% consumed 10-30% fewer 
calories than recommended.158 Families may be making sacrifices in diabetes self-management 
(e.g. using less insulin) in order to accommodate the expense of T1D. This represents an 
important phenomenon to explore in future research.  
There are several notable strengths of the developed method. Food records enabled 
participants to query restaurants, wives, and other persons who may be preparing their food, 
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thereby reducing recall biases and improving recipe reporting. Additional strengths include 
training interviewers and using a culturally appropriate portion size picture guide.  
Food records were used to reduce reliance on memory and allow participants to collect recipe 
information, which resulted in more complete and accurate food lists. However, actively 
recording food may have led to changes in behavior. In additional to actual behavior changes, 
we recognize that reported behavior changes may occur. However, purposeful dietary 
misreporting may be uncommon in China.153 In our study, approval biases were addressed by 
using interviewers who were not the participants’ healthcare providers and training them to use 
a standardized protocol and neutral probes.159 Finally, while the sample size was relatively 
small, we were powered to detect expected observable differences in mean nutrient intake.  
In conclusion, we determined that telephone administration of a 24-hour recall is a 
reasonably accurate and practical method for assessing dietary intake in individuals with T1D in 
China compared to a 24-hour recall administered face-to-face. 
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CHAPTER 3:   DIABETES NUTRITION EDUCATION AND DIETARY INTAKE AMONG 
INDIVIDUALS WITH TYPE 1 DIABETES IN CHINA 
 
3.1   Introduction 
The coordination of insulin with dietary intake is essential among individuals with T1D in 
order to maintain near-normal blood glucose levels and prevent acute and chronic 
complications.160 This integration is achieved through individualized diabetes nutrition therapy, 
which typically involves one of two approaches: (1) fixed daily insulin doses matched to 
consistent carbohydrate intake with respect to time and amount or (2) flexible daily insulin doses 
accommodating variability in food intake, typically using carbohydrate counting.161 There is not a 
“one-size-fits-all” eating pattern for diabetes.161 Healthcare providers—preferably dietitians or 
their equivalent—should collaboratively develop eating plans with each individual with diabetes 
and provide ongoing implementation support.161  
To date, no study has evaluated diabetes nutrition therapy among individuals with T1D 
in China. Understanding current practices is an essential first step for developing interventions 
and policies to improve T1D care. The aims of this study were: 1) to describe the contribution of 
diabetes nutrition education and therapy to disease self-management among individuals with 
T1D in China and 2) to estimate the association of diabetes nutrition education and therapy with 
dietary intake. 
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3.2   Methods 
3.2.1   Sample population 
The 3C Study was an epidemiological study of the coverage, cost, and care of T1D in 
China.162 Dietary intake in the 3C Study was assessed using the Summary of Diabetes Self-
Care Activities measure, which includes four questions relating to general dietary intake.163 A 
follow-up study, 3CNAS, was conducted, on average, 1.6 ±0.2 years later and expanded the 3C 
Study to include comprehensive information on diabetes nutrition therapy and dietary intake. 3C 
Study participants who met the following criteria were eligible for 3CNAS: Beijing resident, ≥12 
years of age, no severe diabetes complications (e.g. advanced micro- and macrovascular 
complications, including nephropathy and stroke), and in-service telephone number available.  
 
3.2.2   Diabetes nutrition therapy assessment 
Trained interviewers administered a survey during the 3CNAS visit that queried 
recommendations received from healthcare providers relating to general diabetes care and 
nutrition. Specifically, participants were asked how often, if ever, they had met with a dietitian; if 
they had received an eating plan and if yes, how often they followed it; and if they had ever 
been taught carbohydrate counting and if yes, who taught them and how often they use it. An 
open-ended question was also asked relating to what the participant would like to know about 
how food interacts with their diabetes care.  
Information on insulin administration method, type and dose, and SMBG were also 
collected during the 3CNAS visit. Four insulin regimens were defined as follows: (1) multiple 
daily injections (MDI; ≥3 injections) with glargine or detemir plus more than/or other than rapid-
acting insulin (“MDI: With basal”), (2) continuous subcutaneous infusion (“Pump”), (3) MDI with 
any insulin types excluding glargine and detemir (“MDI: No basal”), and (4) 1-2 injections per 
day of any insulin types (“1-2 injections”).  
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3.2.3   Dietary intake assessment 
At the end of the 3CNAS visit, participants were trained by dietitians to record their 
dietary intake on food records provided in an introductory packet. Emphasis was placed on 
estimating portion sizes using food samples, an electronic scale, and a culturally appropriate 
portion size picture guide. On average, beginning 3.0 ±2.8 days after this visit, participants 
completed three telephone administered 24-hour recalls. The 24-hour recall food lists were 
converted into nutrients and food groups using the Chinese Food Composition Tables.151,152  
 
3.2.4   Covariates 
Demographic and socioeconomic data were collected via an interviewer-administered 
survey during the 3C Study visit. Diabetes duration was calculated as the period from July 1 of 
the year of diagnosis (because the 3C Study only queried year of diagnosis) to the 3CNAS visit.  
A blood sample was collected by venipuncture during the 3CNAS visit and HbA1c was 
measured using standardized procedures in whole blood with an automated high-performance 
liquid chromatography system (Primus Ultra2, Trinity Biotech, Bray, Co Wicklow, Ireland). 
 
3.2.5   Statistical analysis  
Univariate descriptive statistics were used to summarize diabetes nutrition therapy and 
dietary intake. Differences in diabetes nutrition therapy across disease self-management 
subgroups were evaluated using chi-square tests for categorical variables and Kruskal-Wallis 
tests for continuous variables. The association between diabetes nutrition therapy and dietary 
intake was estimated using analysis of covariance (ANCOVA). Potential confounders, including 
age, diabetes duration, sex, education, household income, occupation, marital status, medical 
insurance coverage, and urban versus rural residence were evaluated by examining their 
independent associations with the exposures and outcomes, and using directed acyclic 
graphs164 (for example, meeting with a dietitian and fruit intake, Supplemental Figure S3.1). 
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The final adjustment set included age and occupation. All statistical analyses were conducted 
using SAS 9.2 (SAS Institute, Cary, North Carolina).  
 
3.3   Results 
A total of 195 3C Study participants met the inclusion criteria. Of these, 72 (37%) 
refused to participate and 23 (12%) dropped out before the 3CNAS visit. The final sample size 
was therefore 100. There were no differences in diabetes duration, sex, education, or urban 
versus rural residence between those who participated and those who refused or dropped out 
(all p >0.05). However, those who participated tended to be older (p=0.001), have higher 
household incomes (p=0.05), and be retired/unemployed/never worked (p=0.06) and 
married/cohabitating (p=0.02).  
Participants were 41.7 ±16.3 years old, had a diabetes duration of 11.8 ±9.7 years, and 
an HbA1c of 8.22 ±1.77% (Table 3.1). Approximately one-third of participants were on insulin 
regimens classified as “MDI: No basal”; the most common insulin combination in this category 
was 3 injections/day of short-acting insulin (Regular) and 1 injection/day of intermediate-acting 
insulin (NPH). SMBG frequency was low: only 8% of participants reported testing ≥ 3 times/day.  
Fewer than half of participants reported “ever” meeting with a dietitian (Table 3.2) and 
only one participant reported meeting with a dietitian in the past 12 months. While a greater 
proportion of participants reported attending an education session in the past 12 months that 
covered nutrition, the number was still low: only 18%.  
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Table 3.1   Demographic and clinical characteristics of individuals with type 1 
diabetes in China participating in the 3C Nutrition Ancillary Study 
 All 
n=100 
Males 
n=54 
Females 
n=46 
Age, years 41.7 (16.3) 41.1 (16.7) 42.4 (15.8) 
Diabetes duration, years 11.8 (9.7) 9.8 (7.4) 14.2 (11.4) 
Highest level of education  
     <University 32 (32%) 13 (25%) 19 (41%) 
     Junior University 16 (16%) 8 (15%) 8 (17%) 
     ≥University 51 (52%) 32 (60%) 19 (41%) 
Household income, RMB/month  
     <3000 20 (20%) 10 (19%) 10 (22%) 
     3000 - <5000 23 (23%) 12 (22%) 11 (24%) 
     5000 - <10 000 30 (30%) 16 (30%) 14 (30%) 
     ≥10 000 27 (27%) 16 (30%) 11 (24%) 
Occupation  
     Non-government worker  31 (31%) 20 (37%) 11 (24%) 
     Government worker  17 (17%) 8 (15%) 9 (20%) 
     Student  17 (17%) 12 (22%) 5 (11%) 
     Farmer 7 (7%) 4 (7%) 3 (7%) 
     Retired/unemployed 28 (28%) 10 (19%) 18 (39%) 
Marital status  
     Married/cohabitating 58 (60%) 31 (61%) 27 (60%) 
     Single/divorced/widowed 38 (40%) 20 (39%) 18 (40%) 
Medical insurance  
     Urban employee 47 (47%) 26 (48%) 21 (46%) 
     Urban resident 26 (26%) 12 (22%) 14 (30%) 
     New cooperative 15 (15%) 8 (15%) 7 (15%) 
     Other 7 (7%) 4 (7%) 3 (7%) 
     None 5 (5%) 4 (7%) 1 (2%) 
Residency status  
     Urban 82 (85%) 44 (85%) 38 (84%) 
     Rural 15 (15%) 8 (15%) 7 (16%) 
Met glycemic control goal
 1
  
     Yes 24 (24%) 13 (24%) 11 (24%) 
     No 75 (76%) 41 (76%) 34 (76%) 
 
Values are given as mean (SD) or n (%) 
1 
HbA1c <7.0% for participants >19 years old and <7.5% for participants ≤19 
years old 
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In regards to diabetes nutrition therapy strategies, 64% of participants reported that they 
had been taught carbohydrate counting (Table 3.2) and the majority of these had been taught 
by a physician (56%). The remaining participants were taught by dietitians (30%), diabetes 
educators (5%) or some other source including printed educational materials (3%), the Internet 
(2%), and nurses (3%). The vast majority (81%) of participants taught carbohydrate counting 
reported “never” using this self-management tool. Only two participants who had been taught 
carbohydrate counting reported practicing carbohydrate counting every day. Participants who 
had been taught carbohydrate counting by dietitians were nearly twice as likely to report 
sometimes using it (26%) compared to participants who had been taught by physicians (14%), 
but the difference was not statistically significant (p=0.51). 
While a slightly greater proportion of participants (72%) had been given an eating plan 
by a healthcare provider (Table 3.2) relative to being taught carbohydrate counting (64%), 
participants only followed their prescribed eating plans, on average, 2.6 ±3.2 days in the past 
week. Of note, 11% of participants had never been taught carbohydrate counting and had never 
been given an eating plan by a healthcare provider. 
 Dietary flexibility in this sample was low: 67% of participants reported eating about the 
same amount of food at the same time everyday (Table 3.2). When participants were asked to 
describe what they do when they eat more or less food than usual, 20% reported that they do 
nothing because they have a rigid diet. In response to a query about what they would like to 
know about how food interacts with their diabetes care, 14% of participants responded that they 
wanted to know how they could eat fruit and 4% explicitly asked if a rigid diet is necessary for 
patients with T1D and how they could increase the diversity of their diets.  
Participants on pumps had the highest dietary flexibility: over half of participants in this 
group reported eating different amounts or at different times every day and 0% reported doing 
nothing if their diet varies (Table 3.2). Participants on 1-2 injections/day were least likely to 
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adjust their insulin in response to eating more or less than usual. Participants on pumps had 
higher fruit (p=0.07) and dairy (p=0.04) intakes relative to other participants.  
Participants who tested ≥1 time/day were more likely to report adjusting insulin in 
response to dietary variability and less likely to report doing nothing because they have a rigid 
diet (p=0.05) (Supplemental Table S3.1). They also had significantly (p=0.005) higher fruit 
intakes compared to participants testing with lower frequencies.  
Participants who had ever met with a dietitian or who had attended an education session 
in the past 12 months that covered nutrition were marginally significantly more likely to have 
been given an eating plan (Supplemental Table S3.2). While a greater proportion of 
participants who had attended an education session that covered nutrition had been taught 
carbohydrate counting and used it sometimes (22%) compared to those who did not attend such 
a session (10%), the difference was not statistically significant (p=0.31). 
Participants who attended an education session that covered nutrition in the past 12 
months tended to be (p=0.11) more likely to achieve HbA1c goals compared to participants who 
did not attend such a session: 29% of participants attending a session met HbA1c goals 
compared to only 15% of participants not attending a session (Supplemental Table S3.3). 
While a greater proportion of participants who had ever met with a dietitian met HbA1c goals 
(58%) compared to those who had never met with a dietitian (44%), the difference was not 
statistically significant (p=0.22).  
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Table 3.2   Diabetes nutrition therapy and dietary intake according to insulin regimen among individuals with type 1 diabetes in China 
 
All 
n=100 
MDI: 
With basal 
n=42 
Pump 
n=9 
MDI: 
No basal 
n=30 
1-2 injections 
n=19 
P- 
value 
1
 
Self-monitoring of blood glucose       
     <1 time/week or do not test 31 (31%) 6 (14%) 1 (11%) 17 (57%) 7 (37%) 
0.005 
     1-2 times/week 27 (27%) 10 (24%) 2 (22%) 8 (27%) 7 (37%) 
     3-6 times/week 12 (12%) 7 (17%) 2 (22%) 2 (7%) 1 (5%) 
     ≥1 time/day 30 (30%) 19 (45%) 4 (44%) 3 (10%) 4 (21%) 
Dietary flexibility        
     Eat same amount at same time everyday 67 (67%) 32 (76%) 4 (44%) 17 (57%) 14 (74%) 
0.14      Eat different amounts or at different  
     times everyday  
33 (33%) 10 (24%) 5 (56%) 13 (43%) 5 (26%) 
Action if diet varies       
     Adjusts insulin 57 (57%) 26 (62%) 6 (67%) 17 (57%) 8 (42%) 
0.21 
     Adjusts insulin or exercise 8 (8%) 5 (12%) 2 (22%) 0 (0%) 1 (5%) 
     Adjusts exercise 15 (15%) 5 (12%) 1 (11%) 5 (17%) 4 (21%) 
     Nothing, rigid diet 20 (20%) 6 (14%) 0 (0%) 8 (27%) 6 (32%) 
Ever met with a dietitian       
     Yes 48 (48%) 22 (52%) 4 (44%) 15 (50%) 7 (37%) 
0.71 
     No 52 (52%) 20 (48%) 5 (56%) 15 (50%) 12 (63%) 
Attended education session in past 12 
months that covered nutrition  
  
     Yes 18 (18%) 10 (24%) 0 (0%) 5 (17%) 3 (16%) 
0.39 
     No 82 (82%) 32 (76%) 9 (100%) 25 (83%) 16 (84%) 
Carbohydrate counting    
     Taught and use sometimes 12 (12%) 6 (14%) 1 (11%) 4 (13%) 1 (5%) 
0.20      Taught but never use 52 (52%) 26 (62%) 6 (67%) 13 (43%) 7 (37%) 
     Never taught 36 (36%) 10 (24%) 2 (22%) 13 (43%) 11 (58%) 
Eating plan    
     Given and use sometimes 32 (32%) 16 (38%) 1 (11%) 11 (37%) 4 (21%) 
0.32      Given but never use 40 (40%) 17 (40%) 5 (56%) 12 (40%) 6 (32%) 
     Never given 28 (28%) 9 (21%) 3 (33%) 7 (23%) 9 (47%) 
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Nutrients 
     Fat (% kcal) 35.9 (7.9) 36.1 (7.0) 35.7 (9.7) 35.3 (8.1) 36.5 (8.9) 0.80 
     Carbohydrates (% kcal) 47.1 (8.4) 46.5 (7.7) 49.6 (11.3) 46.5 (8.1) 48.0 (9.4) 0.77 
     Protein (% kcal) 16.3 (3.0) 16.9 (2.9) 15.7 (3.3) 16.3 (3.1) 15.3 (2.8) 0.28 
     Fiber (g/1000 kcal) 7.5 (2.6) 7.8 (2.4) 7.2 (2.9) 6.9 (2.3) 7.8 (3.1) 0.37 
     Iron (mg/1000 kcal) 11.2 (2.6) 11.6 (2.3) 11.1 (3.2) 11.2 (2.7) 10.2 (2.7) 0.15 
Food groups (g/1000 kcal)   
     Rice  79 (52) 79 (48) 91 (58) 62 (47) 101 (62) 0.10 
     Wheat products 107 (72) 89 (48) 106 (112) 130 (87) 108 (59) 0.10 
     Beans & bean products 45 (44) 42 (39) 40 (26) 47 (43) 53 (60) 0.98 
     Vegetables 257 (138) 288 (143) 238 (117) 217 (118) 260 (158) 0.18 
     Fruit  49 (59) 51 (55) 70 (66) 31 (53) 63 (70) 0.07 
     Red meat 44 (32) 49 (37) 40 (30) 39 (30) 42 (24) 0.81 
     Eggs 31 (21) 31 (18) 27 (23) 34 (25) 30 (21) 0.75 
     Milk & milk products 138 (93) 146 (102) 190 (81) 135 (78) 99 (89) 0.04 
 
Values are given as mean (SD) or n (%) 
1 
Chi-square test for categorical variables and Kruskal-Wallis test for continuous variables 
MDI; multiple daily injections
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There were few differences in dietary intake across subgroups of diabetes nutrition 
therapy (Table 3.3). Participants who had ever met with a dietitian had higher mean iron 
(p=0.007) and egg (p=0.03) intakes compared to participants who had never met with a 
dietitian. Participants who had attended an education in the past 12 months that covered 
nutrition had higher mean vegetable intakes (p=0.02) compared to those who had not. Finally, 
participants who had been given an eating plan but never used it had a lower mean percent of 
calories from fat (p=0.01) and a higher mean percent of calories from carbohydrate (p=0.05) 
compared to those who had been given an eating plan and used it and those who had never 
been given an eating plan. 
 39 
 
Table 3.3 Estimated mean (standard error) nutrient and food group intakes, adjusted for age and 
occupation, across groups of diabetes nutrition education and therapy among individuals with type 1 
diabetes in China 
 
Ever met with a dietitian 
 
Attended education session in 
past 12 months that covered 
nutrition 
Yes 
n=52 
No 
n=48 
P- 
value 
1
 
Yes 
n=18 
No 
n=82 
P-
value 
1
 
Nutrients 
     Fat (% kcal) 36.2 (1.2) 35.6 (1.2) 0.72  37.6 (1.9) 35.5 (0.9) 0.33 
     Carbohydrates (% kcal)  46.6 (1.2) 47.5 (1.2) 0.64  45.3 (2.0) 47.5 (0.9) 0.34 
     Protein (% kcal) 16.8 (0.4) 15.8 (0.4) 0.13  16.4 (0.7) 16.3 (0.3) 0.83 
     Fiber (g/1000 kcal) 7.6 (0.4) 7.4 (0.4) 0.72  7.6 (0.6) 7.5 (0.3) 0.82 
     Iron (mg/1000 kcal) 11.9 (0.4) 10.5 (0.4) 0.007  12.0 (0.6) 11.0 (0.3) 0.12 
Food Groups (g/1000 kcal) 
     Rice  81 (7.9) 78 (7.5) 0.81  77 (13) 80 (5.8) 0.86 
     Wheat products 111 (11) 103 (10) 0.62  107 (17) 107 (8) 0.99 
     Beans & bean products 44 (6.5) 46 (6.3) 0.85  48 (10) 45 (4.8) 0.79 
     Vegetables 274 (21) 241 (20) 0.26  329 (32) 241 (15) 0.02 
     Fruit  42 (8.8) 55 (8.4) 0.32  48 (14) 49 (6.5) 0.96 
     Red meat 47 (4.9) 41 (4.7) 0.38  54 (7.8) 42 (3.6) 0.15 
     Eggs 37 (3.1) 27 (2.9) 0.03  34 (5.0) 31 (2.3) 0.51 
     Milk & milk products 145 (14) 130 (13) 0.45  146 (22) 136 (10) 0.66 
 
Values are given as mean (standard error), adjusted for age and occupational status 
1 
Pr >F from analysis of covariance, adjusted for age and occupational status
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Table 3.3   Continued 
 Carbohydrate counting 
 
Eating plan 
Taught and 
sometimes 
use 
n=12 
Taught but 
never use 
n=52 
Never 
taught 
n=36 
P- 
value 
1
 
Given and 
sometimes 
use 
n=32 
Given 
but never 
use 
n=40 
Never 
given 
n=28 
P-
value 
1
 
Nutrients 
     Fat (% kcal) 37.0 (2.4) 36.8 (1.1) 34.2 (1.3) 0.31  37.0 (1.4) 33.0 (1.3) 38.8 (1.5) 0.01 
     Carbohydrates (% kcal)  45.8 (2.5) 46.8 (1.2) 48.0 (1.4) 0.68  46.0 (1.4) 49.6 (1.3) 44.6 (1.5) 0.05 
     Protein (% kcal) 15.9 (0.9) 16.2 (0.4) 16.5 (0.5) 0.77  16.3 (0.5) 16.2 (0.5) 16.4 (0.6) 0.99 
     Fiber (g/1000 kcal) 7.0 (0.7) 7.7 (0.4) 7.4 (0.4) 0.67  7.4 (0.4) 7.4 (0.4) 7.7 (0.5) 0.85 
     Iron (mg/1000 kcal) 11.0 (0.8) 10.9 (0.4) 11.6 (0.4) 0.51  10.7 (0.5) 11.7 (0.4) 11.0 (0.5) 0.28 
Food Groups (g/1000 kcal) 
     Rice  81 (15) 71 (7.2) 90 (8.7) 0.24  67 (9.2) 94 (8.4) 72 (9.9) 0.10 
     Wheat products 97 (21) 106 (9.8) 110 (12) 0.85  98 (13) 116 (11) 103 (13) 0.56 
     Beans & bean products 57 (13) 38 (6.0) 51 (7.2) 0.27  43 (7.8) 46 (7.2) 48 (8.4) 0.89 
     Vegetables 275 (41) 258 (19) 249 (23) 0.85  229 (25) 268 (23) 272 (27) 0.40 
     Fruit  46 (18) 48 (8.2) 51 (9.9) 0.95  64 (10) 46 (9.5) 36 (11) 0.17 
     Red meat 31 (9.7) 46 (4.6) 45 (5.4) 0.36  48 (5.8) 38 (5.3) 49 (6.3) 0.35 
     Eggs 45 (6.1) 28 (2.8) 31 (3.4) 0.05  30 (3.8) 33 (3.4) 31 (4.0) 0.85 
     Milk & milk products 163 (27) 131 (13) 139 (15) 0.56  148 (16) 142 (15) 119 (17) 0.44 
 
Values are given as mean (standard error), adjusted for age and occupational status 
1 
Pr >F from analysis of covariance, adjusted for age and occupational status 
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3.4   Discussion 
This is the first study to assess the integration of diabetes nutrition education, self-
management practices, and dietary intake among T1D patients in a developing country. Fewer 
than half of participants had “ever” met with a dietitian and the frequency of diabetes nutrition 
therapy approaches such as carbohydrate counting was low. Results indicate that diabetes 
nutrition therapy in China typically involves matching fixed insulin doses to a diet that is rigid 
with respect to amount and timing. While the consistency of this self-management regimen may 
be appropriate for some participants, others expressed a desire to diversify their diets, 
particularly with respect to fruit intake.  
The ADA recommends meeting with a dietitian annually or attending a diabetes self-
management education program that includes instruction on nutrition therapy.161,165 Only one 
out of the 100 participants in this sample—an older male in poor control with possible 
microalbuminuria—had met with a dietitian in the past 12 months suggesting that dietitians may 
only be used in high-risk situations in China. A larger proportion of participants had attended an 
education session that covered nutrition in the past 12 months, but the proportion was still 
dismally low at only 18%. This may explain why only 12% of participants sometimes use 
carbohydrate counting and only 32% sometimes follow an eating plan given to them by their 
healthcare provider. This is a stark contrast to youth with T1D in the United States, 97% of 
whom have been taught carbohydrate counting and 86% of whom report using this approach 
“often.”77  
Although participants on MDI with basal or pumps had significantly higher SMBG 
frequencies compared to participants on other insulin regimens, only about half of them tested 
≥1 time/day. The ADA recommends SMBG prior to all meals and snacks, occasionally 
postprandially, and at bedtime, in addition to other situations (e.g., when hypoglycemia is 
suspected)—a total of 6-8 times/day.68 The reportedly low frequency of SMBG in this sample 
population, which is consistent with the most recently published data in China (from 2001-2002; 
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average SMBG of 8 times/month),120 may help explain why diabetes nutrition therapy frequency 
is so low and why such a large proportion of participants on MDI reported having rigid dietary 
intakes. This low SMBG frequency poses a significant barrier for physicians in China who 
cannot advise patients appropriately with respect to diet due to a lack of information on SMBG 
(most patients do not bring SMBG results to their outpatient visits). For example, a patient may 
ask a physician in the outpatient department how she can eat fruit, but without data on SMBG 
the physician’s ability to advise the patient is severely limited. 
In this sample, vegetable and fruit intakes were below the Chinese Food Guide Pagoda 
recommendations: mean of 389 g/day of vegetables compared to 400-500 g/day recommended 
and mean of 78 g/day of fruit compared to 100-200 g/day recommended.166 This may have 
contributed to the observed fiber intakes, which were half that recommended by the U.S. 
Institute of Medicine.167 Interestingly, 14% of participants responded that they wanted to know 
how they could eat fruit, which indicates that individuals with T1D in China are purposefully 
restricting fruit intake. This phenomenon has also been reported in the United States: in a small 
focus group study of youth, although all participants perceived fruit as healthful, a few parents 
reported limiting or even excluding fruit consumption because of risk of postprandial 
hyperglycemia.168 In our study, participants on pumps and those who tested more frequently 
had higher fruit intakes relative to other participants, suggesting that these may be viable self-
management options for participants wishing to increase their fruit intakes.  
In this sample, participants who attended an education session that covered nutrition in 
the past 12 months tended to be more likely to achieve HbA1c goals compared to participants 
who did not attend such a session.  A similar trend was observed for ever meeting with a 
dietician, but it was not significant, perhaps because only one participant had met with a dietitian 
in the past 12 months. It may be the case that more frequent nutrition education and contact 
with dietitians are needed in China in order to observe more significant improvements in 
glycemic control.  
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We did not find a clear association between diabetes nutrition therapy and dietary intake 
in this sample of individuals with T1D in China. Evidence from both structured169,170 and 
psychosocial171 education interventions suggests that nutrition education can lead to 
improvements in dietary intake and guideline adherence among individuals with T1D. 
Furthermore, studies in Europe172-174 have reported adoption of healthier diets with the receipt of 
nutrition recommendations as part of routine care, where routine care varied from a single, 5-
day in-patient education program in France172 to meeting with a dietitian during routine 
outpatient medical consultations every 3 months173 or twice per year174 in Italy. There are 
several potential reasons why no consistent association was observed between diabetes 
nutrition therapy and dietary intake in this sample of individuals with T1D in China. Perhaps 
chief among them is that nutrition education was infrequent and as a result, implementation 
support may be insufficient to empower patients to make modifications to their diet. Indeed, 74% 
of participants in our study wanted to know more about how food interacts with their diabetes 
care. Patients in China often express discontent with the education they are currently receiving, 
complaining that they have not been given the tools they need to understand their body’s 
glycemic response to food and how to appropriately respond. To address this gap in knowledge, 
trained clinical dietitians are urgently needed in China and should be integrated into routine 
patient care. This would require a shift in the role of dietitians to support patient counseling in 
addition to their traditional role of advising hospital kitchens.  
There are several strengths and challenges associated with this study. An important 
limitation is the use of self-reported diabetes nutrition therapy: participants may have modified 
their responses according to what they perceive to be socially desirable, which may have 
resulted in misclassification. The potential for this bias was addressed by using interviewers 
who were not the participants’ healthcare providers and training them to use a standardized 
protocol and neutral probes.159 Compared to ineligible participants and refusals, individuals who 
completed this study were older, and as a result were more likely to be married and to not be 
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working. In order to improve participant enrollment and generalizability, study visits were 
conducted both in urban Beijing and in a rural Beijing suburb. Nonetheless, we recognize that 
as with all observational studies, the generalizability of the results presented here may be 
limited. Finally, the sample size of the study was small and therefore limited our power to detect 
significant differences. Nonetheless, the thoroughness and quality of the data are valuable for 
improving our grasp of the situation in China and informing future, larger studies. 
In this sample of individuals with T1D in China there is little dietitian involvement in 
continuing diabetes education and very few participants practice carbohydrate counting. While 
most participants had been given an eating plan by their healthcare provider, few reported using 
this plan regularly. In order to improve health outcomes for individuals with T1D in China, 
greater access to nutrition education led by dietitians and diabetes nutrition therapy as 
appropriate for patient preferences and insulin regimen is needed.  
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3.5   Supplemental figures and tables 
 
Supplemental Figure S3.1   Directed acyclic graph for relationship between meeting with a dietitian and fruit intake as drawn using the 
tool, www.dagitty.net. Two minimal sufficient adjustment sets were identified for estimating the total effect of meeting with a dietitian on 
fruit intake: {age, occupation} and {marital status, occupation} 
 
 
  
 
4
6
 
Supplemental Table S3.1   Diabetes nutrition therapy and dietary intake according to self-monitoring of blood glucose among 
individuals with type 1 diabetes in China 
 
All 
n=100 
<1 time/week or 
do not test 
n=31 
1-2 
times/week 
n=27 
3-6 
times/week 
n=12 
≥1 time/day 
n=30 
P- 
value 
1
 
Dietary flexibility        
   Eat same amount at same  
   time everyday 
67 (67%) 17 (55%) 22 (81%) 8 (67%) 20 (67%) 
0.20 
   Eat different amounts or at  
   different times everyday  
33 (33%) 14 (45%) 5 (19%) 4 (33%) 10 (33%) 
Action if diet varies       
   Adjusts insulin 57 (57%) 14 (45%) 13 (48%) 9 (75%) 21 (70%) 
0.05 
   Adjusts insulin or exercise 8 (8%) 1 (3%) 2 (7%) 0 (0%) 5 (17%) 
   Adjusts exercise 15 (15%) 5 (16%) 6 (22%) 1 (8%) 3 (10%) 
   Nothing, rigid diet 20 (20%) 11 (35%) 6 (22%) 2 (17%) 1 (3%) 
Ever met with a dietitian       
   Yes 48 (48%) 12 (39%) 13 (48%) 5 (42%) 18 (60%) 
0.39 
   No 52 (52%) 19 (61%) 14 (52%) 7 (58%) 12 (40%) 
Attended education session in past 12 months 
that covered nutrition  
 
   Yes 18 (18%) 4 (13%) 6 (22%) 2 (17%) 6 (20%) 
0.81 
   No 82 (82%) 27 (87%) 21 (78%) 10 (83%) 24 (80%) 
Carbohydrate counting    
   Taught and use sometimes 12 (12%) 1 (3%) 7 (26%) 1 (8%) 3 (10%) 
0.23    Taught but never use 52 (52%) 17 (55%) 13 (48%) 7 (58%) 15 (50%) 
   Never taught 36 (36%) 13 (42%) 7 (26%) 4 (33%) 12 (40%) 
Eating plan    
   Given and use sometimes 32 (32%) 12 (39%) 7 (26%) 5 (42%) 9 (27%) 
0.69    Given but never use 40 (40%) 13 (42%) 10 (37%) 5 (42%) 12 (40%) 
   Never given 28 (28%) 6 (19%) 10 (37%) 2 (17%) 10 (33%) 
Nutrients   
   Fat (% kcal) 35.9 (7.9) 35.1 (8.7) 35.7 (7.6) 40.9 (9.0) 34.9 (6.4) 0.24 
   Carbohydrates (% kcal) 47.1 (8.4) 47.6 (9.0) 46.9 (8.9) 42.8 (8.9) 48.4 (6.8) 0.38 
   Protein (% kcal) 16.3 (3.0) 15.8 (3.1) 16.3 (2.5) 16.5 (3.6) 16.7 (3.0) 0.56 
   Fiber (g/1000 kcal) 7.5 (2.6) 7.3 (2.9) 7.4 (2.5) 7.6 (2.6) 7.8 (2.4) 0.65 
   Iron (mg/1000 kcal) 11.2 (2.6) 10.6 (2.6) 11.6 (2.8) 11.1 (2.2) 11.3 (2.6) 0.60 
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Food groups (g/1000 kcal)   
   Rice  79 (52) 73 (53) 93 (55) 91 (35) 68 (54) 0.06 
   Wheat  107 (72) 128 (94) 110 (72) 84 (44) 91 (44) 0.22 
   Beans 45 (44) 41 (39) 51 (55) 58 (23) 39 (42) 0.25 
   Vegetables 257 (138) 220 (127) 328 (166) 259 (86) 230 (118) 0.02 
   Fruit  49 (59) 38 (70) 35 (39) 58 (72) 68 (52) 0.005 
   Red meat 44 (32) 43 (33) 37 (23) 66 (44) 42 (29) 0.26 
   Eggs 31 (21) 27 (21) 39 (19) 38 (28) 26 (18) 0.05 
   Dairy 138 (93) 109 (82) 158 (109) 145 (108) 146 (78) 0.17 
 
Values are given as mean (SD) or n (%) 
1 
Chi-square test for categorical variables and Kruskal-Wallis test for continuous variables
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Supplemental Table S3.2   Relationship between diabetes nutrition therapy variables among individuals with 
type 1 diabetes in China 
 
Ever met with a dietitian 
 
Attended education session in 
past 12 months that covered 
nutrition 
Yes 
n=52 
No 
n=48 
P-
value 
1
 
Yes 
n=18 
No 
n=82 
P-
value 
1
 
Dietary flexibility  
     Eat same amount at  
     same time everyday 
31 (65%) 36 (69%) 0.62  13 (72%) 54 (66%) 0.60 
     Eat different amounts  
     or at different times  
     everyday  
17 (35%) 16 (31%)  5 (28%) 28 (34%) 
Carbohydrate counting  
     Taught and use  
     sometimes 
6 (13%) 6 (12%) 0.87  4 (22%) 8 (10%) 0.31 
     Taught but never use 26 (54%) 26 (50%)  9 (50%) 43 (52%) 
     Never taught 16 (33%) 20 (38%)  5 (28%) 31 (38%) 
Eating plan  
     Given and use  
     sometimes 
16 (33%) 16 (31%) 0.12  9 (50%) 23 (28%) 0.11 
     Given but never use 23 (48%) 17 (33%)  7 (39%) 33 (40%) 
     Never given 9 (19%) 19 (37%)  2 (11%) 26 (32%) 
 
Values are given as n (%) 
1
 Chi-square test
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Supplemental Table S3.3   Comparison of characteristics of individuals with type 1 
diabetes in China meeting HbA1c goals and not meeting HbA1c goals 
 Met 
HbA1c Goal 
1
 
n=24 
Did Not Meet 
HbA1c Goal 
1
 
n=75 
P- 
value 
2
 
Ever met with a dietitian    
     Yes 58.3% (14) 44.0% (33) 0.22 
     No 41.7% (10) 56.0% (42) 
Attended education session in past 
12 months that covered nutrition 
   
     Yes 29.2% (7) 14.5% (11) 0.11 
     No 70.8% (17) 85.3% (64) 
Ever taught carbohydrate counting    
     Yes 66.7% (16) 64.0% (48) 0.81 
     No 33.3% (8) 36.0% (27) 
Who taught carbohydrate counting    
     Physician 50.0% (8) 58.3% (28) 0.73 
     Dietitian 37.5% (6) 27.1% (13) 
     Other 12.5% (2) 14.6% (7) 
Ever given eating plan    
     Yes 66.7% (16) 73.3% (55) 0.53 
     No 33.3% (8) 26.7% (20) 
 
1 
HbA1c <7.0% for participants >19 years old and <7.5% for participants ≤19 years old 
2 
Chi-square test 
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CHAPTER 4:   COMPARISON OF THE DIETARY INTAKES OF INDIVIDUALS WITH AND 
WITHOUT TYPE 1 DIABETES IN CHINA 
 
4.1   Introduction 
Modifications to dietary intake have consistently been an essential component of T1D 
treatment.175-177 In a considerable shift from the prescriptive diets characteristic of much of the 
20th century,175-181 in 1994, the ADA published nutrition recommendations emphasizing 
individualization of dietary advice with a focus on the effects of nutrition therapy on metabolic 
control.182 The most recent ADA recommendations (2013) reiterate that there is no “one-size-
fits-all” diet for individuals with diabetes and that food choices should only be limited when 
supported by scientific evidence.161  
There is a dearth of information on the dietary intakes of individuals with T1D from low- 
and middle-income countries where economic development and urbanization have resulted in a 
transition from traditional foods to foods high in saturated fat and sugar, and low in fiber.183,184 
Whether this nutrition transition has also impacted the dietary intakes and self-management 
practices of individuals with T1D in these countries has yet to be explored.  
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China has undergone dramatic changes in diet over the past 20 years:137,185-187 increases 
in snacking episodes and shifts in consumption of steamed and boiled foods to fried foods are 
just two examples of the many changes that have been documented.136 The objective of the 
study presented in this chapter was to compare the dietary intakes of individuals with T1D in 
China to those of individuals without diabetes in Beijing. Such a comparison will improve our 
understanding of how patients with T1D are modifying their diet relative to the general 
population in order to manage their condition and will inform future interventions and policies to 
improve the lives of individuals with T1D in China. 
 
4.2   Methods 
4.2.1   Study samples  
Data on individuals with T1D are from 3CNAS, described in Chapter 3. Data on 
individuals without T1D residing in Beijing came from the most recent (2011) CHNS. CHNS is 
an ongoing open cohort of the health and nutritional status of the Chinese population.134 For the 
first time in 2011, 24 communities from Beijing were included in the survey. CHNS participants 
who met the following criteria were eligible for this analysis: Beijing resident, ≥12 years old, no 
diagnosed diabetes, and dietary data available. 
 
4.2.2   Dietary intake assessment 
Dietary intake in 3CNAS was assessed using three (two weekdays and one weekend 
day) telephone administered 24-hour recalls assisted by food records. Telephone administration 
was used to overcome the cultural stigma associated with T1D in China, which precluded 
visiting the homes of participants. This method was validated against in-person administration in 
a subset of participants.188 At the end of the 3CNAS visit, participants were trained by dietitians 
to record their dietary intake on food records provided in an introductory packet. Emphasis was 
placed on estimating portion sizes using food samples, an electronic scale, and a culturally 
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appropriate portion size picture guide. On average, beginning 3.0 ±2.8 days after this visit, 
participants completed the three 24-hour recalls.  
Dietary intake in CHNS was assessed using three consecutive in-person administered 
24-hour recalls randomly allocated to start between Monday and Sunday in combination with a 
household food inventory conducted over the same 3-day period.186 Food models and picture 
aids were used by trained interviewers to assist with estimating portion sizes. For dishes 
prepared at home, the recipe components were taken from the household food inventory and 
portion sizes were based on the proportion of the dish reportedly consumed by the participant.  
For both 3CNAS and CHNS, the 24-hour recall food lists were converted into nutrients 
using the Chinese Food Composition Tables.151,152 Nutritionally meaningful food groups were 
derived by a collaborative working group that included researchers at The University of North 
Carolina, Chapel Hill, and the Chinese National Institute of Nutrition and Food Safety.186 
Nutrients were specified continuously as energy densities.189 Due to the non-normal distribution 
of some food groups largely stemming from large proportions of non-consumers, food groups 
were specified as binary variables. Food groups with ≥ 80% consumers (n=5/17 food groups, 
including rice, wheat, vegetables, red meat, and eggs) were dichotomized as below versus 
above the median of the corresponding food group distribution in g/1000 kcal among 
participants without diabetes, and food groups with <80% consumers (n=12/17 food groups, 
including beans & bean products, fruit, poultry, fish & shellfish, milk & milk products, low-fat 
cakes, high-fat cakes, fried foods, nuts & seeds, fungi & seaweed, sugar-sweetened beverages, 
and fast food) were dichotomized as non-consumers versus consumers.  
 
4.2.3   Covariate assessment 
Self-reported demographic and socioeconomic data were collected via interviewer-
administered questionnaires during the 3C Study visit and the CHNS visit. Both studies used 
standardized protocols to measure weight and height. BMI was calculated as weight in 
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kilograms divided by height in meters-squared. Underweight and overweight for adults (≥18 
years) were defined according to the World Health Organization’s recommendation as 
underweight, BMI <18.5 kg/m2, and overweight, BMI ≥25 kg/m2,190 and for adolescents (<18 
years) using the sex- and age-specific cut-points recommended by the International Obesity 
Task Force.191,192 
Information on insulin administration method, type, and dose were collected during the 
3CNAS visit. Two insulin regimens were defined as follows: (1) “basal-bolus,” including 
continuous subcutaneous infusion and regimens with ≥ 3 daily injections that included glargine 
or detemir and (2) “fixed,” including regimens with ≥ 3 daily injections with any insulin types 
excluding glargine and detemir and regimens with 1-2 injections per day of any insulin types.  
 
4.2.4   Statistical analysis 
Descriptive statistics were used to summarize sample characteristics, and differences 
between participants with and without diabetes were evaluated using analysis of variance 
(ANOVA) for continuous variables and chi-square tests for categorical variables.  
Potential confounders, including age, sex, marital status, household income, residence 
status, education, occupation, medical insurance coverage, smoking status, and BMI status, 
were explored using a directed acyclic graph164 (Supplemental Figure S4.1) and formally 
evaluated by estimating their associations with both the exposure (diabetes status) and 
outcomes (nutrients and food groups). We found that BMI status was a collider in the directed 
acyclic graph analysis, being both the result of diabetes status and dietary intake. We therefore 
did not include BMI status in our final models as adjustment for colliders results in biased 
estimates.193,194 The final adjustment set included sex, age (<22 years versus ≥22 years), and 
residence status (urban versus rural) as these factors were associated with the exposure (Table 
4.1) and the outcomes (data not shown). Because n=3 participants with T1D were missing 
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residence status, the final sample size for this analysis was n=1059 without diabetes and n=97 
with T1D (n=49 on basal-bolus insulin regimens and n=48 on fixed insulin regimens). 
Confounder-adjusted differences were calculated using ANCOVA for continuous 
variables (nutrients) and multivariable logistic regression for binary variables (food groups). 
Given that dietary recommendations for T1D management are specific to an individual’s insulin 
regimen, and differ between flexible, basal-bolus regimens and fixed regimens 195, analyses 
were conducted with 1) all participants with T1D combined and 2) participants with T1D 
stratified by insulin regimen (basal-bolus versus fixed). 
All statistical analyses were conducted using SAS 9.2 (SAS Institute, Cary, North 
Carolina). Values presented are mean ±SD or % (n) unless otherwise indicated. 
 
4.3   Results 
Participants with T1D were more likely to be <22 years old (p=0.04) and 
single/divorced/widowed  (p<0.0001), had higher incomes (p=0.002) and education (p=0.01), 
and were more likely to be underweight and less likely to be overweight (p<0.0001) compared to 
participants without diabetes (Table 4.1). There were no statistically significant differences in 
medical insurance coverage or smoking status (all p>0.05). Participants with T1D on fixed 
insulin regimens were more likely to be male compared to the other two groups (p=0.04), and 
participants with T1D on basal-bolus insulin regimens were more likely to be urban residents 
(p=0.008) compared to the other two groups. 
The macronutrient composition of the diets of participants with and without T1D differed 
substantially, particularly with respect to carbohydrate content (Table 4.2). Participants with T1D 
had a significantly (p=0.01) lower adjusted mean percent of energy from carbohydrates 
compared to participants without diabetes: approximately 47% kcal from carbohydrates in those 
with T1D versus 50% in those without diabetes. Consistent with this observation, participants 
with T1D had a significantly higher adjusted mean percent of energy from fat (p=0.04) and from 
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protein (p=0.02). Stratification by insulin regimen revealed that the differences in carbohydrate 
and fat were stronger among participants with T1D on fixed insulin regimens, while the 
difference in protein was more evident in participants on basal-bolus insulin regimens. No 
statistically significant differences were observed in adjusted mean fiber intake.
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Table 4.1   Comparison of demographic and clinical characteristics between participants without diabetes and those with type 1 
diabetes (T1D) in China, combined and stratified by insulin regimen 
 
No diabetes 
n=1059 
T1D 
n=97 
Basal-bolus 
insulinT1D 
n=49 
Fixed 
insulin T1D 
n=48 
P-value 
combined 
T1D 
1
 
P-value 
stratified 
T1D 
2
 
Age, years 43.1 (15.3) 41.3 (16.3) 41.9 (17.4) 40.7 (15.3) 0.28 0.52 
Age       
     <22 years 8.3 (88) 14.4 (14) 16.3 (8) 12.5 (6) 0.04 0.10 
     ≥22 years 91.7 (971) 85.6 (83) 83.7 (41) 87.5 (42) 
Diabetes duration, years N/A 11.6 (9.3) 13.6 (10.9) 9.5 ( 6.9) N/A 0.03 
Sex       
     Female 53.2 (563) 46.4 (45) 57.1 (28) 35.4 (17) 0.20 0.04 
     Male 46.8 (496) 53.6 (52) 42.9 (21) 64.6 (31) 
Marital status       
     Married/cohabitating 88.0 (871) 59.6 (56) 52.2 (24) 66.7 (32) <0.0001 <0.0001 
     Single/divorced/widowed 12.0 (119) 40.4 (38) 47.8 (22) 33.3 (16) 
Household income, RMB/month        
     <3000  22.4 (234) 19.0 (18) 12.8 (6) 25.0 (12) 0.002 0.009 
     3000 - <5000  25.3 (264) 23.2 (22) 23.4 (11) 22.9 (11) 
     5000 - <10,000  39.9 (417) 31.6 (30) 34.0 (16) 29.2 (14) 
     ≥10,000  12.4 (130) 26.3 (25) 29.8 (14) 22.9 (11) 
Residence       
     Urban 78.9 (836) 84.5 (82) 95.9 (47) 72.9 (35) 0.19 0.008 
     Rural 21.1 (223) 15.5 (15) 4.1 (2) 27.1 (13) 
Highest level of education       
     <University 48.0 (506) 32.3 (31) 25.0 (12) 39.6 (19) 0.01 0.02 
     Junior college 12.4 (131) 14.6 (14) 14.6 (7) 14.6 (7) 
     ≥University  39.6 (417) 53.1 (51) 60.4 (29) 45.8 (22) 
Occupation       
     Non-government worker  37.5 (364) 30.9 (30) 28.6 (14) 33.3 (16) <0.0001 <0.0001 
     Government worker  22.8 (221) 17.5 (17) 16.3 (8) 18.8 (9) 
     Student  1.8 (17) 17.5 (17) 16.3 (8) 18.8 (9) 
     Farmer 1.4 (14) 7.2 (7) 4.1 (2) 10.4 (5) 
     Retired or not working 36.5 (354) 26.8 (26) 34.7 (17) 18.8 (9) 
Medical insurance coverage       
     Yes 94.7 (1000) 95.9 (93) 95.9 (47) 95.8 (46) 0.62 0.88 
     No 5.3 (56) 4.1 (4) 4.1 (2) 4.2 (2) 
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Smoking status       
     Non-smoker 79.1 (834) 80.4 (78) 85.7 (42) 75.0 (36) 0.77 0.41 
     Smoker 20.9 (220) 19.6 (19) 14.3 (7) 25.0 (12) 
BMI status 
3
       
     Underweight 3.1 (33) 16.5 (16) 14.3 (7) 18.8 (9) <0.0001 <0.0001 
     Normal weight 55.0 (580) 73.2 (71) 67.4 (33) 79.2 (38) 
     Overweight  41.8 (441) 10.3 (10) 18.4 (9) 2.1 (1) 
 
Values are given as mean (SD) or percentage (n) 
1 
Chi-square test for categorical variables and ANOVA for continuous variables comparing participants without diabetes and 
participants with T1D 
2 
Chi-square test for categorical variables and ANOVA for continuous variables comparing participants without diabetes, 
participants with T1D on basal-bolus insulin regimens, and participants with T1D on fixed insulin regimens 
3 
Underweight and overweight for adults (≥18 years) were defined according to the WHO’s recommendation as underweight, BMI 
<18.5 kg/m
2
, and overweight, BMI ≥25 kg/m
2
, and for adolescents (<18 years) using the sex- and age-specific cut-points 
recommended by the International Obesity Task Force 
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Table 4.2   Comparison of nutrient intake between participants without diabetes and those with type 1 diabetes (T1D) in China, 
combined and stratified by insulin regimen 
 
No diabetes 
n=1059 
T1D 
n=97 
Basal-bolus 
insulin T1D 
n=49 
Fixed 
insulin T1D 
n=48 
P-value 
T1D vs.  
no diabetes 
1
 
P-value 
basal-bolus vs.  
no diabetes 
2
 
P-value 
Fixed vs.  
no diabetes 
2
 
Energy intake 
(kcal/day) 
1769 ±18 1560 ±60 1543 ±85 1578 ±86 0.001 0.01 0.03 
Fat  
(% kcal) 
33.8 ±0.3 36.0 ±1.0 35.7 ±1.5 36.4 ±1.5 0.04 0.21 0.08 
Carbohydrate  
(% kcal) 
49.9 ±0.3 47.2 ±1.0 47.5 ±1.4 46.8 ±1.4 0.01 0.10 0.04 
Protein  
(% kcal) 
15.3 ±0.1 16.2 ±0.4 16.3 ±0.5 16.1 ±0.5 0.02 0.06 0.15 
Fiber  
(g/1000 kcal) 
8.2 ±0.1 7.4 ±0.5 7.4 ±0.7 7.4 ±0.7 0.13 0.27 0.27 
 
Values are given as LS mean ±SD from analysis of covariance, adjusted for sex (male versus female), age (<22 years versus ≥22 
years), and residence status (urban versus rural) 
1 
Pair-wise comparison of LS means from analysis of covariance. Pr > |t| for H0: LS mean(T1D) = LS mean(no DM) 
2 
Pair-wise comparison of LS means from analysis of covariance. Pr > |t| for H0: LS mean(basal-bolus or fixed) = LS mean(no DM) 
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Participants with T1D in both insulin regimen groups were significantly (p <0.05) more 
likely to be consumers of low-fat cakes and fungi & seaweed compared to participants without 
diabetes: adjusted odds ratio (OR) (95% confidence interval [CI]) comparing T1D combined to 
no diabetes (referent) 3.19 (1.99, 5.10) for low-fat cakes and 2.69 (1.76, 4.12) for fungi & 
seaweed (Table 4.3). They were also significantly more likely to be above the median intake for 
vegetables: adjusted OR (95% CI) comparing T1D combined to no diabetes (referent) 8.33 
(4.37, 15.86).  
Participants with T1D on basal-bolus insulin regimens had several distinct dietary 
modifications (Table 4.3): they were less likely to be consumers of fried foods (adjusted OR 
[95% CI], 0.48 [0.23, 1.00]) and more likely to be consumers of fish & shellfish (adjusted OR 
[95% CI], 1.95 [1.08, 3.52]) compared to participants without diabetes. 
Participants with T1D on fixed insulin regimens also had several distinct dietary 
modifications (Table 4.3): they were more likely to be above the median intake for wheat 
products (adjusted OR [95% CI], 2.03 [1.08, 3. 18]), and they were more likely to be consumers 
of high-fat cakes (adjusted OR [95% CI], 2.73 [1.25, 5.95]) and milk & milk products (adjusted 
OR [95% CI], 2.57 [1.19, 5.53]). Furthermore, they were less likely to be consumers of fruit 
(adjusted OR [95% CI], 0.47 [0.26, 0.87]). Indeed, only 54% of participants with T1D on fixed 
insulin regimens reported consuming fruit compared to 82% of those on basal-bolus insulin 
regimens and 74% of those without diabetes.  
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Table 4.3   Comparison of food group intake between participants without diabetes and those with type 1 diabetes (T1D) in China, combined and 
stratified by insulin regimen 
 
No diabetes 
n=1059 
T1D 
n=97 
Basal-bolus 
insulin 
T1D 
n=49 
Fixed 
insulin T1D 
n=48 
OR (95% CI) 
T1D 
vs. 
no diabetes 
(ref) 
2
 
Basal-bolus 
vs. 
no diabetes 
(ref) 
2
 
Fixed 
vs. 
no diabetes 
(ref) 
2
 
Rice         
   ≤ Median 
1
 (ref) 50.1 (530) 56.7 (55) 55.1 (27) 58.3 (28) 0.74 
(0.49, 1.13) 
0.81 
(0.45, 1.45) 
0.68 
(0.38, 1.23)    > Median 50.0 (529) 43.3 (42) 44.9 (22) 41.7 (20) 
Wheat products         
   ≤ Median 
1
 (ref) 50.1 (530) 38.1 (37) 44.9 (22) 31.3 (15) 1.66 
(1.08, 2.56) 
1.39 
(0.78, 2.49) 
2.03 
(1.08, 3.81)    > Median 50.0 (529) 61.9 (60) 55.1 (27) 68.8 (33) 
Low-fat cakes        
   Non-consumer (ref) 87.0 (921) 68.0 (66) 65.3 (32) 70.8 (34) 3.19 
(1.99, 5.10) 
3.25 
(1.74, 6.06) 
3.12 
(1.62, 6.03)    Consumer 13.0 (138) 32.0 (31) 34.7 (17) 29.2 (14) 
High-fat cakes        
   Non-consumer (ref) 90.9 (963) 81.4 (79) 81.6 (40) 81.3 (39) 2.25 
(1.28, 3.95) 
1.91 
(0.89, 4.09) 
2.73 
(1.25, 5.95)    Consumer 9.1 (96) 18.6 (18) 18.4 (9) 18.8 (9) 
Fried foods        
   Non-consumer (ref) 69.3 (734) 76.3 (74) 81.6 (40) 70.8 (34) 0.68 
(0.42, 1.11) 
0.48 
(0.23, 1.00) 
0.93 
(0.49, 1.77)    Consumer 30.7 (325) 23.7 (23) 18.4 (9) 29.2 (14) 
Fast food        
   Non-consumer (ref) 42.5 (450) 41.2 (40) 44.9 (22) 37.5 (18) 1.03 
(0.68, 1.58) 
0.87 
(0.49, 1.55) 
1.23 
(0.68, 2.25)    Consumer 57.5 (609) 58.8 (57) 55.1 (27) 62.5 (30) 
Vegetables        
   ≤ Median 
1
 (ref) 50.1 (530) 11.3 (11) 8.2 (4) 14.6 (7) 8.33 
(4.37, 15.86) 
11.45 
(4.06, 32.26) 
6.53 
(2.88, 14.78)    > Median 50.0 (529) 88.7 (86) 91.8 (45) 85.4 (41) 
Fruit         
   Non-consumer (ref) 26.0 (275) 32.0 (31) 18.4 (9) 45.8 (22) 0.70 
(0.44, 1.13) 
1.20 
(0.56, 2.57) 
0.47 
(0.26, 0.87)    Consumer 74.0 (784) 68.0 (66) 81.6 (40) 54.2 (26) 
Fungi & seaweed        
   Non-consumer (ref) 65.3 (692) 41.2 (40) 34.7 (17) 47.9 (23) 2.69 
(1.76, 4.12) 
3.47 
(1.89, 6.36) 
2.10 
(1.17, 3.77)    Consumer 34.7 (367) 58.8 (57) 65.3 (32) 52.1 (25) 
Nuts & seeds        
     Non-consumer (ref) 66.3 (702) 56.7 (55) 57.1 (28) 56.3 (27) 1.49 
(0.97, 2.29) 
1.31 
(0.73, 2.36) 
1.71 
(0.94, 3.11)      Consumer 33.7 (357) 43.3 (42) 42.9 (21) 43.8 (21) 
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Beans & bean products         
     Non-consumer (ref) 25.4 (269) 19.6 (19) 14.3 (7) 25.0 (12) 1.40 
(0.83, 2.36) 
2.10 
(0.93, 4.74) 
1.00 
(0.51, 1.96)      Consumer 74.6 (790) 80.4 (78) 85.7 (42) 75.0 (36) 
Red meat         
     ≤ Median 
1
 (ref) 50.0 (529) 42.3 (41) 42.9 (21) 41.7 (20) 1.32 
(0.86, 2.02) 
1.24 
(0.69, 2.23) 
1.40 
(0.77, 2.54)      > Median 50.1 (530) 57.7 (56) 57.1 (28) 58.3 (28) 
Poultry        
     Non-consumer (ref) 64.4 (682) 69.1 (67) 65.3 (32) 72.9 (35) 0.72 
(0.46, 1.14) 
0.79 
(0.43, 1.46) 
0.65 
(0.34, 1.26)      Consumer 35.6 (377) 30.9 (30) 34.7 (17) 27.1 (13) 
Fish & shellfish        
     Non-consumer (ref) 59.1 (626) 48.5 (47) 40.8 (20) 56.3 (27) 1.52 
(1.00, 2.32) 
1.95 
(1.08, 3.52) 
1.18 
(0.65, 2.13)      Consumer 40.9 (433) 51.6 (50) 59.2 (29) 43.8 (21) 
Eggs        
     ≤ Median 
1
 (ref) 50.1 (530) 39.2 (38) 34.7 (17) 43.8 (21) 1.55 
(1.01, 2.38) 
1.76 
(0.96, 3.21) 
1.38 
(0.77, 2.48)      > Median 50.0 (529) 60.8 (59) 65.3 (32) 56.3 (27) 
Milk & milk products        
     Non-consumer (ref) 34.0 (360) 17.5 (17) 14.3 (7) 20.8 (10) 2.39 
(1.35, 4.25) 
2.19 
(0.95, 5.05) 
2.57 
(1.19, 5.53)      Consumer 66.0 (699) 82.5 (80) 85.7 (42) 79.2 (38) 
Sugar-sweetened 
beverages 
       
     Non-consumer (ref) 89.9 (952) 90.7 (88) 85.7 (42) 95.8 (46) 0.85 
(0.41, 1.74) 
1.24 
(0.54, 2.87) 
0.40 
(0.10, 1.70)      Consumer 10.1 (107) 9.3 (9) 14.3 (7) 4.2 (2) 
 
Values are given as percentage (n) or OR (95% CI) 
1 
Median defined according to distribution in g/1000 kcal among participants without diabetes 
2 
OR (95% CI) from multivariable logistic regression, adjusted for sex (male versus female), age (<22 years versus ≥22 years), and residence status 
(urban versus rural) 
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4.4   Discussion 
Individuals with T1D in China, regardless of insulin regimen, had a lower mean percent 
of energy from carbohydrates compared to individuals without diabetes. In addition, they had 
higher intakes of vegetables, fungi & seaweed, and low-fat cakes. Several distinguishing 
characteristics of insulin regimen groups also emerged: participants on fixed regimens had 
higher intakes of wheat and were less likely to consume fruit and more likely to consume high-
fat cakes and dairy compared to participants without diabetes. In contrast, participants on basal-
bolus regimens were less likely to consume fried foods and more likely to consume fish & 
shellfish compared to participants without diabetes. Together, these observations suggest that 
dietary modifications are common among individuals with T1D in China. 
Few studies have systematically compared the dietary intakes of individuals with T1D 
and the general population. One study conducted in the United States between 2000 and 2002 
found similar results to our study, reporting that adults with T1D had a higher mean percent of 
energy from fat (36.0% in males and 34.7% in females with T1D versus 33.3% and 32.3%, 
respectively, in controls) and protein (18.8% in males and 19.6% in females with T1D versus 
18.0% and 18.9%, respectively, in controls) and a lower mean percent of energy from 
carbohydrates (44.0% in males and 45.9% in females with T1D versus 47.0% and 48.5%, 
respectively, in controls) compared to controls.85 A similarly higher mean percent of energy from 
fat compared to controls has also been observed in several small samples of youth with T1D in 
Europe.196,197 
In contrast to the aforementioned studies, a small study conducted in Australia between 
1984 and 1995 did not find any statistically significant differences in dietary intake between 
adults with newly diagnosed T1D and controls despite the fact that all of the T1D participants 
were reportedly following fixed insulin regimens matched to a set diet.198 Two other studies, both 
conducted in youth with T1D in Europe, also did not find significant differences in the 
macronutrient composition of the diet between participants with T1D and controls.199,200 In our 
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study, most participants with T1D were on fixed insulin regimens matched to a rigid diet with 
respect to timing and amount of food,188 and we observed substantial differences in dietary 
intake between participants with T1D and those without despite previously reporting limited 
nutrition education in this group of participants.188 This result may partially stem from the fact 
that our sample, relative to the aforementioned European samples, was older and had longer 
disease durations. More research is needed to identify the underlying factors contributing to the 
observed dietary modifications of individuals with T1D in China. 
The mean fiber intakes of participants with T1D (7.4 g/1000 kcal) and those without 
diabetes (8.2 g/1000 kcal) were well below the recommended level of 14 g/1000 kcal.161 While 
there was no statistically significant difference between these means after adjustment for 
confounders, the fiber intake of participants with T1D was, on average, approximately 0.8 
g/1000 kcal lower than that of participants without diabetes. Given that fiber intake is inversely 
associated with all-cause mortality and cardiovascular disease risk among individuals with 
diabetes,201,202 identifying strategies for improving dietary fiber intake should be an important 
goal of future research.   
Individuals with T1D in both insulin regimen groups had higher intakes of vegetables, 
fungi & seaweed, and low-fat cakes (including biscuits/crackers) compared to individuals without 
diabetes. The observation that they were more likely to consume fungi & seaweed may be the 
result of recommendations during diabetes education courses to eat more sugar-free foods, of 
which fungi are used as an example. The increased intake of low-fat cakes, which includes 
biscuits/crackers, likely reflects the common use of these food items to treat hypoglycemia.  
We observed that individuals with T1D on fixed insulin regimens were increasing their wheat 
product intake relative to individuals without diabetes. They also restricted their rice intake 
relative to individuals without diabetes, though it was not statistically significant (OR [95% CI], 
0.68 [0.38, 1.23]). These observations may reflect the fact that physicians in China, when 
discussing the effects of carbohydrates on blood glucose, often use rice as an example. In the 
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absence of additional nutrition education, we hypothesize that patients may subsequently 
equate rice with high blood glucose and replace rice with wheat products (such as noodles or 
buns) for their staple food. Similarly, we observed that these individuals were more likely to 
consume high-fat cakes compared to individuals without diabetes, perhaps because sugar-free 
cakes tend to be higher in fat and patients focus on low-sugar, low-carbohydrate foods rather 
than the totality of nutritional information. Finally, individuals with T1D on fixed insulin regimens 
(but not those on basal-bolus insulin regimens) restricted fruit intake, a phenomenon also 
reported in the United States,168 and again, likely the result of a carbohydrate focus rather than 
a healthy diet focus. Overall, the lack of physician time and dietitian involvement in T1D care in 
China may be contributing to patient misconceptions relating to nutrition. In-depth, qualitative 
research into this phenomenon may prove to be informative for future nutrition interventions in 
this population.   
Participants with T1D on basal-bolus insulin regimens had a generally healthier diet than 
the other groups, consuming fewer fried foods and more fish & shellfish. They also had higher 
intakes of beans (typically soy-based products such as tofu) and eggs relative to individuals 
without diabetes, though these differences were not statistically significant (OR [95% CI], 2.10 
[0.93, 4.74] and 1.76 [0.96, 3.21], respectively).These observations are consistent with the 
higher protein intake found in this group. Together, these results suggest that individuals with 
T1D in China who are on basal-bolus insulin regimens may be more motivated and/or have 
higher adherence to self-management recommendations, including those relating to nutrition. 
Participants with T1D were significantly less likely to be married or cohabitating compared to 
participants without diabetes even after adjustment for age: only 60% reported being married or 
cohabitating compared to 88% of participants without diabetes. Given epidemiological evidence 
linking social support with improved self-management behaviors and health outcomes,203-205 the 
results of this study highlight an important barrier for individuals with T1D in China.  
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Participants with T1D in both insulin regimen groups had significantly lower energy 
intake compared to participants without diabetes. They were also more likely to be underweight 
and less likely to be overweight compared to individuals without diabetes: 17% of participants 
with T1D were underweight compared to only 3% of those without diabetes, and 10% of 
participants with T1D were overweight compared to 42% of those without diabetes. This 
observation is consistent with a study conducted in Guangdong in southern China, which 
reported underweight and overweight prevalences of 19.6% and 11.8%, respectively, among 
individuals with T1D.26 Several factors may be underlying these results including the fact that 
most participants with T1D in 3CNAS reported a rigid diet with respect to timing and amount of 
food, including those on a basal-bolus insulin regimen,188 and this might prevent overeating and 
weight gain. Furthermore, the diabetes duration in this sample was relatively long, 
approximately 12 years, and though 3C Study participants with self-reported advanced micro- 
and macrovascular complications were not eligible for 3CNAS, it is possible that the natural 
progression of T1D and undiagnosed complications contributed to the relatively high prevalence 
of underweight in this sample population.  
This study focused on individuals with T1D in a large urban area in northern China. 
Therefore, results may not be generalizable to more rural areas or southern China where the 
diet differs substantially from the north. Additional challenges of this study were differences in 
dietary assessment methods between 3CNAS and CHNS. While interviewers from both studies 
were trained by staff from the China Center for Disease Control, and the 24-hour recall 
questionnaire and food composition tables were the same between studies, we cannot rule out 
that some of the differences observed between individuals with and without diabetes were the 
result of slight differences in dietary assessment methods rather than true differences between 
these populations. Related to this, dietary intake was self-reported and therefore subject to 
differential misclassification as individuals with T1D may be more accustomed to reporting 
dietary intake. Finally, participants with T1D on basal-bolus insulin regimens were more urban 
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and therefore may have more modern lifestyles than the other two groups. Although we 
controlled for residence status in the analysis, we cannot rule out residual confounding by 
unmeasured correlates of a more urbanized, modern lifestyle.  
Comparing the dietary intakes of individuals with T1D in China to those without diabetes 
allowed us to conclude that differences in observed dietary intake were the result of T1D rather 
than the result of cultural differences. To our knowledge, this is the first study to report on the 
dietary intakes of individuals with T1D relative to controls in a low- or middle-income country. 
One recent study reported on general dietary plans and nutritional therapy among individuals 
with T1D in Brazil, but to our knowledge, did not collect actual dietary intake data.206 
The substantial differences in macronutrient content and food groups between 
individuals with T1D in China and those without diabetes suggest that dietary modifications are 
common and reflect carbohydrate-conscious nutrition recommendations for individuals with 
T1D. Future research should focus on the effects of these modifications on quality of life and 
health outcomes. 
 
 
 
 
 
6
7
 
4.5   Supplemental figure 
 
Supplemental Figure S4.1   Directed acyclic graph for relationship between diabetes status (yes or no, T1D) and dietary intake as 
drawn using the tool, www.dagitty.net. Body mass index (BMI) was identified as a collider. No minimal sufficient adjustment sets were 
identified for estimating the total effect of diabetes status on dietary intake. One minimal sufficient adjustment set was identified to 
estimate the direct effect of diabetes status on dietary intake: {education, income, marital status, occupation, and residence status (urban 
versus rural)} 
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CHAPTER 5:   DIETARY PATTERNS ASSOCIATED WITH HBA1C AND LDL 
CHOLESTEROL AMONG INDIVIDUALS WITH TYPE 1 DIABETES IN CHINA 
 
5.1   Introduction 
 Improvements in treatment over the past 30 years have reduced the risk of CVD and all-
cause mortality among individuals with T1D;51-53 however, CVD and mortality rates remain 
significantly higher among adults with T1D relative to the general population.52,59 Furthermore, 
substantial geographic variation in mortality rates even among developed countries66,67 
suggests that improvements in T1D treatment have not been shared equally across the globe.  
 Since the completion of the landmark DCCT,70 treatment efforts to reduce CVD and 
other complications among individuals with T1D have focused on intensifying SMBG and insulin 
dose adjustments to achieve tight glycemic control.68,69 However, these intensive treatment 
regimens are uncommon in many parts of the world including China where the median number 
of times per day patients monitor is 0.4,26 in stark contrast to the recommended 6-8.68 China has 
the largest number of individuals with T1D in the Western Pacific Region207 and there is some 
evidence to suggest that the burden of comorbidities in this population is higher than that in the 
United States: 2001-2002 data from two centers in China on hypertension in youth <15 years 
old with T1D estimated a hypertension prevalence of 24%120 compared to 5.9% among youth 3 
to 17 years old with T1D in the United States.208 Strategies to reduce CVD and other 
complications in this high-risk population are urgently needed. 
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Dietary factors including, for example, high fiber intake,209 are prospectively associated 
with reduced risk of CVD and all-cause mortality among European adults with T1D. Dietary 
intake may therefore represent an important point of intervention to improve health outcomes for 
this population. RRR has emerged over the past 10 years as a method to identify disease-
specific dietary patterns.210 The objective of this analysis was to use RRR to identify dietary 
patterns maximizing the explained variation in two key health indicators, HbA1c and LDL 
cholesterol, among individuals with T1D in China.   
 
5.2   Methods 
5.2.1   Sample population 
The 3C Study was an epidemiological study of the coverage, cost, and care of T1D in 
China.162 A follow-up study, 3CNAS, was conducted, on average, 1.6 ±0.2 years later and 
expanded the 3C Study to include detailed information on dietary intake. 3C Study participants 
who met the following criteria were eligible for 3CNAS: Beijing resident, ≥ 12 years old, no 
severe diabetes complications (i.e. advanced micro- and macrovascular complications, 
including nephropathy and stroke), and in-service telephone number available.  
 
5.2.2   Data collection 
Self-reported demographic and socioeconomic data were collected during the 3C Study 
visit. A fasting blood sample was collected by venipuncture during the 3CNAS visit and 
biomarkers were assessed using standardized laboratory procedures. Specifically, HbA1c was 
measured in whole blood with an automated high-performance liquid chromatography system 
(Primus Ultra2, Trinity Biotech, Bray, Co Wicklow, Ireland). Blood samples for lipid analysis were 
immediately centrifuged at 2000 RPM for 15 minutes and the serum was stored at -80°C for 
batch analysis using an automated Hitachi-008 system (Hitachi, Chiyoda, Tokyo, Japan). 
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Information on insulin administration method, type, and dose, and SMBG were also 
collected during the 3CNAS visit. Four insulin regimens were defined as follows: (1) MDI (≥ 3 
injections) that included glargine or detemir (“MDI: With basal”), (2) continuous subcutaneous 
infusion (“Pump”), (3) MDI with any insulin types excluding glargine and detemir (“MDI: No 
basal”) and (4) 1-2 injections per day of any insulin types (“1-2 injections”).  
Dietary intake was assessed on average, beginning 3.0 ±2.8 days after the 3CNAS visit 
using three (two weekday and one weekend day) telephone administered 24-hour dietary 
recalls assisted by food records. The 24-hour recall food lists were converted into 42 
nutritionally meaningful food groups by a collaborative working group that included researchers 
at the University of North Carolina, Chapel Hill, and the Chinese Institute of Nutrition and Food 
Safety.186 Four food groups (plant oils, salt, other spices & condiments, and herbs & other 
functional foods) were excluded because of the measurement error associated with estimating 
added oil, salt, and spices, which were not the focus of this analysis. Consistent with previous 
RRR analyses of non-diabetic Chinese adults,211 alcohol was excluded because it was only 
consumed by males. Food groups with <10% consumers (dried vegetables, organ meats, infant 
formula, lard & butter, candy, other high-sugar foods, sweetened dairy products, calorically-
sweetened beverages, and other) were also excluded because of their lack of variability in this 
sample population. Where appropriate given behavioral and cultural considerations, food groups 
were combined. These combinations included: starchy tubers & starchy tuber products; beans 
and bean products; low- and high-beta carotene vegetables; fresh or canned fruit and dried fruit; 
low- and high-fat meat and meat products; low- and high-fat poultry; and fish and shellfish. A 
total of 20 food groups were considered for the RRR analysis (Supplemental Table S5.1). Most 
food groups had a large proportion of non-consumers and therefore all food groups were 
dichotomized for the RRR analysis. Food groups with ≥80% consumers were dichotomized as 
below versus above the median, and food groups with ≥10% but <80% consumers were 
dichotomized as non-consumers versus consumers. 
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5.2.3   Statistical analysis 
 We used RRR to identify dietary patterns maximizing the explained variation in health 
indicators.210 Twenty food groups adjusted for total energy intake using the density method189 
were used as predictors. Two predefined health indicators, HbA1c and LDL cholesterol, log-
transformed to improve normality, were used as responses. HbA1c and LDL cholesterol were 
chosen because they are well established risk factors for CVD and diabetes-related 
complications in individuals with T1D.212-219 RRR produces as many factors (“dietary patterns”) 
as there are responses, and consequently two factors were obtained. To characterize the 
factors, food groups with factor loadings ≥0.25 were considered. Using PLS (partial least 
squares) procedure in SAS software specifying method = RRR, linear functions of the 20 
predictors (known as “dietary pattern scores”) were derived which maximized the proportion of 
explained variation in the set of two responses. These dietary pattern scores were then 
categorized into tertiles. The explained proportion of score variation was calculated for each 
food group strongly associated (factor loadings ≥0.25) with the dietary patterns as the product of 
the standardized score parameter, the correlation coefficient with the dietary pattern score, and 
100%. Results are presented in order of decreasing explained proportion of score variation. 
In order to improve RRR model fit, a backwards elimination approach was used to 
reduce the number of predictor variables. The food group that was explained the least by the 
dietary patterns was eliminated first and the RRR was re-fitted. This procedure was repeated 
until all food groups with <5% of their variance explained by the dietary patterns, and 
consequently those that did not load heavily on either factor, were eliminated. Results were 
largely consistent compared to the full RRR model (20 predictors) with respect to food group 
loadings and associations with the response variables at this point, and therefore only the nine 
remaining predictors (rice, wheat products, high-fat cakes, beans & products, nuts & seeds, 
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pickled vegetables, eggs, fish & shellfish, and low-calorie beverages) were included in the final 
RRR.  
Differences in demographic and clinical characteristics across tertiles of the dietary 
pattern scores were assessed using chi-square tests for categorical variables and Kruskal-
Wallis tests for continuous variables. Furthermore, because sociodemographic characteristics 
may partially explain observed associations between the RRR-derived dietary patterns and the 
responses, we calculated mean values of the health indicators across the dietary pattern score 
tertiles with adjustment for age and household income using ANCOVA. Age and household 
income were chosen because these variables were independently associated (p<0.10) with 
both dietary intake and the risk factors (HbA1c and/or LDL cholesterol) in bivariate analyses 
(data not shown). 
After identifying dietary patterns associated with HbA1c and LDL cholesterol, we 
explored independent, bivariate associations between the food groups identified as being 
important (factor loadings ≥0.25) in the RRR and each of these risk factors. 
Values presented are mean ±SD or n (%). All statistical analyses were conducted in 
SAS 9.2 (SAS Institute, Cary, North Carolina).  
 
5.3   Results 
  Dietary pattern 1 was characterized by low intakes of wheat products and high-fat 
cakes, and high intakes of beans and pickled vegetables (Table 5.1). These four food groups 
together explained 83% of the variation in the first dietary pattern score with the most important 
contributors being high-fat cakes (36%) and wheat products (33%). Dietary pattern 2 was 
characterized by low intakes of high-fat cakes, nuts & seeds, fish & shellfish, and low-calorie 
beverages, and high intakes of rice and eggs. These six food groups together explained 90% of 
the variation in the second dietary pattern score with the most important contributors being low-
calorie beverages (33%) and fish & shellfish (21%).  
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The first RRR-identified dietary pattern explained 5.9% of the variation in HbA1c, 9.8% in 
LDL cholesterol, and 7.9% of the total variation in both health indicators. The second dietary 
pattern explained 7.1% of the variation in HbA1c, 4.2% in LDL cholesterol, and 5.7% of the total 
variation in both health indicators. HbA1c and LDL cholesterol were not significantly correlated 
in this sample (Pearson Correlation Coefficient =0.01, p=0.89). 
 There were few significant differences across tertiles of the dietary pattern scores in 
terms of sociodemographic and diabetes self-management characteristics (Table 5.2). 
Participants in the highest tertile of dietary pattern 1 score had marginally significantly longer 
diabetes durations (p=0.09). The significant association observed with insulin regimen was 
equivocal: participants in the lowest and highest tertile of dietary pattern 1 score were more 
likely to be on “MDI: With basal” or “pumps,” and less likely to be on “MDI: No basal” or “1-2 
injections” compared to participants in the middle tertile. 
Participants in the highest tertile of dietary pattern 1 score had significantly higher HbA1c 
(Figure 5.1A) and LDL cholesterol (Figure 5.2A) levels compared to participants in the lowest 
tertile: mean difference in HbA1c was one percentage point and in LDL cholesterol was 0.36 
mmol/L after adjustment for age and household income. There were no significant differences in 
HbA1c or LDL cholesterol in either unadjusted or adjusted analyses across tertiles of dietary 
pattern 2 score (Figure 5.1B and Figure 5.2B).  
In bivariate analyses estimating the association between key food groups identified in 
the RRR analysis and the risk factors (Table 5.3), only high-fat cakes were associated with 
HbA1c: consumers had significantly lower HbA1c compared to non-consumers (p=0.008). 
Consumers of wheat products had significantly lower LDL cholesterol compared to non-
consumers (p=0.03), and consumers of fish & shellfish and low-calorie beverages had 
marginally significantly higher LDL cholesterol compared to non-consumers (p=0.08 and 
p=0.05, respectively).  
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Table 5.1   Food groups strongly associated (factor loadings ≥0.25) with the dietary patterns obtained by reduced rank 
regression among individuals with type 1 diabetes in China (n=99) 
Food group 
Factor 
loading 
Explained proportion 
of score variation 
1
 
 
Tertile of dietary pattern score 
2
 P- 
value 
3 
1 2 3 
Dietary pattern 1 
     High-fat cakes -0.55 36.0%      
          Consumers    15 (47%) 4 (12%) 0 (0%) 
<0.0001 
          Non-consumers    17 (53%) 29 (88%) 34 (100%) 
     Wheat products -0.57 33.2%      
          Consumers    26 (81%) 20 (61%) 3 (9%) 
<0.0001 
          Non-consumers    6 (19%) 13 (39%) 31 (91%) 
     Pickled vegetables 0.39 8.4%      
          Consumers    2 (6%) 8 (24%) 13 (38%) 
0.009 
          Non-consumers    30 (94%) 25 (76%) 21 (62%) 
     Beans & products 0.28 5.8%      
          Consumers    11 (34%) 14 (42%) 25 (74%) 
0.003 
          Non-consumers    21 (66%) 19 (58%) 9 (26%) 
Dietary pattern 2 
     Low-calorie beverages -0.57 32.9%      
          Consumers    26 (79%) 6 (18%) 0 (0%) 
<0.0001 
          Non-consumers    7 (21%) 28 (82%) 32 (100%) 
     Fish & shellfish -0.43 21.3%      
          Consumers    25 (76%) 18 (53%) 8 (25%) 
0.0002 
          Non-consumers    8 (24%) 16 (47%) 24 (75%) 
     High-fat cakes -0.41 18.9%      
          Consumers    14 (42%) 4 (12%) 1 (3%) 
0.0001 
          Non-consumers    19 (58%) 30 (88%) 31 (97%) 
     Eggs  0.31 10.9%      
          Consumers    13 (39%) 13 (38%) 24 (75%) 
0.003 
          Non-consumers    20 (61%) 21 (62%) 8 (25%) 
     Nuts & seeds  -0.26 0.8%      
          Consumers    18 (55%) 16 (47%) 9 (28%) 
0.09 
          Non-consumers    15 (45%) 18 (53%) 23 (72%) 
1
 Calculated as the product of the corresponding standardized score parameter, the correlation coefficient with the dietary 
pattern score, and 100% 
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2 
Values are given as n (%) 
3 
Chi-square test comparing proportions of consumers and non-consumers of the specified food group across tertiles of 
the dietary pattern score 
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Table 5.2   Demographic and diabetes self-management characteristics  according to tertiles of dietary patterns obtained by reduced 
rank regression among individuals with type 1 diabetes in China  
 
Tertile of Dietary Pattern 1 Score 
P-
value 
1
 
 Tertile of Dietary Pattern 2 Score 
P-
value 
1
 
 
1 
n=32 
2 
n=33 
3 
n=34 
 
1 
n=33 
2 
n=34 
3 
n=32 
Age (years) 41.5 ±15.1 39.6 ±16.4 44.8 ±16.6 0.45  45.5 ± 14.5 41.3 ± 14.9 39.2 ± 18.5 0.28 
Diabetes duration (years) 11.1 ±10.8 9.8 ±7.7 14.7 ±9.9 0.09  13.1 ± 10.9 12.9 ± 9.5 9.6 ± 8.4 0.31 
Female          
     Female 15 (47%) 13 (39%) 17 (50%) 
0.67 
 16 (48%) 16 (47%) 13 (41%) 
0.80 
     Male 17 (53%) 20 (61%) 17 (50%)  17 (52%) 18 (53%) 19 (59%) 
Highest level of education 
     <University 9 (29%) 12 (36%) 10 (29%) 
0.70 
 6 (18%) 12 (36%) 13 (41%) 
0.25      Junior University 5 (16%) 7 (21%) 4 (12%)  5 (15%) 5 (15%) 6 (19%) 
     ≥University 17 (55%) 14 (42%) 20 (59%)  22 (67%) 16 (48%) 13 (41%) 
Household income (RMB/month) 
     <3000 6 (19%) 8 (24%) 6 (18%) 
0.32 
 4 (12%) 6 (18%) 10 (31%) 
0.52 
     3000 - <5000 8 (25%) 10 (30%) 4 (12%)  7 (21%) 7 (21%) 8 (25%) 
     5000 - <10 000 7 (22%) 9 (27%) 14 (41%)  11 (33%) 12 (35%) 7 (22%) 
     ≥10 000 11 (34%) 6 (18%) 10 (29%)  11 (33%) 9 (26%) 7 (22%) 
Marital status 
     Married/cohabitating 17 (55%) 19 (58%) 22 (71%) 
0.38 
 21 (66%) 19 (59%) 18 (58%) 
0.80 
     Single/divorced/widowed 14 (45%) 14 (42%) 9 (29%)  11 (34%) 13 (41%) 13 (42%) 
Residency status          
     Urban 27 (87%) 24 (75%) 30 (91%) 
0.18 
 30 (91%) 26 (81%) 25 (81%) 
0.44 
     Rural 4 (13%) 8 (25%) 3 (9%)  3 (9%) 6 (19%) 6 (19%) 
Insulin regimen          
     MDI: With basal 15 (47%) 9 (27%) 17 (50%) 
0.03 
 14 (42%) 12 (35%) 15 (47%) 
0.58 
     Pump 3 (9%) 0 (0%) 6 (18%)  5 (15%) 2 (6%) 2 (6%) 
     MDI: No basal 9 (28%) 14 (42%) 7 (21%)  8 (24%) 14 (41%) 8 (25%) 
     1-2 injections 5 (16%) 10 (30%) 4 (12%)  6 (18%) 6 (18%) 7 (22%) 
SMBG          
     <1 time/week  8 (25%) 15 (45%) 8 (24%) 
0.44 
 8 (24%) 14 (41%) 9 (28%) 
0.36 
     1-2 times/week 10 (31%) 8 (24%) 9 (26%)  8 (24%) 9 (26%) 10 (31%) 
     3-6 times/week 4 (13%) 4 (12%) 4 (12%)  3 (9%) 3 (9%) 6 (19%) 
     ≥1 time/day 10 (31%) 6 (18%) 13 (38%)  14 (42%) 8 (24%) 7 (22%) 
 
Values are given as n (%) or mean ± SD 
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1
 Chi-square test for categorical variables and Kruskal-Wallis test for continuous variables 
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Table 5.3   Bivariate associations of food groups that loaded 
heavily (loadings ≥0.25) on the reduced rank regression-derived 
dietary patterns with HbA1c and LDL cholesterol in individuals 
with type 1 diabetes in China (n=99) 
 
HbA1c  
(%) 
LDL 
cholesterol 
(mmol/L) 
Beans & bean products   
     Consumers 8.44 (1.72) 2.43 (0.74) 
     Non-consumers 8.00 (1.81) 2.37 (0.68) 
          P-value 
1
 0.14 0.67 
Pickled vegetables   
     Consumers 8.57 (2.12) 2.61 (0.94) 
     Non-consumers 8.12 (1.65) 2.34 (0.62) 
          P-value 
1
 0.44 0.55 
Rice   
     Consumers 8.29 (1.66) 2.33 (0.66) 
     Non-consumers 8.15 (1.89) 2.47 (0.76) 
          P-value 
1
 0.36 0.55 
Wheat products   
     Consumers 8.10 (1.81) 2.25 (0.70) 
     Non-consumers 8.34 (1.74) 2.55 (0.70) 
          P-value 
1
 0.37 0.03 
High-fat cakes   
     Consumers 7.28 (1.12) 2.24 (0.46) 
     Non-consumers 8.45 (1.83) 2.44 (0.75) 
          P-value 
1
 0.008 0.41 
Nuts & seeds    
     Consumers 8.02 (1.62) 2.41 (0.62) 
     Non-consumers 8.38 (1.88) 2.39 (0.78) 
          P-value 
1
 0.30 0.60 
Eggs    
     Consumers 8.52 (2.12) 2.38 (0.71) 
     Non-consumers 7.92 (1.28) 2.42 (0.72) 
           P-value 
1
 0.33 0.48 
Fish & shellfish   
     Consumers 8.13 (1.92) 2.51 (0.69) 
     Non-consumers 8.33 (1.61) 2.28 (0.72) 
           P-value 
1
 0.37 0.08 
Low-calorie beverages   
     Consumers 7.87 (1.39) 2.59 (0.64) 
     Non-consumers 8.39 (1.91) 2.31 (0.73) 
          P-value 
1
 0.23 0.05 
Values are given as mean (SD) 
1 
Kruskal-Wallis test
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Figure 5.1   Mean adjusted HbA1c (%) and 95% confidence intervals from analysis of covariance 
according to tertiles of A) reduced rank regression-derived dietary pattern 1 score and B) dietary 
pattern 2 score among individuals with type 1 diabetes in China (n=99). Adjusted for age and 
household income. *p<0.05 comparing 1st and 3rd tertiles 
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Figure 5.2   Mean adjusted LDL cholesterol (mmol/L) and 95% confidence intervals from analysis of 
covariance according to tertiles of A) reduced rank regression-derived dietary pattern 1 score and B) 
dietary pattern 2 score among individuals with type 1 diabetes in China (n=99). Adjusted for age and 
household income. *p<0.05 comparing 1
st
 and 3
rd
 tertiles 
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5.4   Discussion 
We identified a dietary pattern characterized by low intakes of wheat products and high-
fat cakes, and high intakes of beans & bean products and pickled vegetables that was 
significantly positively associated with HbA1c and LDL cholesterol in a cohort of adolescents 
and adults with T1D in China: the mean adjusted difference between the highest and lowest 
tertile of the dietary pattern score for HbA1c was one percentage point and for LDL cholesterol it 
was 0.36 mmol/L. In a meta-analysis of prospective cohort studies, a one-percentage point 
increase in HbA1c was associated with an increase in CVD risk of 18%,220 thus this finding is 
clinically meaningful. Furthermore, a difference in LDL cholesterol of 0.8 mmol/L can move an 
individual from near optimal to borderline high risk, and therefore our observed difference in LDL 
cholesterol of approximately 0.4 mmol/L was also clinically important. These observations 
improve our understanding of dietary factors influencing CVD risk among individuals with T1D 
living in a country undergoing rapid changes in nutrition and health.221,222 
Participants in the highest tertile of the dietary pattern 1 score were more likely to be 
consumers of pickled vegetables, which tend to be high in salt, and these participants also had 
higher HbA1c and LDL cholesterol levels. This is consistent with a study reporting an 
association between consumption of salted food and hyperlipidemia among Chinese men,223 
and a recent study linking dietary sodium prospectively with end-stage renal disease and 
mortality in Finnish adults with T1D.224 
Interestingly, low intakes of high-fat cakes was an important aspect of dietary pattern 1, 
which was ultimately associated with poor risk factor status. Indeed, “high-fat cakes” was the 
only food group significantly associated with HbA1c in bivariate analyses. This observation 
makes sense given that nearly all T1D patients in China report having been told to limit their 
sweet intake (for example, desserts, non-diet sodas, and candy), and “sugarless” products are 
increasingly available at food retailers in China. Individuals that adhere to recommendations 
may choose sugarless cakes that are high in fat over low-fat cakes that are high in sugar. While 
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not statistically significant, a greater proportion of low-fat cake consumers were in the highest 
tertile of dietary pattern 1 (and therefore had lower high-fat cake intakes): 45% compared to 
26% in the lowest tertile of dietary pattern 1. Together, these observations may explain the 
inverse association between high-fat cake consumption and HbA1c in this analysis.  
In contrast to a small (n=12) crossover dietary intervention trial of a soy diet in young 
adults with T1D and hyperfiltration (defined as glomular filtration rates >120 mL/min/1.73m2),225 
and a meta-analysis of intervention trials in adults without T1D,226 which both found a soy-based 
diet high in isoflavones reduced LDL cholesterol, we found that a dietary pattern characterized 
by high bean & bean product (tofu) intakes was associated with higher LDL cholesterol and 
HbA1c. This result was unexpected, though it is important to consider that only 5.8% of the 
variability in the dietary pattern score was explained by this food group. More research is 
needed to understand the effects of bean & bean product intake on health in this population. 
To our knowledge, only one study has derived dietary patterns using RRR in a 
population of individuals with T1D.227 Using data from the SEARCH for Diabetes in Youth Study, 
a dietary pattern characterized by high intakes of eggs, sweetened coffee and tea, sweetened 
soda/fruit-flavored drinks, diet soda, potatoes, and high-fat meat, and low intakes of 
sweets/desserts and low-fat dairy was positively associated with markers of CVD risk (LDL 
cholesterol, triglycerides, systolic blood pressure, HbA1c, C-reactive protein, and waist 
circumference).227 The differences observed between this dietary pattern and the dietary pattern 
derived in our analysis are likely the result of a combination of factors including different sample 
populations (different continent of residence, age, and disease duration), different response 
variables (disease biomarkers), and different predictor variables (due to cultural differences in 
dietary intake). Nonetheless, the similarities are worth mentioning here, particularly the high 
intakes of eggs, which was an important food group in both studies. Evidence relating egg 
consumption to CVD risk is equivocal: while a recent meta-analysis found that egg consumption 
is related to increased risk of coronary heart disease among adults with T2D (relative risk [95% 
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confidence interval] comparing highest and lowest egg intake 1.54 [1.14, 2.09]), there was no 
association among non-diabetic adults.228 More research on dietary patterns in diverse 
populations is needed to improve our understanding of the effects of foods and beverages on 
disease outcomes.  
The objective of RRR is not to describe dietary patterns that reflect either dietary 
recommendations or cultural patterns described in the literature, but rather to identify dietary 
patterns important in the development of disease. Nonetheless, an important challenge of 
interpreting this analysis is that the dietary patterns identified by RRR do not necessarily 
represent patterns of foods and beverages actually eaten together in the sample population. 
Furthermore, this study was cross-sectional and we cannot rule out reverse causality: the 
process of recording and recalling dietary intake could differentially affect reporting between 
those at high-risk and those at low-risk of CVD. However, purposeful dietary misreporting may 
be uncommon in China.153 In our study, these biases were addressed by using interviewers who 
were not the participants’ healthcare providers and training them to use a standardized protocol 
and neutral probes,159 as well as emphasizing in conversations with participants that we were 
interested in understanding what individuals with T1D usually eat and that it was important that 
they not change their dietary habits. Another limitation of this study is the small sample size, 
which limits the generalizability of our findings. However, this is the largest sample of individuals 
with T1D in a developing country for which comprehensive dietary data are available, and 
therefore these results provide invaluable insight into potential areas for future research.  
In summary, a dietary pattern was identified that is strongly related to two established 
risk factors for serious, chronic complications of T1D. These findings provide support for 
development of behavioral strategies to prevent complications including CVD in adolescents 
and adults with T1D in China. 
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5.5   Supplemental tables 
Supplemental Table S5.1   Food groups consumed by individuals with type 1 diabetes in China included 
in the reduced rank analysis 
Food group Examples of foods included 
Consumers 
n (%) 
Rice 
 
Rice 94 (95%) 
Wheat products 
 
Noodles, buns (baozi), breads (shaobing) 98 (99%) 
Low-fat cakes 
 
Cakes with <15 g fat/100 g cake such as fruit cakes, “Royal style” 
cakes, sesame seed cookies, sachima, and soda biscuits 
 
31 (31%) 
High-fat cakes 
 
 
Cakes with ≥15 g fat/1000 g cake such as “Mooncakes”, walnut 
cookies (taosu), pastries 
19 (19%) 
Deep-fried foods 
 
Deep-fried dough sticks (youtiao) 23 (23%) 
Corn & products 
 
Fresh corn, corn grits, corn flour 45 (45%) 
Tubers & products 
 
Potato, cassava, lotus root, starchy root flours and noodles 58 (59%) 
Beans & products 
 
Soybean, kidney bean, broad bean, soybean curd (tofu) 80 (81%) 
Nuts & seeds 
 
Walnuts, peanuts, sesame seeds 43 (43%) 
Vegetables 
 
Carrot, tomato, broccoli, bok choi, radishes, eggplant 99 (100%) 
Pickled vegetables 
 
Preserved radish, preserved cabbage 23 (23%) 
Fruit 
 
Apples, peaches, watermelon, bananas, lychee, dates 65 (66%) 
Fungi & seaweed 
 
Mushrooms, wood ear fungus, kelp 57 (58%) 
Meat & products 
 
Beef, mutton, pork, sausages 
 
93 (94%) 
 
Poultry 
 
Chicken, duck 29 (29%) 
Eggs 
 
Chicken eggs, quail eggs 91 (92%) 
Fish & shellfish 
 
Carp, shrimp 51 (52%) 
Milk & products 
 
Liquid milk, powdered milk, yogurt, cheese 82 (83%) 
Fast food 
 
 
Chicken fillet burger (KFC); French fries (KFC); frozen dumplings; 
instant noodles; breakfast cereals  
60 (61%) 
Teas & coffee Coffee, Green tea, Jasmine tea 
 
32 (32%) 
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CHAPTER 6:   CHALLENGES 
 Several challenges were faced in conducting 3CNAS and are divided into two broad 
categories: 1) challenges relating to data collection and 2) challenges relating to data analysis. 
Within data collection, getting institutional review board (IRB) approval from our collaborating 
institution in China (Peking University Health Science Center) was the first barrier to moving 
forward on the project. Difficulties were also encountered with recruitment, dietary intake 
assessment via telephone interview, and converting the 24-hour recall food lists into nutrients. 
In regards to data analysis, the small sample size, selection bias, and the dietary pattern 
analysis were key areas requiring additional consideration. Each of these challenges is 
discussed in detail in the sections that follow. 
 
6.1   Data collection 
6.1.1   Institutional Review Board approval  
 In September 2013, Tufts University issued a statement that a study published in the 
American Journal of Clinical Nutrition in August 2012 in which researchers fed children in Hunan 
province, China, genetically modified rice (“golden rice”) had violated Federal rules governing 
human research.229 Tufts’ IRB concluded that the Principal Investigator of the study had not 
provided sufficient evidence that the study had been reviewed by an ethics review board in 
China; some of the consent forms had not been obtained prior to the study start; some of the 
dates on the consent forms had been changed; some of the consent forms were inappropriately 
signed; and none of the consent forms included the phrase, “genetically modified.”229  
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Given this situation, it was not surprising that we ran into difficulties getting IRB approval 
from our collaborating institution in China as we began the process in the fall of 2012. Although 
our study was only observational, it involved children (<18 years old) and the Peking University 
Health Science Center IRB required a full board review. Furthermore, written consent 
(participants ≥18 years old) or written assent and parent permission (participants <18 years old) 
was required, even for the Relative Validity Study, which simply involved completing two 24-
hour recalls (one over the telephone and one in-person at the hospital). The process was 
particularly baffling because there were no clear guidelines as to what qualified for expedited 
review or when oral consent would be acceptable. Thus, we could not anticipate the IRB’s 
comments and prepare our application accordingly. Ultimately, to prevent any further delays in 
study start (we began the IRB application process in November 2012, and still had not received 
approval from Peking University by January 2013), we decided to split the study into three 
distinct parts: 1) Adult Relative Validity Study, 2) Adolescent Relative Validity Study, and 3) 
Main Study in Adults and Adolescents. The Adult Relative Validity Study received approval from 
Peking University by expedited review at the end of January 2013, while the Adolescent 
Relative Validity Study and Main Study in Adults and Adolescents required full board review at 
the end of February 2013 (delayed due to Spring Festival). Following this meeting, the Peking 
University IRB asked our permission to share the Chinese versions of our consent forms with 
other researchers; these forms are now available as a template for scientists in China, a small 
but important contribution to the future protection of human research subjects and efficiency of 
the application process. 
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6.1.2   Recruitment 
6.1.2.1   Following up with 3C Study participants 
A common barrier to all longitudinal follow-up studies is not being able to contact 
participants. 3CNAS was designed as a follow-up study to the 3C Study because of efficiency (it 
would have been time consuming to recruit participants directly from the outpatient clinic as was 
done in the 3C Study), and because it will allow researchers to look at change in key variables 
such as HbA1c. However, a large proportion of participants originally enrolled in the 3C Study 
did not provide a telephone number (especially the adolescents) or the telephone number they 
did provide was no longer in service. Of n=443 Beijing 3C Study participants ≥12 years old, we 
were not able to contact n=233 (52.6%) due to lack of in-service telephone number. Therefore, 
approximately one-fifth of participants were lost to follow up simply because their telephone 
numbers were no longer in service. Future studies could include additional contact information, 
for example, telephone numbers for relatives or employers, to improve researchers’ ability to 
stay in contact with participants.  
 
6.1.2.2   Type 1 diabetes stigma 
Another significant barrier to recruitment was the stigma associated with T1D in China. 
Recent results of the second Diabetes Attitudes, Wishes and Needs (DAWN2) study indicated 
that 19.1% of participants from China reported being discriminated against because of their 
diabetes, compared to 10.6% of participants from the United States.230 However, the majority of 
DAWN2 participants had T2D,230 an increasingly common disease,112 whereas T1D remains 
relatively rare.101 We therefore suspect that the proportion of individuals with T1D who are 
discriminated against is much higher: as with many relatively rare diseases in China (for 
example, epilepsy),231 individuals who are diagnosed with T1D are considered ‘monsters’ by 
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society. One parent of a child with T1D told us: ‘type 1 diabetes in China is not like in the U.S. 
because there are so few people with it here and if anyone finds out that my daughter has it 
they will think she is strange.’  
Structural discrimination—institutional practices that result in disadvantage for 
stigmatized groups—by schools and employers is pervasive in China. For example, there is a 
government regulation stating that individuals with ‘severe endocrine and metabolic diseases’ 
should not be admitted to universities or junior colleges,232 or employed by the government. As 
a result, individuals hide their diabetes in order to ‘save face’ and gain acceptance to schools, or 
government employment; a coping strategy similar to that observed among individuals with 
schizophrenia and AIDS in China.233,234 One man with T1D told us that he does not use his 
government medical insurance card and pays for all of his diabetes care out-of-pocket because 
he does not want his name associated with the disease.  
While designing 3CNAS, we were not aware of the severity of the stigma associated with 
T1D in China or the general population’s lack of trust in doctors conducting medical research 
(perhaps due to recent reports of doctors accepting bribes from pharmaceutical companies).235 
Looking ahead to future research, integration of study visits with semi-annual check-up visits for 
T1D may improve response rates. However, this would require an expanded recruitment and 
enrollment period as well as inclusion of many data collection sites (e.g. including all hospitals 
where patients receive their usual care). 
 
6.1.3   Dietary assessment  
 The severe stigma associated with T1D in China also precluded our ability to go to the 
participants’ houses in order to collect dietary data, as has been done in other studies in 
China.186 Because it would have been burdensome for participants to travel to the hospital on 
three separate occasions to complete the three 24-hour recalls required to estimate usual 
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dietary intake for the sample population,236 we had to administer the 24-hour recalls via 
telephone interview. A critical strength of this study was that we assessed the relative validity of 
this administration method against in-person administration in a subset of participants prior to 
beginning data collection for the larger cohort.  
 One of the biggest difficulties and likely sources of measurement error in 3CNAS and in 
most observational studies of dietary intake is estimation of portion sizes.237 What is a “typical” 
portion size for any given food varies between countries, within countries, and over time. 
Therefore, it was essential that we integrate discussion (in Mandarin, the participants’ native 
language) of culturally appropriate food models and pictures (Figure 6.1) into the in-person visit 
with a trained clinical dietitian. While two-dimensional food pictures have been shown to be as 
helpful as three-dimensional food models in estimating portion sizes in 24-hour recalls,238 
portion size estimates based off of food pictures appear to be more accurate (e.g. closer to 
weighed portion sizes) when there is greater concordance between the food picture and the 
actual food consumed.239 This is why it was essential to develop a food picture guide specific to 
the diets of participants in northern China. 
An added difficulty with estimating portion sizes in China was the fact that “family style” 
meals, in which food is directly consumed from a common dish, were common. This rendered 
ineffectual the plate diagrams typically used to estimate portion sizes in Western settings. To 
overcome this barrier, we asked participants to estimate what proportion of the total recipe they 
consumed.   
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Figure 6.1   Examples of culturally appropriate portion size picture guides 
from book given to 3C Nutrition Ancillary Study participants in their 
Introductory Packet 
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Related to this, given the limited scope of the Chinese Food Composition Tables,151,152 
we had to probe for each ingredient of complex recipes. Because the focus of this study was not 
salt, and because of the inherent errors in estimating spices added to recipes, we did not probe 
specifically for these ingredients. However, we did probe specifically for oil (type and amount), 
other sauces (e.g. soy sauce), vegetables, starches (e.g. wheat noodles), and proteins (e.g. 
pork, soybean curds). This was especially difficult when participants consumed food outside the 
home and did not directly observe the food preparation. This challenge is not limited to our 
study, and will be an important area to address in future dietary assessments in rapidly 
developing countries such as China where food consumed away from home is increasingly 
common.240  
 
6.1.4   Conversion of food lists into nutrients 
 The 2009 Chinese Food Composition Tables151 contain approximately 1500 different 
food items, compared to over 18,000 food items contained in the University of Minnesota 
Nutrition Coordinating Center’s Nutrition Data System for Research.241 The direct implication of 
this limited range of options was that we had to develop a set of rules for entering codes 
associated with each food reported by participants (the codes were then used to determine the 
nutrient composition of the corresponding food). For example, several participants reported 
consuming a newly formulated product, whole-wheat mantou (bun), for which there was no food 
code. After consulting with two Chinese nutrition specialists, we decided to use the food code 
for “standard wheat mantou” for any whole-wheat mantou and “average mantou” for any non-
whole-wheat mantou. Other examples of substitutions included: “chicken broth” for “fish broth,” 
“peanut oil” for “chili oil,” “beef tenderloin” for “beef backstrap,” and “raisin” for “dried cranberry.” 
Another limitation of the Chinese Food Composition Tables151,152 was that they did not 
include separate codes for “raw” and “cooked” for all foods. Therefore all vegetable portion sizes 
that were reported as cooked had to be converted to raw, and all rice portion sizes reported as 
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uncooked (grains without water) had to be converted to cooked (with water). While this was a 
time consuming task that assumed constant cooked: uncooked ratios across participants, it had 
the advantage of allowing us to directly compare food group intakes in absolute amounts 
(grams) between participants. 
 
6.2   Data analysis 
6.2.1   Small sample size 
In the proposal for 3CNAS, we assumed an enrollment rate of approximately 50% and a 
sample size of n=54 <18 years old and n=100 ≥18 years old. Despite the integration of several 
elements to improve study enrollment (e.g. recruiting from hospital telephone, 20 RMB travel 
reimbursement + 50 RMB mobile phone gift card + test results as an incentive for adults, and 
additionally a glucometer for adolescents), the final sample size was only n=10 <18 years old 
and n=90 ≥18 years old, for reasons discussed previously (Section 6.3) and summarized in 
Figure 6.2. Several implications of this small sample size for data analysis are discussed in 
detail in the sections that follow.  
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Figure 6.2   Participant flow in the 3C Nutrition Ancillary Study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3C Study 
n=867 
Beijing ≥12 yrs old 
n=443 
n=322 Shantou 
n=102 <12 years old 
Eligible for 3CNAS 
n=195 
Final 3CNAS Sample 
n=100 
n=38 refused, too busy 
n=18 refused, not interested 
n=16 refused, too far to travel 
n=23 dropped out 
n=233 no in-service phone number available  
n=7 no longer in Beijing 
n=8 ill or deceased since parent 3C Study 
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6.2.1.1   Implications for subgroup analyses within 3CNAS 
 The proposed data analysis plan for 3CNAS involved stratification of all results by age: 
<22 years versus ≥22 years. The age of 22 years was chosen as a cut-point after preliminary 
recruitment results indicated that it would be difficult to achieve an adequate sample size with a 
cut-point of 18 years, and because at the age of 22 years in China, young adults tend to move 
out of their parents’ house and transition into independent living; a very important period for 
diabetes self-management as responsibility shifts entirely to the patient with T1D. However, 
even with this new cut-point, the sample size was small for the younger age group: only n=14 
participants were <22 years old, hence, we did not stratify results by age. 
 Another important effect modifier of interest was insulin regimen because dietary 
recommendations for T1D management are specific to an individual’s insulin regimen and differ 
between flexible, basal-bolus regimens and fixed regimens.195 While we evaluated four insulin 
regimen categories (MDI: With basal, Pump, MDI: No basal, and 1-2 injections) for the analyses 
presented in Chapter 3, we combined “MDI: With basal” with “Pump” and “MDI: No basal” with 
“1-2 injections” to create two categories for Chapter 4 (Basal-bolus and Fixed) to improve 
power and interpretability of results (ISPAD nutrition recommendations, for example, focus on 
“conventional” or fixed insulin regimens versus basal-bolus including pumps).195 A larger sample 
size would have improved our ability to detect differences in effect across these important 
subgroups, and the fact that significant effects were observed despite the relatively small 
sample size suggests strong differences warranting further research.    
A specific example of insulin regimen as an effect modifier was explored as a sensitivity 
analysis to the dietary exposure-cardiometabolic risk factor outcome analyses presented in 
Chapter 5 (RRR). This particular sensitivity analysis was conducted because we hypothesized 
that participants with less intensive insulin regimens (e.g. 1-2 injections/day) may be more 
vigilant about following prescribed eating plans and more reliant on diet to control their diabetes, 
and therefore we may see a stronger association in these participants relative to participants on 
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more intensive insulin regimens (e.g. pumps). However, after excluding participants with 1-2 
injections/day, the bivariate associations between the food groups and health outcomes (HbA1c 
and LDL cholesterol) were the same except that the association between fish & shellfish and 
LDL cholesterol was no longer marginally significant (p=0.08 when all participants were 
included, p=0.21 after exclusion of participants on 1-2 injections/day). It was interesting that 
results remained after adjustment with only slight attenuation. This could be because 
participants with MDI but no basal were also relying heavily on diet (because we did not exclude 
all participants not using basal, only those on 1-2 injections/day without basal). Alternatively, it 
may indicate that being on a less intensive insulin regimen does not influence underlying diet-
disease relationships. Taking into account the totality of our 3CNAS analyses, we suspect that 
all participants regardless of insulin regimen are depending on diet more heavily than in high-
income countries such as the United States. Stratification by insulin regimen would have been a 
more appropriate method to answer this question than exclusion, but the limitation of a small 
sample size precluded our ability to conduct such an analysis.  
 
6.2.1.2   Implications for comparing 3CNAS to SEARCH for Diabetes in Youth 
Because of the differences in age distribution between the final 3CNAS sample and the 
SEARCH for Diabetes in Youth cohort study, we were not able to compare the dietary intakes of 
individuals with T1D in China with the dietary intakes of individuals with T1D in the United 
States as originally proposed. Results of such a comparison would not only improve our 
understanding of diabetes care in China relative to diabetes care in the United States, but also 
inform personalized chronic disease care for Asian Americans via integration of sociocultural 
context. The relatively small number of Asians with T1D in the United States precludes our 
ability to study this group: among T1D cases incident in 2002-2003 (n=1902 total) in SEARCH, 
only n=56 (2.9%) were Asian.242,243 Thus, this would have been an ideal context for developing 
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population-specific guidelines. Given that few other large cohort studies of T1D have dietary 
data (e.g. T1D Exchange), additional primary data collection may be needed before these 
important questions can be addressed. 
 
6.2.2   Selection bias  
The collapse of the commune-supported Cooperative Medical System in 1982 and the 
subsequent privatization of ‘barefoot doctors’ (a.k.a. ‘village doctors’) has created a substantial 
gap in access to care between urban and rural areas in China.244,245 Indeed, preliminary analysis 
of the 3C Study has revealed large urban-rural disparities in care with more urban areas 
experiencing improvements in SMBG and insulin regimens over the past 10 years while 
treatment remains substandard in more rural areas.125 This has important implications for the 
external validity or generalizability of our results, which are based on a largely urban sample 
and therefore may not be applicable to rural T1D populations. We attempted to address this 
limitation by expanding our in-person visits to include a hospital in Pinggu District at the extreme 
eastern end of Beijing, a more rural area. A total of n=16 participants living in Pinggu who 
previously declined to participate in 3CNAS because it was ‘too far to travel,’ agreed to 
participate when visits were held at the hospital in Pinggu. Combined with the n=3 participants 
living in Pinggu who agreed to travel to Peking University People’s Hospital (where all other 
visits were held), nearly 20% of our sample was from this relatively rural District of Beijing.  
In order to understand the degree to which our sample was comparable to participants 
that 1) were eligible and 2) refused to participate or dropped out, we conducted a sensitivity 
analysis, the results of which are presented in Table 6.1. Compared to participants who refused 
to participate or dropped out, our sample was older and more likely to be married or 
cohabitating (versus single, divorced, or widowed) (all p<0.05). Compared to Beijing 3C Study 
participants ≥12 years old who were not eligible due to not having a phone number in service, 
no longer living in Beijing, or being ill or deceased since the parent 3C Study, our sample was 
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older, more likely to be married or cohabitating, more likely to be retired or unemployed or never 
worked, less likely to be a student, and more urban (all p<0.05). 
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Table 6.1   External validity of 3C Nutrition Ancillary Study 
 
3CNAS 
n=100 
Refusals and 
Drop-outs
 1
 
n=95 
Not Eligible
 2
 
n=248 
P- 
value
 3
 
P- 
value
 4
 
Age (years) 40.1 (16.2) 32.0 (16.8) 26.3 (15.2) 0.001 <0.001 
Diabetes duration (years) 10.2 (9.7) 9.8 (10.4) 8.9 (10.3) 0.78 0.27 
Male  54 (54%) 41 (43%) 113 (46%) 0.13 0.15 
Residence  
     Urban 82 (85%) 74 (79%) 168 (69%) 0.30 0.003 
     Rural 15 (15%) 20 (21%) 77 (31%) 
Highest level of education 
     <University 32 (32%) 35 (37%) 104 (42%) 0.79 0.09 
     Junior University 16 (16%) 15 (16%) 47 (19%) 
     ≥University 51 (52%) 45 (47%) 95 (39%) 
Household income (RMB/month) 
     <3000 20 (20%) 27 (28%) 78 (31%) 0.05 0.18 
     3000 - <5000 23 (23%) 23 (24%) 48 (19%) 
     5000 - <10,000 30 (30%) 34 (36%) 69 (28%) 
     ≥10,000 27 (27%) 11 (12%) 53 (21%) 
Occupation 
     Worker (non-government) 31 (31%) 25 (27%) 64 (26%) 0.06 <0.001 
     Worker (government) 17 (17%) 13 (14%) 14 (6%) 
     Student  17 (17%) 33 (35%) 113 (46%) 
     Farmer 7 (7%) 5 (5%) 8 (3%) 
     Retired/unemployed 28 (28%) 17 (18%) 45 (18%) 
Marital status 
     Married/cohabitating 58 (60%) 40 (44%) 85 (34%) 0.02 <0.001 
     Single/divorced/widowed 38 (40%) 51 (56%) 163 (66%) 
Values are given as mean (SD) or n (%) 
1 
Eligible participants that refused to participate or dropped out before the in-person visit 
2 
3C Study participants residing in Beijing and ≥12 years old who were not eligible due to not having a phone 
number in service, no longer living in Beijing, or being ill or deceased since the parent 3C Study   
3 
Chi-square test (categorical variables) or ANOVA (continuous variables) comparing 3CNAS sample to Refusals 
and Drop-outs 
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4 
Chi-square test (categorical variables) or ANOVA (continuous variables) comparing 3CNAS sample to those 
Not Eligible
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6.2.3   Dietary pattern analysis 
Dietary pattern analysis is an emerging method used to capture holistic dietary 
exposures in nutritional epidemiology studies.210 Because dietary patterns allow nutrient 
interactions, some have argued that they better represent dietary intake and improve prediction 
of disease. Especially in the case of international studies, dietary patterns have the additional 
advantage that they do not rely on food composition databases, which assume that the nutrient 
composition of foods is constant and that the data provided by laboratory analyses are accurate 
and reflect current food composition.  
There are also several criticisms and limitations of dietary pattern analysis. Subjectivity 
can be introduced when, for example, in principal component analysis, one must decide the 
number of factors to retain and the criteria for retention (such as eigenvalue cut-points) and 
whether to use rotation (and if so, what type of rotation). Furthermore, it is difficult (and often 
impossible) to determine the underlying biological and physiological mechanisms responsible 
for the observed effects. This is an especially important challenge for RRR, the dietary pattern 
analysis technique used in 3CNAS, because the association observed with the biomarkers is 
the result of the specific combination of dietary factors, not any one dietary factor. This is where 
nutrient-based or food group-based analyses are useful for testing specific hypotheses relating 
to the contribution of certain dietary components to disease outcomes. 
There were several challenges specific to the RRR analysis used in 3CNAS discussed in 
detail in the sections that follow: 1) specification of predictor variables (food groups), 2) selection 
of predictor variables (food groups), and 3) selection of response variables (biomarkers).  
 
6.2.3.1   Specification of predictor variables 
 Most dietary pattern analyses are conducted in large cohort studies that used food 
frequency questionnaires to collect dietary data. However, we used 24-hour recalls to collect 
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dietary data. One important implication of this was that we had several food groups with very 
few consumers, and therefore the distribution of the food group intake in the sample was non-
normally distributed. To our knowledge, only one other dietary pattern analysis has encountered 
and addressed this problem, a study conducted using CHNS data.246  
The Pearson’s correlation matrix used in RRR was robust to modeling one binary and 
one continuous variable, though using a mixed set of predictors (e.g. binary and continuous 
food groups) would have been difficult as it would have required two different correlation 
matrices. With these considerations in mind, we decided to specify all of the predictor variables 
(food groups) as binary variables, keeping the response variables (biomarkers) continuous.  
Another important issue when specifying the predictor variables was adjustment for 
energy intake. Two approaches are generally used to adjust for energy intake in RRR: 1) 
specify food groups as energy densities or 2) calculate residuals.247,248 For continuous variables, 
the residuals are the amount consumed not explained by the variables included in the residual 
model (e.g. total energy intake), and for dichotomous variables, the residuals can be defined as 
the difference between the consumption predicted by the variables included in the residual 
model (e.g. total energy intake, and in some cases, other confounding variables) and the actual 
(0 or 1) consumption. The difficulty with the latter of these is that the resulting residuals are 
continuous, but their distribution is often closer to bimodal than normal.  
To verify this in our dataset, we used a series of logistic regression models to estimate 
the predicted probability of being a consumer of the food group (food groups with <80% 
consumers) or being a consumer above the median of the food group (food groups with ≥80% 
consumers) given energy (continuous, kcal/day), age (continuous, years), and income 
(categorical). The residuals were then calculated as the difference between the observed value 
for the food group (0 or 1) and the predicted probability (between 0 and 1) estimated by the 
logistic regression model. As predicted, the distribution of the residuals for all food groups was 
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bimodal (Figure 6.3). It was therefore determined that this approach would not work for RRR, 
which requires continuous predictor variables to be normally distributed.    
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Figure 6.3   Examples of bimodal distribution of residuals calculated for two food groups: a) rice and 
b) eggs 
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6.2.3.2   Selection of predictor variables 
Another challenge, also stemming from the small sample size, was reducing the number 
of predictors (food groups) because factor analysis requires a sample size of 10-30 per 
predictor variable, with the range primarily reflecting level of communality between predictor 
variables and number of factors to be determined.249 Overdetermined factors (e.g. factors that 
exhibit high loadings on at least 3-4 variables and simple structure) are a goal of factor analysis, 
particularly in this study as sample size may have less impact on the quality of results when 
factors are highly overdetermined.249  
Given our sample size of n=99 and n=2 factors (RRR produces as many factors as there 
are response variables), we could have, at the most, 10 predictor variables (food groups) and 
still meet these sample size considerations. We used a backwards elimination procedure to 
reduce the number of predictor variables. The food group that was explained the least by the 
dietary patterns was eliminated first and the RRR was re-fitted. This procedure was repeated 
until all food groups with <5% of their variance explained by the dietary patterns, and 
consequently those that did not load heavily (≥0.25) on either factor, were eliminated. Results 
were largely consistent compared to the full RRR model (20 predictors) with respect to food 
group loadings and associations with the response variables at this point (Table 6.2). 
Particularly for the first dietary pattern, results were robust: there was very little change in the 
factor loadings from 20 food groups to 9 food groups. The results for the second dietary pattern 
were different in that the sign (positive versus negative) of key food groups “flipped.” However, 
the direction of the associations with the response variables also “flipped,” thus the 
interpretation was consistent. There were a couple of minor differences for the second dietary 
pattern, namely that high-fat cakes and nuts & seeds loaded more heavily when food groups 
were eliminated, but these food groups were close to the cutpoint of 0.25 when 20 food groups 
were included.  
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Table 6.2   Factor loadings for food groups that loaded heavily (factor loading ≥0.25) on dietary patterns derived using reduced rank regression 
after backwards elimination of food groups 
  
All food 
groups 
(20) 
 Drop 
fungi 
(19) 
 Drop 
fungi + 
fruit  
(18) 
 Drop fungi 
+ fruit + 
veges (17) 
 Drop  
fungi +  
fruit + veges 
+ poultry  
(16) 
 Drop  
fungi + fruit 
+ veges + 
poultry + 
corn  
(15) 
 Drop  
fungi +  
fruit +  
veges + 
poultry + corn 
+ 
meat  
(14) 
Dietary Pattern 1 
     Negative loadings 
       High-fat cakes  -0.60  -0.61  -0.61  -0.61  -0.61  -0.61  -0.62 
       Wheat products  -0.44  -0.40  -0.40  -0.42  -0.42  -0.42  -0.42 
     Positive loadings 
       Pickles  0.34  0.31  0.32  0.33  0.33  0.33  0.33 
       Beans & products  0.31  0.32  0.32  0.32  0.32  0.32  0.32 
       Eggs  0.25  0.27  0.27  0.27  0.27  0.27  0.27 
Dietary Pattern 2 
     Negative loadings 
       Wheat products  -0.33  -0.38  -0.38  -0.37  -0.37  -0.38  -0.38 
       Rice  -0.25  -0.25  -0.25  -0.25  -0.25  -0.25  -0.26 
     Positive loadings 
       Low-calorie beverages  0.55  0.56  0.56  0.56  0.56  0.57  0.57 
       Fish & shellfish  0.44  0.45  0.45  0.45  0.46  0.46  0.46 
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Table 6.2   Continued 
 
Drop  
fungi + fruit +  
veges + poultry +  
corn + meat + 
tubers 
(13) 
Drop  
fungi + fruit +  
veges + poultry +  
corn + meat + 
tubers + 
dairy 
(12) 
Drop  
fungi + fruit +  
veges + poultry + 
corn + meat + 
tubers + 
dairy + 
fried foods 
(11) 
Drop  
fungi + fruit +  
veges + poultry + 
corn + meat + 
tubers + 
dairy + 
fried foods + 
fast food 
(10) 
Drop  
fungi + fruit +  
veges + poultry +  
corn + meat + 
tubers + 
dairy + 
fried foods + 
fast food + 
low-fat cakes 
(9) 
Dietary Pattern 1 
     Negative loadings 
       High-fat cakes -0.60 -0.59 -0.54 -0.55 -0.55 
       Wheat products -0.48 -0.51 -0.56 -0.57 -0.57 
     Positive loadings 
       Pickles 0.35 0.37 0.38 0.39 0.39 
       Beans & products 0.31 0.30 0.27 0.27 0.28 
       Eggs 0.25     
Dietary Pattern 2 
     Negative loadings 
       Wheat products -0.32 -0.27    
       Eggs  -0.26    
       Rice -0.25 -0.25    
       Teas & coffee   -0.54 -0.56 -0.57 
       Fish & shellfish   -0.41 -0.42 -0.43 
       High-fat cakes   -0.40 -0.40 -0.41 
       Nuts & seeds   -0.25 -0.26 -0.26 
     Positive loadings 
       Teas & coffee 0.57 0.57 0.56   
       Fish & shellfish 0.45 0.44 0.45   
       High-fat cakes 0.25 0.31    
       Eggs   0.30 0.30 0.31 
       Rice     0.25 
 
 107 
 
6.2.3.3   Selection of response variables 
Because of the small sample size (n=99 with biomarker data available), only two 
response variables could be selected. The number of response variables used throughout the 
RRR/dietary pattern literature varies from two250 up to seven.251 Prior to beginning the RRR 
analysis, all biomarkers assessed during the 3CNAS visit (e.g. HbA1c, HDL cholesterol, LDL 
cholesterol, total cholesterol, and triglycerides) were carefully considered for inclusion as 
response variables. By focusing on HbA1c and LDL cholesterol, we improved the translational 
potential of this analysis as these are two commonly measured biomarkers in clinical practice, 
and they are commonly reported throughout the scientific literature.  
HbA1c was chosen given unequivocal evidence from the DCCT that HbA1c is a strong 
predictor of future diabetes complications.70 Specifically, intensive glycemic control in the DCCT 
significantly decreased rates of microvascular (retinopathy and nephropathy) and neuropathic 
complications in patients with T1D.70 The relationship between HbA1c and CVD is less clear, 
but data from long-term follow-up of the DCCT cohort suggests that participants who were 
randomized to the intensive glycemic control arm had a lower risk of nonfatal myocardial 
infarction, stroke, and cardiovascular disease death compared to those in the standard arm.214  
LDL cholesterol was chosen because, according to the ADA Standards of Medical Care 
(2014), the first priority of dyslipidemia therapy in patients with T1D is to lower LDL cholesterol 
to <2.60 mmol/L.68 Furthermore, LDL cholesterol is a well established risk factor for 
cardiovascular disease and diabetes-related complications in individuals with T1D.212-219 While 
HDL cholesterol and triglycerides would have been interesting to explore, the ADA does not 
provide targets for these risk factors, except for severe hypertriglyceridemia (>11.2 mmol/L), for 
which it recommends immediate pharmacological therapy (fibric acid derivative, niacin, or fish 
oil).68 Finally, though BMI would have been an interesting response variable to evaluate, it was 
measured, on average, 1.6 years prior to dietary intake during the 3C Study visit. 
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CHAPTER 7:   IMPLICATIONS AND FUTURE DIRECTIONS 
 In 2006, T1D was proposed as a “tracer condition” for international benchmarking of 
healthcare systems, used to identify potential problems and to stimulate discussion about what 
can be done to address them.252,253 The reason for this is that optimal management of T1D 
requires surveillance, collaborative healthcare teams, access to essential medicines, education 
that promotes patient empowerment, and continuity of care,253 and these are also critical 
components of optimal management for other chronic diseases (e.g. HIV/AIDS, T2D, and 
hypertension). Therefore, in completing 3CNAS, not only were the specific aims addressed, but 
also valuable information was learned that can be used to inform research into health systems 
strengthening in China. This chapter will first discuss the substantial gap that remains in our 
understanding of the burden of T1D in China, and then describe the implications of 3CNAS in 
the larger context of improving care for T1D in China and translating observations to other low- 
and middle-income countries.  
 
7.1   Improving type 1 diabetes surveillance in China  
We do not know the current burden of T1D in China. The most recent T1D incidence 
rate reported in the IDF Diabetes Atlas for China is from the WHO DIAMOND project, conducted 
between 1990 and 1999.22 Not only is this estimate severely outdated, it only covers children 
<15 years of age.22 Given recent evidence suggesting that the peak age of onset of T1D may be 
10 years later in China compared to Caucasian populations,254 we suspect that previous 
estimates of incidence are significantly underestimating the population burden of T1D. 
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In addition, the incidence rate estimates from the WHO DIAMOND project varied from 0.1 cases 
per 100,000 person-years in Zunyi to 4.5 cases per 100,000 person-years in Wuhan, only 700 
miles away.100 Given that China is also largely ethnically homogenous (91.5% Han ethnicity),255 
this large range in incidence rates is somewhat unexpected and could be the result of variation 
in methodologies across sites or genetic heterogeneity in T1D susceptibility (e.g. HLA alleles) 
within the Han Chinese population. While studies have supported differences in susceptibility 
(e.g. prevalence of high-risk HLA alleles and association between HLA alleles and diabetes 
autoantibodies) between the Han Chinese population and Caucasian populations,256-258 there is 
limited research on differences within the Han Chinese population. 
To address this significant gap in knowledge, a National Type 1 Diabetes Registry 
project was started this year by researchers from the Guangdong Type 1 Diabetes Mellitus 
Translational Medicine Study and will include 10 cities across China. Modeled after the U.S.-
based SEARCH study,33 the Chinese Registry project should provide valuable information on 
the incidence of T1D in the years to come. Additional research on age of onset, presenting 
symptoms, and prevalence of insulin autoantibody positivity and HLA alleles will further improve 
our understanding of the etiology of T1D in the Chinese population. 
 
7.2   Improving type 1 diabetes care in China 
7.2.1   Summary of key 3CNAS results 
This is the first study to evaluate T1D self-management, including the integration of 
insulin regimen, SMBG, and dietary intake, in a low- or middle-income country. A key result was 
that diabetes education, particularly as relates to nutrition, is severely limited in China. Fewer 
than half of participants had “ever” met with a dietitian and only 18% had attended a diabetes 
education session in the past 12 months that covered nutrition. Nutrition therapy for T1D in this 
sample typically involved matching fixed insulin doses to a diet that was rigid with respect to 
amount and timing, rather than an individualized approach that allows a flexible insulin-dosing 
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regimen to match variable food intake, as recommended by the American and European 
Diabetes Associations. An effect of this self-management approach was that participants with 
T1D had a significantly lower mean percentage of energy from carbohydrates and higher mean 
percentage of energy from fat and protein compared to a similar cohort of individuals without 
diabetes. Several distinguishing characteristics of insulin regimen groups also emerged: when 
compared to individuals without diabetes, participants on fixed regimens tended to substitute 
wheat products for rice intake and restrict fruit, while those on basal-bolus regimens had 
healthier diets characterized by lower fried food intakes and higher fish & shellfish intakes. 
Finally, we identified a dietary pattern characterized by high intakes of wheat products and low-
sugar (high-fat) cakes, and low intakes of beans & bean products and pickled vegetables that 
was significantly associated with lower HbA1c and LDL cholesterol. Together, these results 
highlight an important need for nutrition counseling for individuals with T1D in China that is 
consistent with current clinical practice guidelines to promote health and reduce risk for both 
acute and chronic complications of diabetes.  
 
7.2.2   Gaps that remain in addressing 3CNAS specific aims 
The key limitation of 3CNAS that we were not able to overcome and that will need to be 
addressed in future research is generalizability (e.g. external validity). While we made every 
effort to enroll participants from a more rural district of Beijing (Pinggu), this area was still peri-
urban. Furthermore, we only enrolled participants from Beijing, and language, cultural norms, 
dietary intake, physical activity, and the prevalence of CVD risk factors (for example, blood 
pressure and obesity) differ significantly in northern versus southern China.259-262 Therefore, our 
results may not be generalizable to the entire Chinese T1D population, but only to the northern, 
urban Chinese T1D population. Future research should expand to include more rural and 
southern populations of individuals with T1D in China to determine if the lack of nutrition 
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education and carbohydrate counting is universal and if similar dietary patterns predictive of 
cardiometabolic risk are uncovered.  
Another gap that remains, which will require longitudinal data from a larger cohort of 
individuals with T1D to address, is the predictors of HbA1c in China. Bivariate analyses in our 
sample indicated that high intakes of low-sugar (high-fat) cakes were significantly associated 
with lower HbA1c. However, perhaps due to the cross-sectional study design, the small sample 
size, or limited variability in HbA1c, few other factors (e.g. insulin regimen, SMBG frequency, 
nutrition education, nutrition therapy, or other dietary factors) were consistently, statistically 
significantly associated with glycemic control. It is interesting that, despite having severely 
outdated self-management practices, the mean HbA1c of our sample (8.2 ±1.8%) was lower 
than that reported for the T1D Exchange in the United States (8.3 ±1.5%).263 Indeed, the HbA1c 
recently reported for a large sample of children and adults with T1D in Guangdong Province in 
southern China, 36.2% of whom were on 1-2 injections/day, was also similar to that reported in 
the United States (median, Q1-Q3: 8.4%, 7.0-10.2%).26  
One hypothesis explaining this observation may be that the later age at onset in the 
Chinese cohorts correlates with less rapid beta cell destruction, as has been seen in European 
cohorts.27,264 The median (25th percentile, 75th percentile) age of onset in our sample was 28.4 
years (17.9 years, 40.8 years). Alternative hypotheses may relate to the strict dietary 
management of T1D observed in Chinese patients, improved insulin sensitivity (a substantial 
proportion of individuals with T1D in the United States and Europe have insulin resistance),265-
268 genetics, or interactions between these factors. More research is needed to understand 
predictors of HbA1c in China. One study that may begin to answer these questions is the 30-
year Study, led by researchers at Peking University People’s Hospital and modeled after the 
Joslin 50-year Medalist Study.269,270 Extensive survey data and a blood sample for risk factor 
assessment and DNA analysis will be collected in approximately 100 patients in China who 
have had T1D for at least 30 years.  
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7.2.3   Next research questions 
The following section seeks to address the question: in addition to expanding 3CNAS to 
other sites throughout China and exploring predictors of HbA1c, what other research questions 
remain to be answered relating to T1D care in China? 
 
7.2.3.1   Improving training for healthcare providers  
We found that fewer than half of participants had “ever” met with a dietitian and only 
18% had attended a diabetes education session in the past 12 months that covered nutrition. 
Interestingly, 56% of participants who had been taught carbohydrate counting were taught by 
physicians while only 30% were taught by dietitians, 5% by diabetes educators, and 3% by 
nurses. Participants who had been taught carbohydrate counting by dietitians were nearly twice 
as likely to report sometimes using it (26%) compared to participants who had been taught by 
physicians (14%). Together, these results suggest that dietitians can be as effective as 
physicians at nutrition counseling, but are rarely part of the healthcare team. Furthermore, 
despite the fact that nutrition is a critical component of T1D self-management, it is rarely part of 
ongoing diabetes education.  Severely limited time with physicians in outpatient departments, an 
absence of certified diabetes educators, lack of dietitian involvement in care, and overall 
deficiencies in T1D nutrition therapy training are likely the main factors underlying these 
observations.  
To date, no studies have been published regarding the impact of physician education on 
process and patient outcomes for diabetes in China. However, a Cochrane review recently 
summarized the literature regarding the effect of continuing education meetings and workshops 
and found that educational meetings, particularly mixed interactive and didactic meetings, can 
improve professional practice, health outcomes, and simple behaviors.271 Specific to diabetes 
care, several studies have also supported positive effects of provider education. For example, 
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an intervention in Louisiana found that providing physicians with performance reports and 
scientific literature regarding the validity of HbA1c testing along with personal contact by a 
knowledgeable colleague regarding the importance of HbA1c testing significantly improved the 
frequency and values of HbA1c in patients with T2D.272 A short (7 hour), small group continuing 
education program in Canada significantly improved provider knowledge and self-reported 
practice relating to national clinical practice guidelines for diabetes, though the impact of the 
program declined after 1 year.273 Similarly, an intervention in an outpatient clinic in Texas 
consisting of two lectures and a quality assurance announcement at a staff meeting significantly 
improved compliance with foot examination recommendations for diabetes patients.274 Finally, a 
1-year intervention in South African physicians consisting of quarterly interactive training 
sessions significantly decreased the average number of clinic visits and increased the 
consultation times relative to the control group, though HbA1c did not differ significantly 
between groups.275  
A project is currently underway that will improve our understanding of the impact of 
physician education on process and patient outcomes for diabetes in China. CIDE is an 
innovative program started in 2010 to provide specialty training for 500 endocrinologists using a 
train-the-trainer approach.115 The program is taught by a collective faculty from the WHO 
International Diabetes Center, the Mayo Clinic, and the Chinese Diabetes Society, and is based 
on Staged Diabetes Management, developed by the Park Nicollet International Diabetes 
Center.276 Preliminary results presented at the World Diabetes Congress in December 2013 
showed significant improvements in healthcare provider diabetes knowledge pre- and post-
training (mean test score increased from 74% to 86%).115 Although the program briefly covers 
T1D, it is largely based on T2D and gestational diabetes. A T1D-specific curriculum 
emphasizing nutrition therapy is under development and will be implemented using existing 
CIDE infrastructure.  
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In addition to physician education, there is also scientific evidence to support the 
effectiveness of mid-level providers such as nurses in providing care for chronic diseases. A 
recent systematic review of 28 studies comparing the effectiveness of care provided by nurses 
to care provided by doctors in patients with chronic diseases found no significant differences in 
the need for a repeat consultation, improvements in physical functioning, attendance at follow-
up visits, or attendance at an emergency department after receiving care.277 Furthermore, they 
reported that dissatisfaction with care was significantly lower when care was provided by nurses 
compared to when care was provided by doctors.277 Specific to diabetes, the use of mid-level 
providers to cover an increased frequency of visits was associated with more successful weight 
loss among adults with pre-diabetes,278 and when mid-level providers led DSME in a study of 
youth with T1D in Pakistan, significant improvements in HbA1c were reported.279
 
 Along the lines of integrating mid-level providers into healthcare teams, a Gillings 
Innovative Labs proposal is being developed by a team of researchers at UNC, Chapel Hill in 
collaboration with Peking University People’s Hospital, with the aim of advancing collaborative 
care in China. The ultimate goal of the proposal is to identify ways to incorporate nutrition more 
effectively as part of T1D self-management and patient education in China. 
 
7.2.3.2   Stigma and psychosocial issues 
From my observations interacting with participants as part of 3CNAS and talking with 
physicians who regularly see patients with T1D in China, I hypothesize that the stigma 
associated with T1D in China underlies many of the psychosocial issues faced by patients; 
however, there is currently no data on this topic. Several small studies have reported the 
prevalence of depressive symptoms in youth with T1D in China,280-283 but only one was 
published in English, reporting a prevalence of 17.6% in Hunan Province.282  Given data from 
elsewhere in the world, we have reason to believe that the prevalence of depression in 
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individuals with T1D in China is substantially higher than the general population: a systematic 
review of studies conducted in the United States in Europe reported a pooled prevalence of 
clinical depression of 12.0% for individuals with T1D compared to 3.2% for controls.284 We do 
not know the prevalence of discrimination or diabetes-related distress in individuals with T1D in 
China. While the DAWN2 study collected data on psychological well-being, diabetes-related 
distress, diabetes empowerment, family support, and discrimination, only 16% of the sample 
had T1D and results were not published according to diabetes type.230  
Dr. Brock Chisholm, the first Director-General of the WHO, famously proposed the 
notion that there can be ‘no health without mental health.’285 This is especially true for diabetes 
as comorbid depression is associated with poor glycemic control (stronger in youth than adults), 
diabetes complications, increased healthcare costs, and early mortality.286 A significant barrier 
to improving T1D care in China is access to mental healthcare. There is a shortage of mental 
health professionals in China, particularly trained nurses and especially in under-developed 
western areas.287 In 2011, nationally, there were 1.53 psychiatrists per 100,000 population, 0.18 
psychologists per 100,000 population, and 2.65 psychiatric nurses per 100,000 population 
(compared to global averages of 1.27, 0.30, and 5.80, respectively).288 In additional to the 
challenge of limited personnel, the Chinese mental health system continues to focus on 
‘psychosis management’287 rather than mental wellbeing integrated into community health 
systems and multidisciplinary healthcare teams. As a result, the majority of mental healthcare is 
provided in psychiatric hospitals, and the government funding structure for mental health is still 
primarily based on psychiatric hospital beds rather than care received from personnel.287  
Data on discrimination and mental health among individuals with T1D in China is 
extremely limited. Addressing this issue will therefore require quantitative data on prevalence of 
experienced discrimination, depression, and other psychosocial outcomes, and qualitative data 
on acceptability of interventions (for example, peer-support groups). In regards to clinical T1D 
care, healthcare providers in China, particularly physicians, must begin to take a holistic rather 
 116 
 
than biomedical approach to disease management recognizing that the salience of stigma 
confounds disease management. Counseling on coping skills should be an integral component 
of care. Researchers can also play a role by expanding the scope of interventions to consider 
the psychosocial realities of T1D in China.  
 
7.2.3.3   Improving access to and use of glucose monitoring supplies 
 Several studies in the United States and Europe have found a significant correlation 
between increased frequency of SMBG and improved glycemic control (e.g. lower HbA1c), in all 
age groups and across insulin regimens (e.g. basal-bolus and fixed).263,289-292 In our sample of 
individuals with T1D in China, the frequency of SMBG was abysmal: 31% of participants 
reported testing <1 time per week or never. Given some evidence from the United States that 
patients tend to overestimate self-reported frequency of SMBG compared to meter-downloaded 
frequency of SMBG (by, on average, approximately 1 test/day) due to social desirability bias,263 
an even greater proportion of our participants may have fallen into this category of <1 time per 
week or never. In the United States, <1% of patients with T1D reported testing <1 time per 
day.263   
An example of the rarity of blood glucose testing in China was encountered in 3CNAS: 
as part of the standard protocol for a fasting blood draw in individuals with T1D, we did a finger-
prick blood glucose test at the beginning of the 3CNAS in-person visit. This blood glucose test 
was discussed in the written consent document, and several participants questioned the need 
for such a test during the consent process; testing was such a rare activity that it seemed odd to 
them to test prior to the blood draw. Indeed, very few participants had tested prior to coming to 
the in-person visit, after an overnight fast.  
The factors underlying this low frequency of SMBG in China have not been explored, but 
may relate to the fact that testing strips are expensive and not covered by insurance. Given that 
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SMBG is a critical component of flexible, basal-bolus self-management of T1D, barriers to 
SMBG will need to be addressed before patients can be advised to follow such regimens. A 
positive deviance analysis of individuals with T1D in China who do achieve recommended 
SMBG frequencies could be informative.  
 
7.3   Translating results to type 1 diabetes in other resource-limited settings 
3CNAS is unique relative to other T1D studies in that it evaluated individual-level self-
management approaches. There is very limited research on T1D care from other resource-
limited regions of the world and the vast majority has focused on access to insulin and cost of 
care.114,293-295 While insulin is the first priority for patients with T1D, it is not sufficient; there is a 
significant difference between access to medicine and access to treatment.296 We therefore 
started 3CNAS knowing very little about T1D care, and ended up learning much more than the 
originally proposed aims; this knowledge will be integral to framing research that follows, in 
China and around the world. 
In 2013, the IDF published a “Pocketbook for Management of Diabetes in Childhood and 
Adolescence in Under-resourced Countries.”297 The Pocketbook focuses on “survival education” 
such as management of DKA and initiation of insulin therapy, and provides detailed flow charts 
for both “Recommended Care” and “Limited Care.”297 Only one page of the 56-page document 
covers nutritional management; only one bullet covers approaches used to estimate 
carbohydrates.297 While hypoglycemia and management of complications are touched on in the 
Pocketbook, only limited guidance is provided and focuses on the components of a “Standard 
Screening Regimen.”297  As T1D care continues to improve in these settings and acute 
complications (e.g. DKA) are managed, the issues of preventing hypoglycemia and long-term 
complications (e.g. CVD and kidney disease) become increasingly important. An overview of 
this shift in focus of T1D care is provided in Figure 7.1. 
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Figure 7.1   Overview of basic needs for type 1 diabetes in resource-limited settings 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The IDF’s Life for a Child program, established in 2000, attempts to address many of 
these aspects of care and is currently providing assistance to over 14,000 children in 46 
countries, ranging from 1835 children in Bangladesh and 1424 in Pakistan to one child in Papua 
New Guinea.298 Diabetes centers established by Life for a Child aim to provide insulin (24.4% of 
direct funds), syringes (2.0% of direct funds), SMBG equipment (33.8% of direct funds), HbA1c 
testing (11.9% of direct funds), diabetes education (8.7% of direct funds), and technical support 
for health professionals (3.4% of direct funds).299 While these centers provide “comprehensive 
clinical feedback” according to the IDF’s website,298 no data on in-country diabetes care is 
published in the Annual Report for Life for a Child.300 In the Annual Report, the IDF estimates 
that “up to 80,000 children with diabetes are in need of assistance,”300 but do not define 
“assistance” or provide any information regarding how they came to that estimate. Clearly, there 
is a need for improved monitoring of this vast network of diabetes centers caring for individuals 
with T1D in low- and middle-income countries. 
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Other organizations involved in T1D care in resource-limited settings include Insulin for 
Life301 and the International Insulin Foundation,302 which developed the Rapid Assessment 
Protocol for Insulin Access (RAPIA),303 a multi-level assessment of healthcare systems 
designed to provide stakeholders (e.g. national Ministries of Health and Diabetes Associations) 
recommendations for action. Of note, RAPIA is now being field tested as a possible method for 
investigating access to care for all chronic diseases.304 The International Insulin Foundation has 
completed RAPIA assessments in seven countries (Vietnam, Philippines, Mali, Mozambique, 
Zambia, Nicaragua, and Kyrgyzstan).295,305-308 Similar to our study, RAPIA assessments in 
Vietnam and the Philippines found that patients had inadequate education due to several factors 
including lack of trained staff, lack of involvement of healthcare providers other than physicians, 
and lack of materials adapted to sociocultural context.305 By collecting individual-level data, our 
study was also able to evaluate associations of this inadequate education with self-management 
practices, diet, and glycemic control. These results will be informative as countries begin to 
focus attention not only on service delivery (e.g. RAPIA), but also the experiences of patients 
(e.g. 3CNAS).  
 
7.4   Concluding remarks  
It is clear from the limited literature discussed above that more data on current T1D care 
practices are urgently needed from low- and middle-income countries to inform country-specific 
guidelines, resource allocation, and future research. The key issues documented in individuals 
with T1D in China are not “T1D issues,” but rather chronic disease issues. Infrequent nutrition 
education provided largely by physicians with limited time rather than trained dietitians in 
conjunction with limited SMBG has resulted in a lack of empowerment to adapt disease self-
management practices to patient preferences and cultural norms. Individuals with T1D in China 
therefore adhere to strict dietary regimens, deviating from the dietary intakes of the general 
population in China. As the prevalence of chronic diseases, including T1D, increases in China 
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and other rapidly developing countries, use of mid-level providers such as dietitians in continued 
care and patient education to improve self-management practices will be essential to reduce 
healthcare costs and prevent morbidity and mortality. Looking ahead to the future, coordinated 
action by multiple stakeholders informed by scientific research will be required in order to 
produce meaningful improvements in the treatment of individuals with T1D in China and around 
the world, ultimately leading to better physical and emotional health outcomes. 
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